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Background: Evidence is required on the cost-effectiveness of alternative changes to the blood
collection service.
Objectives: (1) To estimate the cost-effectiveness of alternative minimum interdonation intervals between
whole-blood donations. (2) To investigate donors’ frequency of whole-blood donation according to
alternative changes to the blood collection service. (3) To estimate the cost-effectiveness of alternative
strategies for maintaining the supply of whole blood.
Methods: We undertook a within-trial cost-effectiveness analysis (CEA) of the INTERVAL trial, stated
preference (SP) surveys to elicit donor preferences and a CEA of different strategies for blood collection.
The strategies considered were reduced minimum intervals between whole-blood donations, introduction
of a donor health report and changes to appointment availability and opening times at blood collection
venues. The within-trial CEA included 44,863 donors, with men randomly assigned to 12- versus 10- versus
8-week interdonation intervals, and women to 16- versus 14- versus 12-week interdonation intervals. We
undertook a SP survey of non-INTERVAL donors (100,000 invitees). We asked donors to state the frequency
with which they would be willing to donate blood, according to the service attribute and level. The CEA
compared changes to the blood service with current practice by combining the survey estimates with
information from the NHS Blood and Transpant database (PULSE) and cost data. The target population was
existing whole-blood donors in England, of whom approximately 85% currently donate whole blood at
mobile (temporary) blood collection venues, with the remainder donating at static (permanent) blood
collection centres. We reported the effects of the alternative strategies on the number of whole-blood
donations, costs and cost-effectiveness.
Results: The reduced donation interval strategies had higher deferral rates caused by low haemoglobin (Hb),
but increased frequency of successful donation. For men in the 8- versus 12-week arm of the INTERVAL trial
[Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J, et al. Efficiency and safety of
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v
varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet
2017;390:2360–71], the Hb-related deferral rate was 5.7% per session versus 2.6% per session, but
the average number of donations over 2 years increased by 1.71 (95% confidence interval 1.60 to 1.80).
A total of 25,187 (25%) donors responded to the SP survey. For static donor centres, extending appointment
availability to weekday evenings or weekends, or reduced intervals between blood donations, increased stated
donation frequency by, on average, 0.5 donations per year. The CEA found that reducing the minimum
interval, extending opening times to weekday evenings and extending opening times to weekends in all
static donor centres would provide additional whole blood at a cost per additional unit of £10, £23 and £29,
respectively, with similar results for donors with high-demand blood types.
Limitations: The study did not consider the long-term rates at which donors will leave the donation
register, for example following higher rates of Hb-related deferral.
Conclusions: Extending opening hours for blood donation to weekday evenings or weekends for all static
donor centres are cost-effective ways of increasing the supply of high-demand blood types.
Future work: To monitor the effects of new strategies on long-term donation frequency.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
B lood transfusions are important in many aspects of NHS care, including general surgery and organtransplantation. Overall demand for blood is decreasing, and demand for particular blood types is
also growing. To increase the supply of high-demand blood, NHS Blood and Transplant is considering
potential service changes to encourage donors to give blood more often. The separate INTERVAL study
of 45,000 blood donors investigated the safety of donating blood more frequently than currently allowed.
This study looked at the costs of each potential service, and also surveyed 32,924 blood donors, to estimate
the impact on the amount of blood collected. The study used data from these surveys, the INTERVAL study
and donors’ current donation records, as well as cost information, to report which possible service changes
were best value for money.
Donors give blood at either a ‘static donor centre’ or a ‘mobile session’ (where blood is collected by a
team who travel around to different venues). The study found that donors at static donor centres would
donate more if centres were open on weekday evenings or at weekends, and this would be a relatively
cost-effective way of increasing the supply of blood that is in high demand. Giving donors a health report
(e.g. with measurements such as blood pressure or cholesterol) would not be cost-effective. Some donors
said that they would stop donating if changes to the blood collection service meant that they had to travel
for longer to donate blood.
Allowing donors to donate more often could increase the supply of blood in the short term. However,
more donors would be turned away from appointments because of low iron, which may lead them to stop
donating, and so it is unclear whether or not this would be a cost-effective way to increase the supply of
blood in the long term.
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Scientific summary
The NHS Blood and Transplant (NHSBT) service is an essential part of the health service in England andNorth Wales, and in 2015–16 it issued 1.594 million units of red cells at a production cost of approximately
£160M. The demand for the universal blood type [O negative (O–)], as well as A negative (A–), B negative (B–)
and other rare blood types that are more common in black and Asian minority ethnic (BAME) donors is
increasing. A major concern is ensuring that there is a sufficient supply of those blood types that are in relatively
high demand. The 2013–17 NHSBT Blood Donation Strategy recognised that, to encourage existing donors to
donate whole blood at the requisite frequency, changes to the blood collection service were needed to improve
the donor experience. To inform future blood service strategies and research priorities, evidence is therefore
required about the likely effects of changes to the blood service on the frequency and costs of whole-blood
donation. The INTERVAL trial [Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J,
et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL):a randomised trial of
45 000 donors. Lancet 2017;390:2360–71] will provide evidence on whether or not reducing the minimum
interval between whole-blood donations is safe and efficacious, but will not provide information on relative
cost-effectiveness.
The aim of our study [the Health Economics MOdelling of blood donation (HEMO) study] was to evaluate
the cost-effectiveness of alternative future changes to the blood collection service.
Objectives
The objectives of the study were to:
1. estimate the cost-effectiveness of alternative minimum interdonation intervals between
whole-blood donations
2. investigate the frequency with which donors are willing to donate whole blood according to alternative
future changes to the blood collection service
3. estimate the cost-effectiveness of alternative strategies for maintaining the supply of whole blood to
the NHS.
Methods
The HEMO study consisted of three interlinked components: a within-trial cost-effectiveness analysis (CEA)
of the INTERVAL trial strategies, stated preference (SP) surveys that elicited donor preferences and a CEA of
different strategies for changing the blood collection service. The strategies of interest included changes to
opening times and appointment availability at blood collection venues, the introduction of a donor health
report and reduced minimum intervals between whole-blood donations. The overall target population
was existing whole-blood donors in England, of whom approximately 85% currently donate whole blood
at mobile (temporary) blood collection venues, with the remainder donating at static (permanent) blood
collection centres. The study took a Health and Personal Social Services perspective to cost measurement.
The costs measured were those anticipated to differ according to strategy, and included additional collection
and staff costs, but not processing, marketing or fixed costs. The results were reported overall and according
to subgroups, in particular donors whose blood type was defined as ‘high’ (O–, A– and B–) versus ‘standard’
demand, ethnicity and age group. The NHSBT and blood donors helped define the strategies of interest,
design the SP surveys and interpret the findings.
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Trial-based cost-effectiveness analysis of reduced minimum intervals using the
INTERVAL trial
The CEA used data from the INTERVAL trial to report the cost-effectiveness of reducing the minimum
interval between whole-blood donations. The INTERVAL trial included 45,263 whole-blood donors
(22,466 men and 22,797 women). Male participants were randomly assigned to 12- versus 10- versus
8-week interdonation intervals, and female participants to 16- versus 14- versus 12-week interdonation
intervals. The CEA excluded donors who withdrew consent for use of their data (n = 221), died during or
after the trial follow-up period (n = 142), or who did not have requisite PULSE (the NHSBT national blood
supply database) data available (n = 37), leaving an overall sample of 44,863 donors.
The CEA used information on the number of whole-blood donations, deferrals (temporary suspension from
donating blood), including those caused by low haemoglobin (Hb), and donors’ health-related quality of life
(QoL) assessed by the Short-Form 6D utility score, all measured over 2 years. The cost analysis combined
resource use measures, such as the number of deferrals and donations, with unit costs, mainly taken from
NHSBT financial records. We report the incremental cost-effectiveness of the reduced interval strategies,
according to the incremental (difference in means) cost per additional unit of whole blood donated.
Stated preference surveys to predict frequency of whole-blood donation
The HEMO study undertook two SP surveys designed to elicit donor preferences for alternative future
changes to the blood collection service and to predict the effects of these future changes on the annual
frequency of whole-blood donation. The choice of policy-relevant attributes for the surveys was informed
by a rapid literature review, qualitative research with blood donors, input from NHSBT policy-makers and a
pilot study (5016 invitees, 25% response rate). The chosen attributes were travel time to the venue, blood
collection venue opening hours, appointment availability, provision of a health report and the maximum
number of annual whole-blood donations. Donors were asked to state the frequency with which they
would be willing to donate blood according to the alternative attributes and levels in the survey.
The survey had a full factorial design, and 100,000 donors not included in the INTERVAL trial were invited
to take part (non-INTERVAL survey). Donors were considered for inclusion according to the following
criteria: 17–70 years old, donation of at least one unit of whole blood in the past 12 months, e-mail
address held by the NHSBT and resident in mainland England. We repeated the same SP survey with the
eligible ex-INTERVAL participants, as these donors had experienced donation at a static centre during the
trial (n = 28,732). The HEMO study also compared the donation frequencies predicted from the survey
responses with those observed in the PULSE database.
Cost-effectiveness analysis of alternative strategies
The CEA used estimates from the SP surveys on the relative frequency with which donors were predicted
to donate according to proposed changes to the blood service. The CEA also used information from the
PULSE donor database on the absolute levels of donation frequency for the target population of interest,
and according to the characteristics of the blood service experienced by the target population at their
previous donation visit. The CEA incorporated evidence from the INTERVAL trial on the rates of deferral
per attendance to predict the annual frequency of successful donation for each strategy. We calculated
the effects of the alternative strategies on the number of whole-blood donations and the relevant costs of
blood collection over 1 year. The CEA reported the additional costs per extra unit of whole blood donated.
The sensitivity analysis considered whether or not the results were robust to alternative assumptions,
including whether or not additional staff time was required in static donor centres for collecting additional
units of blood.
SCIENTIFIC SUMMARY
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Results
The CEA of the INTERVAL trial strategies found that the average Hb deferral rate was higher following
the introduction of shorter minimum donation interval strategies; for men the rate was 5.7% per session
attended in the 8-week arm compared with 2.6% in the 12-week arm, and for women the corresponding
rates were 7.9% (12-week arm) and 5.1% (16-week arm). For men, the average number of whole-blood
donations increased by 1.71 [95% confidence interval (CI) 1.60 to 1.80] for the 8- versus the 12-week
interval arm, and by 0.79 (95% CI 0.70 to 0.88) for the 10- versus the 12-week interval arm (over 2 years).
For women, the corresponding increase in the average number of donations was 0.85 (95% CI 0.78 to 0.92)
for the 12- versus the 16-week interval. Donors’ QoL was similar across arms for all time points. The shorter
interval strategies led to an increase in the average number of donations, at a small additional average cost,
compared with current practice. For example, the incremental cost-effectiveness ratios (ICERs) were £9.51
(95% CI £9.33 to £9.69) and £10.17 (95% CI £9.80 to £10.54) for the 8- versus the 12-week interval arm
for men, and the 12- versus the 16-week interval arm for women, respectively. These findings were similar
across donor subgroups, including for donors with high-demand blood types.
A total of 25,187 (25%) donors in the non-INTERVAL sample and 9318 (32.4%) in the ex-INTERVAL
sample responded to the SP survey. The analysis of the survey responses provided plausible estimates
of the effects of alternative future changes to the blood collection service on the stated frequency of
whole-blood donation. The results were generally similar for the non-INTERVAL and ex-INTERVAL surveys,
and by donor subgroups. The results showed that, for static donor centres, extending appointment
availability to weekday evenings or weekends, or reducing the minimum interval between whole-blood
donations, would increase the stated frequency of blood donation by on average 0.5 donations per year.
The introduction of the donor health report had a relatively small effect on the predicted frequency of
donation (about 0.2 extra donations per year). Switching mobile sessions from weekdays to weekends,
while maintaining current levels of appointment availability, led to a small average increase in the
predicted donation frequency (about 0.1 extra donations per year).
The survey found that, if travel time was increased by 30 minutes, the proportion of donors who said that
they would ‘probably not donate’ was between 23% and 86% (according to donor subgroup). This effect
was greater for those subgroups of donors who were younger or less experienced (1–4 donations in the
last 5 years) or who donated less frequently in the 12 months prior to the survey, or BAME donors who
responded to the ex-INTERVAL survey.
For men, the average annual frequency of donations predicted from the survey responses was moderately
higher (+20%) than their observed donation frequency recorded on the PULSE register. For women, the
corresponding discrepancy was minimal, and, for both sexes, this discrepancy was similar across subgroups.
The CEA found that the strategies of extending opening times to weekday evenings or weekends in all
static donor centres would provide additional units of whole blood at a cost per additional unit of £23 or
£29, respectively. This finding was similar for the subgroup of donors whose blood type is in high demand.
The introduction of a health report was less cost-effective [£130–140 per additional unit collected (across
all subgroups)]. Reducing the minimum interval between donations to the shortest minimum interval
considered in the INTERVAL trial had a relatively low cost per additional unit of whole blood collected
[£10–20 per unit of blood donated (across all subgroups)]. These findings were robust to alternative
assumptions, in particular the choice of data for predicting donation frequency (either survey or INTERVAL
trial) and assumptions about the level of unit costs implied by different capacity constraints.
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Limitations
The time horizon for the main CEA was 1 year, and so the long-term effects of the alternative strategies
on the rate and costs of donors leaving the donation register were not considered. The study excluded
any additional costs to donors, for example from time off work or increased travel time. The study did not
evaluate all the strategies of potential interest to the NHSBT, such as expanding the number of static donor
collection centres or closing/merging mobile sessions.
Conclusions
The HEMO study found that donors are willing to donate whole blood more often than they do currently,
but the magnitude of the predicted increase differs according to the proposed change to the blood
collection service. Those donors attending static donor centres would strongly prefer more opportunities to
donate during weekday evenings or at weekends. Extending opening hours for blood donation to weekday
evenings or to the weekends for all static donor centres is a relatively cost-effective way of increasing the
blood supply for donors whose blood type is in high demand. Reducing the minimum interdonation interval
could also provide additional whole blood at a small additional cost in the short term, but, as the INTERVAL
trial showed, this would increase rates of Hb-related deferrals over 2 years. As increasing deferrals may
lead to reduced donor retention, which implies higher future costs beyond those considered, it is unclear
whether or not reducing the minimum interval between donations will be cost-effective in the long term.
The HEMO study found that neither moving mobile sessions to the weekends nor providing a donor health
report at each donation visit led to sufficient increases in the frequency of whole-blood donations to justify
the additional costs. Our surveys also found that requiring donors to travel further to donate whole blood
discouraged donors from donating, particularly younger, less experienced and BAME donors, who are
among those subgroups most important to retain. Hence, if the NHSBT continues to close mobile sessions
and increase travel time for donors, it may be important to adopt strategies that lead to other improvements
in the donation experience for these particular donor subgroups.
Future work
1. If any of these strategies are implemented, it will be important to monitor the preferences and donation
frequency for different donor subgroups, and in alternative settings. Such an evaluation could build on
the research framework presented here, and consider the costs and consequences of scaling up the
strategy, in real time, by using large-scale surveys of preferences, calibrated to actual donation behaviour
as recorded in the PULSE registry.
2. Further research is required to investigate the clinical effectiveness and cost-effectiveness of tailoring
opportunities to donate blood according to the preferences of particular donor subgroups. There is a
particular requirement to understand the preferences of BAME donors, as their blood is in high demand
and only a relatively small sample of these donors were surveyed in the HEMO study.
3. Improved understanding of how to predict which donors are likely to have Hb-related deferrals would
allow the stratification of the donor population by likelihood of deferral. This could allow increased
blood collection using shorter interdonation intervals for a defined subpopulation of donors whose
blood type is in high demand.
4. Further research is warranted on evaluating novel marketing strategies to encourage the recruitment of
particular subgroups of new donors (blood type O–, BAME, younger donors), to ensure the required
mix of blood donors to sustain the future blood supply.
SCIENTIFIC SUMMARY
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Chapter 1 Background, aims and objectives
Whole-blood donors provide around 110 million donations worldwide for transfusions used in themanagement of general surgery and severe trauma, high-dose chemotherapy regimens, and stem
cell and organ transplantation.1,2 The NHS Blood and Transplant (NHSBT) service is an essential part of the
health service in England, and in 2015–16 issued 1.594 million units of red cells at a production cost
of approximately £160M.3 The overall demand for red blood cells for the NHS has fallen by about 17%
since 2004–5, due partly to advances in technology and education of health-care professionals, which
have reduced red cell use per surgical procedure.3 The NHSBT has managed the required reduction in the
overall supply of whole blood; between 2012 and 2016 the number of registered whole-blood donors fell
by around 15%4 (C Wickenden, NHSBT, 2016, personal correspondence). There is interest in identifying
cost-effective changes to blood collection services that can be implemented in mobile (temporary) blood
collection venues, where around 85% of whole-blood donors currently donate in England, but also at
static (permanent) blood collection centres. A future challenge for NHSBT is to maintain the requisite
supply of whole blood not just overall, but according to particular donor subgroups.
Demand for some blood types, in particular O negative (O–) (the universal blood type), A negative (A–),
B negative (B–) and other rare blood types more common in black and Asian minority ethnic (BAME) donors,
is increasing. A major concern is to ensure sufficient supply of those blood types that are in relatively
high demand, and there may be times when increased stocks are required to meet higher demand. The
O– blood type is essential for those transfusions required by emergency trauma patients if blood types are
unmatched, and demand for this blood type accounts for around 13% of all hospital requests.5 However,
only around 7% of the donor population are blood type O–, and so the NHSBT encourages these donors
to donate blood more often. A further concern is that patients with genetic blood disorders such as sickle
cell disease and thalassaemia disease require multiple transfusions with extensively matched blood to reduce
adverse reactions. These transfusions require blood subtypes, such as Ro, which are relatively prevalent in
donors from BAME ethnic groups, but BAME donors represent only 5% of the overall donor population.
If the required blood types are unavailable, O– blood is used instead, further increasing demand for this blood
type. Hence, a key policy objective for the NHSBT is to collect more blood from BAME groups and those with
high-demand blood types such as O–.3
The NHSBT could increase investment in marketing strategies to attract new donors, but finding and
retaining donors is costly, and it is more efficient to increase donation frequency among existing donors,
in particular those whose blood type is in high demand.6
A key challenge for the blood service is therefore to develop strategies that can increase the frequency of
donation from those donors whose blood type is in relatively high demand, at low additional cost. A central
pillar of the 2013–17 Blood Donation Strategy4 is to improve the experience of the 1.3 million registered
voluntary blood donors to help encourage existing donors to donate whole blood at the requisite frequency.
The NHSBT has invested in strategies to improve the donation experience; for example, donors can book
appointments online, the 24 static donor centres across England offer free Wi-Fi, and the NHSBT sends text
messages to remind donors about their appointment and then to say when and where the donation has
been used. However, it is unclear whether or not these and other future changes to the blood service are
clinically effective or cost-effective.
The NHSBT surveys donors to help understand which aspects of the donor experience warrant improvement,
but it does not elicit donor preferences using the formal techniques that are required to recognise any
trade-offs between the different aspects of the service (e.g. additional travel time to a donor centre vs.
improved appointment availability). Hence, these surveys do not provide an adequate basis for predicting
the effects of potential service changes on the frequency of whole-blood donation. More generally, there is
little evidence on donors’ relative preferences for alternative types of blood donation service.7–12 The extant
literature suggests that donors prefer shorter waiting times before whole-blood donation and convenient
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locations,13,14 and that non-monetary incentives are more effective than monetary incentives for encouraging
blood donation.15–17 None of these studies have used appropriate formal techniques for preference elicitation,
evaluated strategies of direct relevance to the NHSBT or considered subgroups of current policy relevance,
such as donors whose blood type is in high demand, BAME donors or those donor subgroups who are less
likely to continue donating (younger or less experienced donors).
Economic evaluations of alternative ways of organising the blood service are required, ones that recognise
that donation frequency will be driven by donors’ experiences of, and preferences for, alternative features
of a blood donation service. Such studies are also required to recognise that donors’ relative preferences
for alternative strategies may differ according to the individuals’ characteristics and constraints. There is
limited evidence on the costs and cost-effectiveness of alternative ways of organising the blood donation
service.18–28 Previous studies have estimated the effect of previous policy changes on the volume and
costs of whole blood collected,18–28 and predicted the efficient location and staffing for static donor
centres.19,29–31 None of these studies estimated the cost-effectiveness of possible changes to the blood
donation service that are of direct relevance to future NHSBT strategies, nor have they recognised donors’
relative preferences for alternative changes to the blood service.
A strategy of potential interest to the NHSBT is to invite existing whole-blood donors to donate blood more
often, particularly those donors whose blood type is in high demand. In England, the minimum donation
interval is currently 12 weeks for men and 16 weeks for women.32 It is currently unknown if reducing the
minimum interdonation interval is clinically effective or cost-effective.33 Shorter recall intervals may lead to an
increased risk of iron deficiency, higher rates of donation deferral (temporary suspension of donors giving
blood) and lower health-related quality of life (QoL) for donors.34–36 Increased rates of deferral may lead to
higher costs and encourage donors to leave the register.37,38 International variations in blood service policy
reflect this uncertainty about the optimum minimum interdonation interval. For example, the minimum
intervals between blood donations are every 8 weeks (both sexes) in the USA,39 and every 8 (men) and
12 weeks (women) in France and Germany.40,41 The INTERVAL trial was designed to establish whether or not
reducing the minimum recall interval for donors attending static donor centres in England would increase the
frequency of whole-blood donation while maintaining donor health.42 However, the INTERVAL trial alone will
not provide sufficient evidence to inform whether or not the NHSBT should reduce the minimum donation
interval. In particular, research is also required on the relative costs and cost-effectiveness of reducing the
minimum donation interval, in particular for subgroups of prime policy relevance.
Aims and objectives
The study’s aim is to identify cost-effective strategies for maintaining the blood supply. The study estimates
the relative cost-effectiveness of alternative minimum interdonation intervals (12 vs. 10 vs. 8 weeks for
men; 16 vs. 12 vs. 10 weeks for women). The study adopts formal methods to elicit preferences from
donors using stated preference (SP) surveys to estimate the frequency at which they are willing to donate
whole blood according to alternative potential changes to the blood donation service. We use these
estimates from the surveys along with observed data on deferral rates from the INTERVAL trial to report
the relative cost-effectiveness of alternative strategies overall, and particularly for subgroups of prime
policy relevance, for example donors whose blood type is in high demand and BAME donors.
Objectives
1. To estimate the cost-effectiveness of alternative minimum donation intervals between whole-blood
donations.
2. To investigate the frequency at which donors are willing to donate whole blood according to alternative
hypothetical changes to the blood donation service.
3. To estimate the cost-effectiveness of alternative strategies for maintaining the supply of whole blood to
the NHS.
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Report overview
This report details the three interlinked components of the study. Chapter 2 describes the use of the
INTERVAL trial data to report the relative cost-effectiveness of alternative minimum donation intervals over
2 years. Chapter 3 reports the design, and results, of SP surveys that provide estimates of the frequency
at which donors are willing to donate whole blood according to alternative future changes to the blood
donation service. Chapter 4 estimates the cost-effectiveness of alternative strategies for maintaining the
blood supply, drawing on findings from the surveys and the analyses of the INTERVAL trial. The design,
analysis and interpretation of each component of the research have been informed by the key service
provider (NHSBT), a public representative and current whole-blood donors.
At the design stage, we identified strategies to improve opportunities for existing blood donors to donate.
The strategies were identified through a review of NHSBT documents describing future strategies and
policies, the results of market research, an informal review of relevant published literature, consultation
with NHSBT colleagues and insights from preliminary qualitative research undertaken with INTERVAL
donors (see Appendix 1).
The following strategies were chosen for the evaluation presented in this report:
(a) provision of a health report, including cholesterol and blood pressure tests, for all donors at each
whole-blood donation visit9,43–45
(b) extended opening hours (weekend or evening), for both static donor centres and mobile sessions for
collecting whole blood
(c) increase in the maximum number of whole-blood donations per year for current donors attending
static donor centres, as per the INTERVAL trial.
Changes since the proposal
There were three main changes made to the research originally proposed. First, the cost-effectiveness
analysis focused on alternative strategies for current whole-blood donors and did not consider alternative
strategies for the recruitment of new donors. The NHSBT suggested that an evaluation of the effect of
alternative strategies for pre-existing whole-blood donors would provide more relevant evidence to inform
future strategy. Second, the approach taken to elicit donor preferences for alternative changes to the
blood donation service was to undertake SP surveys rather than a discrete choice experiment (DCE).46
The SP survey design was chosen as, unlike a DCE, it could capture respondents’ stated intentions
regarding frequency of donation. Third, the time horizon chosen for the cost-effectiveness analysis was
1 year, rather than the 10 years originally proposed. This choice of time horizon was in accordance with
NHSBT’s requirements, which, given the uncertainties about the future demand for red blood cells in
the medium term, were to consider the shorter-term effects of the alternative strategies. Each of these
changes was discussed and agreed with the project advisory group.
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Chapter 2 Cost-effectiveness analysis of
alternative minimum recall intervals between
whole-blood donations
Introduction
This chapter will address the question, ‘what is the cost-effectiveness of reducing the minimum interval
between whole-blood donations?’. This economic evaluation compares the costs and consequences of
the alternative minimum donation intervals considered in the INTERVAL trial. Full details of the INTERVAL
trial are provided elsewhere;42,47,48 here we focus on the essential elements of the cost-effectiveness
analysis (CEA). The study followed the main principles set out in the INTERVAL trial protocol42 and
statistical analysis plan. In particular, the study contrasted the costs and consequences of the alternative
randomised arms in INTERVAL according to the intention-to-treat principle.49 The main time horizon was
2 years, as per the follow-up period of the INTERVAL trial. We estimated the effect of randomisation to
alternative minimum recall donation intervals on the mean number of successful whole-blood donations,
overall donation deferrals, donation deferrals caused by low haemoglobin (Hb), quality of life (QoL) and
cost. The study measured costs from the NHS and Personal Social Services perspectives as recommended
by the National Institute for Health and Care Excellence.50 The costs included were those costs of the blood
donation visit that were anticipated to differ over the trial follow-up period and according to strategy,
and included the relevant costs of blood collection but excluded processing costs or fixed costs. The cost
analysis also included the costs of deferrals and any subsequent health-care costs of those deferrals that
were caused by low levels of Hb.
Methods outlines the main features of the INTERVAL trial and the methods used in the CEA. Results
summarises the main results, and Discussion discusses the main findings, and outlines how they will
inform the subsequent CEA of alternative strategies for maintaining the blood supply beyond reducing
the minimum interval between blood donations.
Methods
INTERVAL trial overview
The INTERVAL trial was an open, parallel-group pragmatic randomised controlled trial (RCT) that included a
total of 45,263 whole-blood donors (men, n = 22,466; women, n = 22,797) at 25 static donor centres
in England. Participants were recruited from June 2012 to June 2014. Male participants were randomly
assigned to 12- versus 10- versus 8-week interdonation intervals. Female participants were randomly assigned
to 16- versus 14- versus 12-week interdonation intervals. The primary trial end point was the number of
whole-blood donations obtained secondary outcomes included measures of donors’ health, including the
Short Form questionnaire-36 items (SF-36) health survey and the number of deferrals, both measured over
2 years’ follow-up.
Selection and recruitment of participants, and exclusions from the
cost-effectiveness analysis
Donors were eligible for inclusion in the trial if they were aged ≥ 18 years, met the routine criteria for
whole-blood donation, were willing to be randomised, had an e-mail address and access to the internet
(required to provide baseline and follow-up information), were willing to donate whole blood at a static
centre, and returned the baseline questionnaire. Donors already registered at static donor centres, specific
subgroups of donors attending mobile sessions who were willing to donate at a static centre for the
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duration of the trial, and new donors were all considered for inclusion. Those donors who were eligible
to take part in the trial, and who consented, were randomised to the three sex-specific intervention groups
in a 1 : 1 : 1 ratio. The CEA excluded those donors who withdrew consent for use of their data (n = 221),
who died during or after the trial follow-up period (n = 142) until December 2016, when linked NHSBT
national blood supply database (PULSE) data were extracted, or who did not have requisite PULSE data
available (n = 37), leaving an overall sample for the CEA of 44,863. This is outlined in Figure 1.
Baseline measures including variables for subgroup analysis
Information on donors’ baseline characteristics and their donation history for the 2 years prior to randomisation
was extracted from the NHSBT national blood supply database, PULSE. The baseline measures included
the donors’ sex, age, ethnicity, blood type, whether or not the donor was new, their recruitment source
(donor centre, mobile session, no invitation), and their number of donations and deferrals for low levels of
Hb in the previous 2 years. At the baseline donation visit, a full blood count was provided the levels of Hb
used to define the proportion of low-Hb deferrals who would require additional consultations and tests.
Following this visit, participants were asked to complete the online baseline questionnaire, which included
the SF-36 questionnaire. At this point, participants provided their weight and were randomised.
Measurement of resource use and consequences
For each randomised donor, the numbers of successful whole-blood donations, deferrals and fainting
episodes at a blood donation session over the 2-year follow-up period were extracted from the PULSE
database. The volume of blood donated was measured in units of whole blood (each unit is 470 ml).
The number of deferrals was recorded, and each deferral was categorised by whether or not it was
caused by low levels of Hb, which were anticipated, could differ by randomised arm and have resource
consequences (e.g. additional staff time and additional Hb screening tests). The deferral policy used in
the trial was the same as in routine practice; for example, donors with Hb levels that were ‘low’, that is
< 134 g/l for men and < 124 g/l for women, were deferred for 3 months. The number of deferrals for
other reasons (travel, medication, lifestyle restrictions or infection/illness) was also recorded.
Participants were requested by e-mail to complete an online questionnaire, which included the Short
Form questionnaire-12 items (SF-12), at the 6-, 12- and 18-month follow-ups, and the SF-36 at the final
2-year follow-up time point. We extracted responses to those questions required to report the Short Form
questionnaire-6 Dimensions (SF-6D) utilities, and combined these with the published valuation algorithm51
to report SF-6D utility scores at each time point, anchored on the scale 0 (death) and 1 (perfect health).
Data of relevance to resource use were also collected as part of the web-based follow-up questionnaires,
including the number of health-care events occurring between donation sessions (doctor or hospital visits
required for falls, transport accidents, angina, heart failure, transient ischaemic attack, stroke, myocardial
infarction). Although the numbers of these events were reported, they were not anticipated to differ
between the randomised arms, and so the ensuing costs were not included in the cost analysis.
Units costs
The unit costs related to blood collection were taken from NHSBT financial records in 2016–17 prices
(Laura Hontoria Del Hoyo, NHSBT, June 2016, personal communication; Colin Jackson, NHSBT, April 2017,
personal communication). We used expert opinions to estimate the opportunity cost of additional staff
time required following a deferred appointment caused by low levels of Hb, and for other reasons. As per
NHSBT routine policy, if the donor’s Hb level was ‘very low’, defined as < 125 g/l (men) and < 115 g/l
(women), subsequent tests and consultation with a health-care professional were assumed to be required.
We used data on participating donors’ Hb levels and ensuing deferrals at their baseline visit to calculate
the proportion of low-Hb deferrals where the Hb levels were ‘very low’, and assumed that for this subset
of low-Hb deferrals subsequent monitoring would be required. We then applied this proportion (7% of
low-Hb deferrals) to calculate the unit costs of all deferrals from low levels of Hb (£10.17, outlined in
Table 1).
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7413 (99.0%)7417 (99.1%) 7411 (98.9%) 7549 (99.3%) 7528 (99.1%)7545 (99.2%)
4747 (63.4%)4701 (62.8%) 4746 (63.4%) 4506 (59.3%) 4444 (58.5%)4486 (59.0%)
Units of blood
(n = 44,863; 99%)
INTERVAL trial
45,263 participants
Women randomised
(n = 22,797)
Men randomised
(n = 22,466)
10 weeks 
(n = 7490)
8 weeks
(n = 7485)
12 weeks
(n = 7491)
12 weeks
(n = 7600)
16 weeks
(n = 7598)
14 weeks
(n = 7599)
All participants
(n = 45,263)
41 (0.5%)29 (0.4%) 39 (0.5%) 32 (0.4%) 48 (0.6%)32 (0.4%)
Withdrawn, no further use
(n = 221)
29 (0.0%)36 (0.5%) 36 (0.5%) 14 (0.2%) 12 (0.2%)13 (0.2%)
Withdrawn, death
(n = 140)
O
u
t
c
o
m
e
s
 
SF-6D – complete
responses at 24 months
(n = 27,630; 61%)
7 (0.1%)3 (0.0%) 5 (0.1%) 5 (0.1%) 10 (0.1%)9 (0.1%)
Withdrawn, no PULSE data
(n = 39)
FIGURE 1 The CONSORT flow chart: participation, exclusions and completeness of main CEA (adapted from Di Angelantonio et al.47).
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The frequency of donation visits within the trial follow-up period could reflect trial protocols, including the
intensity of donation appointment reminders; we therefore calculated unit costs for issuing study-specific
attendance reminders. We used information collated by the trial co-ordinator to calculate the staff time,
consumables and, therefore, the unit costs required to issue reminders to donate, according to the
three-stage reminder process specified by the INTERVAL trial protocols (see Table 1 and Appendix 2).
The number of reminder calls and e-mails made to participants without an appointment was not recorded,
and so the requisite unit cost was calculated by dividing the total cost of these reminders by the total
number of trial participants. We then applied a constant unit cost of reminders for those without an
appointment across all trial arms. The number of times a donor did not attend a scheduled appointment
were not measured, and so the ensuing costs were not included in the base-case analysis (see Sensitivity
analysis). The unit costs of a fainting episode were calculated according to the additional staff time
required at a donor centre to manage a typical fainting episode.
We combined resource use data from each INTERVAL participant with these unit costs to report the costs
for each randomised donor over the trial’s 2-year follow-up period. We then calculated the average total
costs per donor over 2 years.
Descriptive statistics, reporting of results and analysis
All descriptive statistics and analyses were reported by sex. For each randomised arm, we estimated the
average resource use and variable cost per donor over the 2-year follow-up period. The main resource-use
measures were the average number of blood donation visits, the average number of deferrals per donor
(overall and caused by low levels of Hb) and the average number of faints per donor. We also report the
deferral rate per attendance, as required in the subsequent economic evaluation (see Chapter 4). We report
the average SF-6D utility score at each time point, according to randomised arm, and the corresponding
mean (95% CI) differences between the arms up to 2 years’ follow-up.
We report the incremental cost-effectiveness of the reduced interval strategies, according to the incremental
(difference in means) variable cost per additional unit of whole blood donated. We report results overall
(by sex), and according to the other prespecified subgroups: high- versus standard-demand blood types,
ethnicity, age group, new donor or not and recruitment source (static donor centre vs. mobile session
vs. other) (see Appendix 3).
The analysis applied logistic regression models (binary end points), linear regression models (continuous,
univariate end points) and seemingly unrelated regressions (SURs) (joint whole-blood donations and cost end
point).52 Rates of deferral were estimated using the data on number of deferrals and attendances, and by
applying logistic regression models for grouped data. QoL was estimated using a generalised estimating equation
(GEE) model described here. Costs and whole-blood donations were estimated jointly by applying a SUR model.
TABLE 1 Unit costs
Resource-generating event Unit cost (£) Main source
Three-stage reminder for invitation to donate 2.68 Expert opinion
Low-Hb deferral, additional costs at donor centre 4.78 Expert opinion
Low-Hb deferral, subsequent health-care costs 5.39 Expert opinion
Deferral caused by other reasons 0.97 Expert opinion
Three-stage reminder following non-attendance 3.10 Expert opinion
Fainting episode at blood donation visit 20.23 Expert opinion
Variable cost of collecting 1 unit of blood (centre operating with capacity) 7.62 NHSBTa
a Laura Hontoria Del Hoyo, NHSBT (personal communication, June 2016) and Colin Jackson, NHSBT (personal
communication, April 2017).
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The incremental analysis of economic end points (QoL, costs, whole-blood donations) adjusted for age, ‘high’
versus ‘standard’ demand blood types, ethnicity, new donor or not and recruitment source (static donor centre
vs. mobile session vs. other). We estimated subgroup effects by including interaction terms for randomised arm
by subgroup. Age was defined as a continuous variable in the model, but predictions were provided according
to the requisite categories. We report the results from likelihood ratio tests, to assess whether or not model fit
improved with the inclusion of interaction effects for each subgroup by randomised group.
There were missing QoL data for those individuals who did not complete the items required for the SF-6D
utility score; the number and percentage of the analysis sample with required responses is reported for each
time point (baseline, 6, 12, 18 and 24 months) (see Appendix 4). These missing data were handled by a GEE
model that included SF-6D utility score as the dependent variable, with randomised group, time point and
the earlier subgroup variables as the fixed effects of interest, together with time point and randomised group
as fixed interaction terms. The model included random intercepts for centre and individual to allow for the
correlations of measurements within each donor and site. The model reported mean QoL utility scores
at each time point including the 2-year follow-up, and the differences in the mean utility scores across the
randomised arms. This model assumed that missing QoL data were ‘missing at random’, conditional on the
variables included in the model.53
The SUR model reported incremental (difference in means) costs and volumes, and the incremental
cost-effectiveness ratio (ICER), as the incremental cost per additional unit of blood donated from the
reduced minimum interval strategies. The CIs around the ICER were constructed by applying a Taylor
series expansion on the incremental estimates of cost and volume of blood donated.54 The accompanying
uncertainty around the incremental estimates, allowing for the correlation between cost and the volume
of blood donated, was represented on the cost-effectiveness plane.
The base-case analyses assumed that expert opinion provided accurate unit costs for reminders to donate
and deferrals, that non-attendances had a zero cost, that there were downstream health-care costs
following a deferral caused by Hb below the specified levels, there were costs attributable to fainting
episodes and there was capacity at static donor centres to increase donations. The statistical models for
blood volume, QoL and cost assume the residuals follow a normal distribution. These assumptions were
challenged in the subsequent sensitivity analyses.
Sensitivity analysis
The sensitivity analysis considered whether the conclusions from the base-case analysis were robust to
alternative assumptions. Specifically, we estimated a cost for non-attendances by calculating the number of
non-attendances as the difference between the observed and maximum number of attendances that could be
scheduled over the 2-year follow-up period, allowing for deferrals, and recognising that some donors dropped
out. In this sensitivity analysis we assigned a unit cost of reminding donors following a non-attendance as per
the trial protocol (see Table 1). The sensitivity analysis also made the alternative assumption that the costs
ensuing from a low Hb level, fainting episodes and the invitation to donate were zero, and so excluded
them. The sensitivity analysis also considered a scenario in which additional staff costs were required for blood
collection donation because the donor centres were at full capacity, and so the unit cost of donation was
assumed to be £24.70 versus the base case of £7.62. Finally, we assumed that costs followed a gamma rather
than a normal distribution.
Results
For both sexes, the baseline characteristics were similar across the randomised arms, as shown in Table 2.
Overall, the mean [standard deviation (SD)] age for men and women was 44.7 years (14.2 years) and
40.9 years (14.0 years), respectively; 13% of men and 14% of women were categorised as having high-
demand blood types, and 8% of men and 11% of women were classified as new donors. Over 90% of
participants were self-defined as of white ethnic origin, and about 65% of the participants were recruited
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from static donor centres. The mean number of blood donations in the 2 years preceding the trial was 4.2
for men and 3.4 for women, with mean deferral for a low Hb level of 0.04 for men and 0.12 for women,
and mean deferral for other reasons of 0.32 for men and 0.34–0.36 for women. The mean baseline QoL was
0.86 for men and 0.85 for women.
The resource use over 2 years is presented in Table 3. For men, the mean number of blood donation visits
was 7.76, 6.60 and 5.68 in the 8-, 10- and 12-week arms, respectively, and for women the corresponding
average number of visits was 5.10, 4.60 and 4.01 in the 12-, 14- and 16-week arms, respectively. The
average rate of deferral for low levels of Hb, per session attended, was higher in the arms that had shorter
minimum donation intervals. For men, this deferral rate was 5.71% in the 8-week arm compared with
3.73% in the 10-week arm and 2.55% in the 12-week arm. For women, this deferral rate increased from
5.05% (16-week arm) to 6.63% (14-week arm) and 7.92% (12-week arm). The corresponding mean
numbers of Hb-related deferrals per donor over 2 years were also higher in the randomised arms with
reduced donation intervals. The proportion of deferrals caused by other reasons, the average number of
fainting episodes (see Table 3) and other donor-reported health-care events (reported in Table 4) were
similar across the randomised arms.
TABLE 2 Baseline characteristics, by randomised arm and sex
Characteristic
Sex
Men Women
Randomised arm Randomised arm
8 weeks
(N= 7417)
10 weeks
(N= 7413)
12 weeks
(N= 7411)
12 weeks
(N= 7549)
14 weeks
(N= 7545)
16 weeks
(N= 7528)
Mean (SD) age (years) 44.7 (14.1) 44.7 (14.2) 44.7 (14.2) 40.77 (14.0) 40.89 (13.9) 40.94 (14.0)
Blood type, n (%)
High demand 996 (13.43) 933 (12.59) 965 (13.02) 1130 (14.97) 1062 (14.08) 1002 (13.31)
Standard demand 6421 (86.57) 6480 (87.41) 6446 (86.98) 6419 (85.03) 6483 (85.92) 6526 (86.69)
Ethnicity, n (%)
White 6751 (91.02) 6752 (91.08) 6745 (91.01) 6984 (92.52) 6992 (92.67) 6949 (92.31)
Black/mixed black 101 (1.36) 96 (1.30) 100 (1.35) 103 (1.36) 93 (1.23) 134 (1.78)
Asian/mixed Asian 255 (3.44) 271 (3.66) 258 (3.48) 171 (2.27) 177 (2.35) 154 (2.05)
Other or not stated 310 (4.18) 294 (3.97) 308 (4.16) 291 (3.85) 283 (3.75) 291 (3.87)
New donor, n (%)
No 6817 (91.91) 6818 (91.97) 6818 (92.00) 6742 (89.31) 6744 (89.38) 6727 (89.36)
Yes 600 (8.09) 595 (8.03) 593 (8.00) 807 (10.69) 801 (10.62) 801 (10.64)
Recruitment source, n (%)
Centre 4907 (66.16) 4840 (65.29) 4855 (65.51) 4851 (64.26) 4921 (65.22) 4901 (65.10)
Mobile 1437 (19.37) 1510 (20.37) 1512 (20.40) 1545 (20.47) 1482 (19.64) 1486 (19.74)
No invite 1073 (14.47) 1063 (14.34) 1044 (14.09) 1153 (15.27) 1142 (15.14) 1141 (15.16)
Mean (SD) number of deferrals
for low levels of Hb in previous
2 years
0.04 (0.24) 0.04 (0.23) 0.04 (0.24) 0.12 (0.39) 0.12 (0.38) 0.12 (0.39)
Mean (SD) number of deferrals
for other reasons in previous
2 years
0.32 (0.69) 0.32 (0.68) 0.32 (0.69) 0.36 (0.68) 0.34 (0.68) 0.34 (0.68)
Mean (SD) number of blood
donation visits in previous 2 years
4.19 (2.40) 4.22 (2.42) 4.18 (2.40) 3.46 (1.91) 3.45 (1.89) 3.44 (1.93)
Mean (SD) SF-6D score at baseline 0.86 (0.08) 0.86 (0.08) 0.86 (0.09) 0.85 (0.09) 0.85 (0.09) 0.85 (0.09)
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The main cost-effectiveness results are presented in Table 5. For both sexes, the average SF-6D utility
scores were similar across the randomised arms at the 2-year follow-up and at each of the intervening
time points (see Appendix 5). For men, the average number of whole-blood donations over the 2-year
follow-up period increased by 1.71 [95% confidence interval (CI) 1.60 to 1.80] for the 8- versus 12-week
interval arm, and by 0.79 (95% CI 0.70 to 0.88) for the 10- versus 12-week interval arm. For women, the
corresponding increase in the average number of donations was 0.85 (95% CI 0.78 to 0.92) for 12 versus
16 weeks, and 0.46 (95% CI 0.40 to 0.53) for 14 versus 16 weeks. The average costs per donor over
2 years increased for each of the reduced interval strategies. The ICERs were £9.51 (95% CI £9.33 to
£9.69) for the 8- versus 12-week interval arm for men, and £10.17 (95% CI £9.80 to £10.54) for the
12- versus 16-week interval arm for women. Figure 2 shows that when the cost-effectiveness results are
plotted on the cost-effectiveness plane, the distributions of the mean costs and mean number of donations
are centred tightly around the means.
TABLE 3 Resource use over the 2-year follow-up period, by randomised arm and sex
Resource use
Sex
Men Women
Randomised arm Randomised arm
8 weeks
(n= 7417)
10 weeks
(n= 7413)
12 weeks
(n= 7411)
12 weeks
(n= 7549)
14 weeks
(n= 7545)
16 weeks
(n= 7528)
Mean blood donation visits 7.76 6.60 5.68 5.10 4.60 4.01
Deferrals for low levels of Hb per
attendance (%)
5.71 3.73 2.55 7.92 6.63 5.05
Deferrals for other reasons per attendance
(%)
4.36 4.58 4.79 6.57 6.95 7.28
Mean deferrals for low levels of Hb per
donor
0.44 0.25 0.15 0.40 0.30 0.20
Mean deferrals for other reasons per donor 0.33 0.30 0.27 0.34 0.32 0.29
Mean faints per donor 0.02 0.02 0.02 0.04 0.03 0.03
TABLE 4 Other health-care events over the 2-year follow-up period, by randomised arm and sex
Health-care event
Sex
Men Women
Randomised arm Randomised arm
8 weeks
(n= 7417)
10 weeks
(n= 7413)
12 weeks
(n= 7411)
12 weeks
(n= 7549)
14 weeks
(n= 7545)
16 weeks
(n= 7528)
Any serious adverse event 284 (3.83) 257 (3.47) 267 (3.60) 290 (3.84) 289 (3.83) 288 (3.83)
Doctor-confirmed heart problems 25 (0.34) 36 (0.49) 21 (0.28) 5 (0.07) 3 (0.04) 12 (0.16)
Been to hospital after a fall 172 (2.32) 130 (1.75) 149 (2.01) 230 (3.05) 232 (3.07) 226 (3.00)
Been to hospital after a transport accident 104 (1.40) 110 (1.48) 115 (1.55) 66 (0.87) 63 (0.83) 61 (0.81)
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TABLE 5 The SF-6D score (at 2 years), whole-blood donations, costs and incremental cost per additional unit of whole blood donated, over 2-years’ follow-up (by sex)
Resource use
Sex
Men Women
Randomised arm Mean (95% CI) difference Randomised arm Mean (95% CI) difference
8 weeks
(n= 7417)
10 weeks
(n= 7413)
12 weeks
(n= 7411) 8 vs. 12 weeks 10 vs. 12 weeks
12 weeks
(n= 7549)
14 weeks
(n= 7545)
16 weeks
(n= 7528) 12 vs. 16 weeks 14 vs. 16 weeks
Mean SF-6D score 0.84 0.84 0.84 0.002
(–0.002 to 0.006)
–0.001
(–0.004 to 0.003)
0.82 0.82 0.82 0.001
(–0.003 to 0.005)
0.003
(–0.001 to 0.007)
Mean number of
whole-blood
donationsa
6.89 5.98 5.19 1.71
(1.60 to 1.80)
0.79
(0.70 to 0.88)
4.29 3.91 3.45 0.85
(0.78 to 0.92)
0.46
(0.40 to 0.53)
Mean costs (£)a 61 52 45 16 (15 to 17) 7 (6 to 8) 41 37 33 9 (8 to 9) 5 (4 to 5)
ICERa 9.51
(9.33 to 9.69)
9.00
(8.66 to 9.34)
10.17
(9.80 to 10.54)
9.98
(9.32 to 10.64)
a The results for whole-blood donations are rounded to two decimal places and costs are rounded to no decimal places. The ICER results are rounded to two decimal places.
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The likelihood ratio test shows that the inclusion of interaction effect for subgroups by randomised group
improved model fit (male: χ2 = 79.28, p = 0.0002; female: χ2 = 46.55, p = 0.0153). The subgroup results
reported in Table 6 show that the ICERs were similar across almost all subgroups. The main exception was
for the 14- versus 16-week contrast for women whose ethnicity was defined as black/mixed black. For this
subgroup, the incremental effect of the reduced interval on the number of whole-blood donations was
small, and so the accompanying ICER was large (> £200). However, the sample size for this subgroup is
low, and the estimates are somewhat unstable (n = 330 across all three arms).
The sensitivity analysis found that the estimates of incremental cost-effectiveness were generally similar
when alternative assumptions were taken to those in the base-case analysis, shown in Table 7. The base-case
results were most sensitive to the inclusion of the additional staff costs required if the donor centres had no
capacity to collect the additional units of blood. Under this scenario, the ICERs increased to £26.59 (95% CI
£26.41 to £26.77) for the 8- versus 12-week interval arm for men, and to £27.25 (95% CI £26.88 to £27.62)
for the 12- versus 16-week interval arm for women, compared with the base-case ICERs of £9.51 (95% CI
£9.33 to £9.69) and £10.17 (95% CI £9.80 to £10.54), respectively.
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FIGURE 2 Uncertainty in the incremental costs (£) and number of whole-blood donations, and their joint distribution,
for reduced interval strategies vs. standard practice (control arm) over 2 years’ follow-up. (a) Male and (b) female.
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TABLE 6 Incremental cost-effectiveness ratios by subgroup over the 2-year follow-up period, by sex
Characteristic
Sex
Men Women
8 vs. 12 weeks 10 vs. 12 weeks 12 vs. 16 weeks 14 vs. 16 weeks
Age group (years)
17–30 9.23 8.54 11.78 11.03
31–45 9.24 8.64 10.04 9.99
46–60 9.59 9.01 9.87 9.70
≥ 61 10.24 10.48 9.32 9.32
Blood type
High demand 9.48 9.42 9.40 9.23
Standard demand 9.51 8.95 10.33 10.13
Ethnicity
White 9.47 8.93 10.10 9.89
Black/mixed black 13.34 13.29 13.26 257.80
Asian/mixed Asian 10.24 10.78 18.81 4.62
Other or not stated 9.42 9.21 10.22 10.67
New donor
No 9.52 9.02 10.16 9.85
Yes 9.32 8.8 10.36 13.11
Recruitment source
Donor centre 9.57 9.06 10.05 10.36
Mobile session 9.32 8.69 10.08 8.89
No invite 9.50 9.24 10.82 10.14
TABLE 7 Incremental cost-effectiveness ratios according to alternative assumptions compared with the base case
over the 2-year follow-up period, by sex
Alternative assumptions
Sex
Men Women
8 vs. 12 weeks 10 vs. 12 weeks 12 vs. 16 weeks 14 vs. 16 weeks
Base case 9.51 9.00 10.17 9.98
Including costs of non-attendance 13.91 12.54 12.90 12.48
Excluding health-care costs caused by
Hb deferral
8.56 8.31 8.88 8.78
Excluding costs of fainting 9.44 8.96 10.09 9.94
Excluding invitation costs 9.51 9.00 10.17 9.98
Additional staff costs to collect extra
blood
26.59 26.08 27.25 27.06
Gamma distribution for costs 9.22 8.70 7.45 8.80
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Discussion
The main finding from this trial-based CEA undertaken in 25 static donor centres was that, compared with
the control arm strategy, which was the current minimum interval specified by the NHSBT, the reduced
minimum donation interval strategies increased the average number of donations, at a small additional
average variable cost over 2 years. The rate of deferral because of low levels of Hb and the average
number of deferrals per donor was higher for the reduced minimum interval strategies. The main finding
was that reducing the minimum recall interval yields additional units of blood donated at an additional
average variable cost of around £10. This finding was generally similar across the subgroups considered,
including those with high-demand blood types, among whom it is particularly important to increase the
volume of blood supplied. The time horizon was limited to 2 years in accordance with the follow-up period
in the INTERVAL trial. The CEA did not consider the effects that the increased rates of deferrals may have
on the rate at which donors leave the donation register, and any additional costs from, for example,
recruiting new donors.
The main trial analysis reported that reducing donation intervals resulted in a higher proportion of donors
(especially male) reporting symptoms such as fatigue, potentially as a result of iron deficiency or blood
donation, but did not find any evidence of an effect on randomised arm according to the physical or
mental summary score of the SF-36.47 The CEA also found that donors’ QoL, measured according to the
SF-6D utility score, was similar across arms for all time points concerned. There were no differences in
the self-reported fainting episodes or adverse events across the arms. The CEA found that the reduced
minimum donation intervals did not lead to an increase in health-care resource use, or in morbidity among
donors. The SF-6D is a recommended measurement of health utility, an appropriate approach was taken
to handling missing data, and the average utility scores were similar to those for the age- and sex-matched
general population (0.81 for men and 0.79 for women).55 Unlike other generic instruments, such as the
EuroQol 5-dimension questionnaire, the SF-6D does include dimensions for vitality and fatigue, but there
is still no guarantee that it is sensitive to the small differences in minor symptoms, such as dizziness or
restless leg syndrome, reported across randomised arms in the main INTERVAL trial analysis.47
The INTERVAL trial protocol specified a comprehensive system of reminders to donors to make and keep
appointments to donate blood. The trial protocol therefore implied some additional resource use versus
routine NHSBT practice, but as this reminder system may have been important in encouraging donors to
attend donation sessions according to the frequency observed during the RCT, the costs of reminders
for sessions attended were according to the trial protocol. Indeed, a non-randomised comparison of the
donation frequency pre versus post randomisation suggests that, for both sexes, the donation frequency for
the control arm increased by around 40%, which could reflect a ‘trial effect’ or other temporal differences
beyond the INTERVAL trial. As part of an extension to the INTERVAL trial (Phase II), approximately 50%
of INTERVAL donors agreed to continue on their previously allocated study donation interval for a further
period of 6–24 months, and also to be randomised to receive the enhanced trial protocol reminders or the
reminders undertaken as part of routine NHSBT practice. It would be useful to extend the economic analysis
undertaken here to examine whether or not the more intensive reminder system undertaken as part of the
original INTERVAL trial was in itself cost-effective.56,57
A strength of the CEA is that it used data from a large, well-conducted RCT with complete follow-up data
for the main end points of interest, and included as a control arm the current minimum donation interval
in England. The large sample size meant that it was possible to report both the overall effect of alternative
minimum donation intervals (on frequency of attendance to donate whole blood and deferrals) and the
effect according to subgroups of key policy relevance. The trial provided an excellent vehicle for estimating
the rate of deferral per donation on attendance according to alternative donor characteristics. In particular,
the INTERVAL trial analysis found that, for 7% of Hb-related deferrals, the level of Hb was sufficiently low
to imply additional health-care consultations and costs. These estimates of deferral rates will be used in
Chapter 3 in adjusting the estimates from the stated preference survey to predict actual rates of successful
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donation. The estimated deferral rates will also be used in the subsequent economic evaluation of a wider
range of strategies to increase donation frequency (see Chapters 3 and 4).
The economic evaluation of the INTERVAL strategies has the following limitations. First, although the
INTERVAL trial followed donors for 2 years, the higher deferral rates from low levels of Hb reported in
the reduced interval arms could lead to a higher rate of donors leaving the blood donation registry in the
long run. This is plausible if the levels of Hb, which were on average lower in the reduced interval arms
after 2 years, continue to diverge.47 The Phase II INTERVAL extension study will provide some additional
evidence about the relative rate at which donors leave the register, and the potential higher costs of
replacing them with new donors. Second, the RCT was undertaken at 25 static donor centres; it is unclear
whether or not it would be cost-effective to roll out the reduced interval strategy to mobile sessions. Third,
the CEA did not include the full range of costs that may differ according to the minimum recall interval. In
particular, data were not available on the number of non-attendances for each individual. In the sensitivity
analysis, when we approximated these costs, we found that the ICERs of the reduced interval strategies
increased somewhat, but generally remained below an additional variable cost of £30 for an additional
unit of blood donated. The results were most sensitive to the assumption that there would be sufficient
capacity within the static donor centres to collect the additional units of blood donated. This assumption
may not be realistic if this strategy is rolled out to all donors attending static centres. However, if the
reduced interval strategies are applied only to those groups whose blood type is in high demand, then
current capacity (on average, 75%) may be sufficient to collect the additional units of blood; in which case
the base-case ICER is more relevant (around £10 per additional unit of blood collected).
The INTERVAL trial considered only a single set of strategies for maintaining the future blood supply, and yet
NHSBT may consider these strategies in conjunction with other changes to the blood service (e.g. extending
opening hours at donor centres). Hence, studies that complement the INTERVAL trial in investigating the costs
and consequences of other strategies for maintaining the supply of whole blood are required. Chapter 3
reports on surveys of non-INTERVAL but also ex-INTERVAL donors that were undertaken to elicit their
preferences for alternative blood donation strategies (including reduced donation intervals). The subsequent
economic evaluation then uses estimates from the survey, combined with estimates from INTERVAL for
deferral rates, to estimate the cost-effectiveness of a range of strategies for maintaining the blood supply.
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Chapter 3 Measuring and analysing donors’
preferences for alternative changes to the blood
collection service
Introduction
This chapter reports the design and analysis of the SP surveys. Thus, it is concerned with our second
objective: to investigate the frequency with which donors are willing to donate whole blood according to
alternative future changes to the blood collection service.
This chapter has the following structure. Development of the stated preference survey describes the
development of the SP survey, in particular emphasising the key considerations that drove our design
choices. Selection of attributes and levels outlines the process by which the attributes and their levels
were selected. Sample size and efficient design details the design of the survey, including the number
and allocation of SP questions to participants. Administration of the surveys describes the administration
of the surveys, which comprised a pilot survey, a survey of blood donors who had not participated in
the INTERVAL trial (non-INTERVAL) and a survey of INTERVAL trial participants (ex-INTERVAL). Analysis of
annual frequency of donation from the stated preference surveys describes the analysis of the intended
annual frequency of donation. Survey respondents reports response rates to the non-INTERVAL and
ex-INTERVAL surveys and describes the respondents in terms of a number of characteristics. Results
reports the results of the analysis of the SP surveys and the chapter concludes with Discussion.
Development of the stated preference survey
Five main considerations influenced the design of the SP survey. First, the purpose of the survey was to
help inform future changes to the blood collection service. Hence, the attributes chosen were those judged
to reflect aspects of the blood collection service that the NHSBT could change in the short term. This has
important implications for the selection of attributes, specifically attributes that are under the control
of the NHSBT. Second, there were separate male and female questionnaires because of well-established
differences between men and women in permitted donation frequency, and our explicit interest in the
strategies contrasted in the INTERVAL trial. Third, the donation scenarios presented to donors distinguished
between the last place (LP) the respondent donated and a different place (DP). This is necessary because
some changes in the opportunity to donate would involve the donor donating in a DP, whereas for others
the venue would not change. Fourth, we chose an unlabelled design, which in this context implies that
an opportunity to donate was not indicated as being at a static donor centre or a mobile session. Fifth,
our interest lay in making predictions regarding frequency of donation by existing blood donors. We were
not concerned with the broader question of what factors influence decisions to become a donor or to
stop donating.
Donors donate at different annual rates depending on a combination of their personal characteristics
and on the opportunities that they have to donate. In effect, we are assuming that donors consider the
marginal costs and benefits of donating blood. Changes that increase the cost to the donor of donating
(e.g. increased travel time) will tend, other things being equal, to reduce the frequency with which they
donate. However, changes that increase the benefits to donors of donating (e.g. provision of a health
report) will increase their preferred frequency of donation.
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The maximum number of donations allowed annually depends on the donor’s sex. Some donors may be
unconstrained in that they are already donating at their preferred frequency, whereas others may be
constrained by this maximum in the sense that they would like to donate more frequently. Changes to the
maximum frequency with which donors can donate will not change the costs and benefits of donating to
an individual donor. However, decreases in the interval required between donations will result in previously
constrained donors being able to donate more often. More speculatively, an increased permitted frequency
of donation might alter donors’ perceptions regarding a donation norm, which may encourage some
donors to donate more frequently.
Selection of attributes and levels
The selection of attributes and levels always involves compromises given limits on the feasible number
of scenarios about which to ask respondents. Our choice of attributes to describe the opportunities to
donate was informed by a rapid literature review, input from policy-makers at the NHSBT and preliminary
findings from qualitative research with blood donors participating in the INTERVAL trial [R Lynch and S Cohn,
London School of Hygiene & Tropical Medicine (LSHTM), personal communication, October 2015]. The pilot
study explored five attributes identified as pertinent to determining the impact of a number of policy-relevant
strategies, namely travel time, opening hours, total donation time, provision of a health report and the
maximum number of donations per year. The first three attributes influence the cost to the donor of the
blood donation, whereas the provision of a health report potentially increases the benefits to the donor.
The INTERVAL trial is investigating the safety of increasing the maximum frequency of donation (three or four
times per year for women and 4–6 times for men). This attribute is included to understand how donors
might respond if the limits were altered alongside the other possible future changes to the blood service.
As noted earlier, this does not affect the costs or benefits of donation but rather the scope for donors to
achieve their preferred donation frequency.
Donation venue was not included as an attribute, but the survey had two sections: the first asks the donor
to think about donation opportunities at the ‘last place you gave blood’ (LP), and the second asks the
donor to ‘imagine you were asked to donate at a different place’ (DP). This was in order to capture more
of the context not included in the attributes (e.g. the community aspect of blood donation and familiarity
of staff) that had been identified as important to some donors in the qualitative research conducted as
part of the INTERVAL trial.
The appropriate levels for each attribute were defined according to summary estimates from the PULSE
database, NHSBT market research and consultation with blood donors. Table 8 shows the attributes
and levels used in the non-INTERVAL and ex-INTERVAL surveys (see Appendix 6 for those used in the
pilot survey).
The analysis of the pilot survey results revealed a systematic over-prediction of the frequency of blood
donation compared with the donation frequency observed in practice. One potential explanation, and a
view expressed at our donor workshop, was that some donors might wish to donate more frequently but
face additional constraints in practice, which cause observed behaviour to diverge from that predicted. Our
analysis of these discrepancies (between the predicted donation frequencies and those observed) showed
that these were consistent across various subgroups.58 For the main survey of non-INTERVAL donors, we
replaced the time taken to make the donation with an appointment availability attribute. The appointment
availability attribute is a means of ensuring that the SP scenarios explicitly address differences in appointment
availability. Two further changes from the pilot survey were made: we reduced the number of levels for the
opening times attribute from eight to four and adopted a full factorial design in place of a main effects
fractional design. The reduction in opening hours levels was made in order to increase the feasibility of a
full factorial design and to facilitate analysis of preference differences between subgroups of donors.
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For each set of attribute levels, we asked donors to state the frequency with which they would be willing
to donate blood. The survey included the option ‘I would probably not donate’. Figure 3 gives an example
of a typical question.
Sample size and efficient design
The purpose of the pilot survey was threefold: (1) to ensure that our overall systems for selecting and
inviting donors to participate, and for recording their responses, worked as intended; (2) to obtain reliable
information on the likely response rate; and (3) to identify any issues with respect to individual questions
and the questionnaire as a whole.
For the pilot study, the NHSBT issued 5016 e-mail invitations to eligible donors. We had anticipated a
response rate between 10% and 20% (based on previous NHSBT surveys); however, a response rate of
25% was achieved. The mean time to complete the whole survey was just under 6 minutes (5 minutes
and 47 seconds). No calls relating to our pilot survey were logged at NHSBT’s national call centre.
TABLE 8 Attributes and levels from the SP survey
Attributes as described in the SP survey Levels as described in the SP survey
1. Travel time 10 minutes shorter than your typical travel time
Your typical travel time
15 minutes longer than your typical travel time
30 minutes longer than your typical travel time
2. Opening times 9 a.m.–12 p.m. and 2–5 p.m.
9 a.m.–5 p.m.
9 a.m.–8 p.m.
2–8 p.m.
3. Appointment availability Every day: Monday–Sunday
Every weekday: Monday–Friday
1 day every 2 months: Monday–Friday
1 day every 2 months: Saturday or Sunday
4. Health report provided Health report provided after each blood donation
Not provided
5. Maximum number of donations per year Female
l Three donations per year
l Four donations per year
Male
l Four donations per year
l Five donations per year
l Six donations per year
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The pilot had a main effects design because to do otherwise was infeasible given the sample size.
A full factorial design for men would have involved 96 possible LP (11 × 22 × 31 × 81) and 384 possible DP
scenarios (22 × 31 × 41 × 81). For women, 64 possible LP (12 × 23 × 81) and 256 possible DP scenarios
(23 × 41 × 81) would have been required. An efficient design was adopted based on the need to estimate
the marginal rate of substitution between attributes with reasonable precision (main effects only). NgeneTM
1.1.2 (Choice Metrics Pty Ltd, Sydney, Australia) was used to establish an efficient design by considering
each section of the survey as one choice set compared with an ‘opt-out’, resulting in eight LP and 12 DP
scenarios for women (12 versions of the survey) and 24 LP and 24 DP scenarios for men (72 versions of the
survey). Reflecting the greater number of male scenarios, two men were invited for every women in the
pilot survey.
Sample size calculations for SP surveys are not straightforward, and although the response rate in the pilot
(given its size) was informative, the likely response rate to the main survey remained uncertain. A sample
size of 100,000 was chosen for the main non-INTERVAL survey. This sample size took account of the
successful experience from the pilot and the practical challenges associated with inviting larger numbers.
The main survey, being much larger, provided an opportunity to adopt a full factorial design. It appeared
likely that there would be significant interaction effects; for example, a donor’s willingness to travel
might be influenced by the opening hours and appointment availability. Taking into account the changes
following the pilot survey with respect to attributes and levels, there are 96 potential LP scenarios for men
At the place where you last gave blood, suppose the service is like this:
Description of service
Travel time Your typical travel time
Appointment availability Every weekday: Monday – Friday
Opening times 9 a.m. – 12 p.m. and 2 p.m. – 5 p.m.
Health report provided Yes, after each donation
Maximum number of donations per year Three times per year
In this scenario, how many times a year would you give blood? 
I would probably not donate
Once a year
Twice a year
Three times a year
Four times a year
FIGURE 3 Example of a question from the stated preference survey.
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(42 × 3 × 2) and 384 potential DP scenarios (43 × 3 × 2). The LP scenarios can be divided into 48 blocks of
two, and the DP scenarios into 96 blocks of four. For women, the 64 LP scenarios (42 × 22) and 256 DP
scenarios (43 × 22) can be divided into 32 blocks of two and 64 blocks of four, respectively. As in the pilot
survey, two men were invited for every women in the non-INTERVAL survey, because there were many
more possible scenarios in the male survey.
Administration of the surveys
The non-INTERVAL survey received ethics approval from the NHS (reference number 16/YH/0023) and
LSHTM (reference number 10384) Research Ethics Committees in November 2015 and January 2016,
respectively, and non-substantial amendments were made following the pilot survey in May 2016. For the
final protocol for the survey of non-INTERVAL donors, see Report Supplementary Material 1. A total of
100,000 donors were randomly selected from the PULSE database to be invited to participate in the survey
of non-INTERVAL donors, according to the following criteria: 17–70 years old, donation of at least one unit
of whole blood in the past 12 months, e-mail address held by NHSBT and residence in mainland England.
Donors were excluded from the surveys if they were temporarily suspended from giving blood (e.g. donors
who had recently had a tattoo), had previously stated that they did not want to participate in surveys or
had received a request to participate in a survey or research from the NHSBT (including the INTERVAL trial)
in the preceding 6 months. Owing to the recent NHSBT communication policy, women with AB-positive
(AB+) blood were also excluded. Selected donors were sent an e-mail invitation from the NHSBT with a
link to the online survey built and hosted on FluidSurveysTM (1 January 2015 version; SurveyMonkey®, Palo
Alto, CA, USA). For the e-mail invitation sent to non-INTERVAL donors, see Report Supplementary Material 2,
and for the consent form and donor information sheet, see Report Supplementary Material 3. Donors who
did not complete the survey (excluding those who refused consent) within the first 3 days were sent a
reminder e-mail, and the survey closed 3 days after the reminder e-mail. Figure 4 provides a CONSORT-style
diagram for the survey.
To assess the generalisability of the survey results, the characteristics of the donors who completed the
survey were compared with a larger PULSE sample of donors who have donated at least once in the
12 months prior to March 2016.
We repeated the same SP survey with the ex-INTERVAL participants using similar exclusions to the previous
surveys, but this time did not exclude donors if they had not given blood in the 12 months prior to the survey
(in December 2016). For the final protocol of the survey of ex-INTERVAL donors see Report Supplementary
Material 4. The ex-INTERVAL participants are of particular interest because many of them have experienced
the higher rates of donation featured in some of the SP scenarios. Moreover, all INTERVAL trial donations
were made at donor centres and the non-INTERVAL survey had relatively small numbers whose last donation
took place in a donor centre (n = 2970), reflecting that most blood in England is collected at mobile sessions.
All eligible ex-INTERVAL participants were invited, by e-mail, to participate in the survey. For the ex-INTERVAL
donors the invitation e-mail and consent and donor information sheets are available in Report Supplementary
Material 5 and 6, respectively. Figure 5 provides a CONSORT-style diagram for the ex-INTERVAL survey.
Examples of the non-INTERVAL (which are the same as those administered to the ex-INTERVAL sample)
and pilot surveys are reproduced in Appendix 7. In addition to the SP questions, all respondents to the
pilot, non-INTERVAL and ex-INTERVAL surveys were asked to complete a series of background questions
(see Appendix 8). These included questions about how often the donor recalled giving blood in the past
12 months and how often they wanted to give blood. Regarding the last donation visit, questions related
to from where they travelled, how they travelled, how far they travelled, how long it took, how they made
the appointment and how easy it was to get a suitable appointment. Finally, they were asked whether
their total visit duration was < 1 hour or > 1 hour.
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All donors in March 2016 extract of PULSE database
(n = 1,942,477) (who have donated in the last 5 years)
Excluded (by NHSBT)
(n = 1,708,005)
•
•
• 
• 
• 
• 
• 
Donors who had not successfully donated a unit of whole blood at least once in the 
12 months prior to the survey (29 June 2016), n = 987,112
Donors who were temporarily suspended from giving blood (e.g. donors who have had
a tattoo recently), n = 145,265
Donors aged over 70 years on 29 June 2016, n = 21,924
Female donors with AB+ blood, n = 16,786
Donors who had participated in the INTERVAL trial, n = 7173
Donors whose last procedure code was not whole-blood donation, n = 0
Donors who did not have an e-mail address held by NHSBT, donors who did not reside in
mainland England and donors who are unwilling to participate in routine NHSBT surveys
or who had received a request to participate in a survey in the 6 months prior to this
survey (29 June 2016), n = 529,745
Donors eligible for survey
(n = 234,472) (12% PULSE)a
(Men, n = 123,503; women, n = 110,969)
Donors invited to survey
(n = 100,000) (43% eligible donors)b
(Men, n = 66,664; women, n = 33,336)
Refused consent, n = 216
(Men, n = 145; women, n = 71)
Donors sent reminder e-mail
(n = 83,184)
(Men, n = 55,631; women, n = 27,553)
Donors who responded to survey
(n = 25,187) (25.2% response rate)
(Men, n = 16,420; women, n = 8767)
Refused consent after reminder, n = 194
(Men, n = 130; women, n = 64)
Responded to the survey but did 
not complete stated preference 
questions, n = 1206
Donors who completed at least one stated preference question
(n = 23,981)
(Men, n = 15,652; women, n = 8329)
Randomly selected
FIGURE 4 A CONSORT-style diagram stated preference survey of non-INTERVAL participants. a, Complete PULSE data are not available for 24 of these donors; b, complete
PULSE data are not available for 11 of these donors.
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All INTERVAL participants
Donors who gave consent to participate in the INTERVAL trial and
were randomised to an arm of the trial
(n = 45,263) 
Excluded (by INTERVAL team)
(n = 361)
•
•
Donors who have been reported as deceased, n = 140
Donors who have withdrawn consent for the future use of their data collected during
the trial, n = 221
Excluded (by NHSBT)
(n = 16,170)
•
•
•
•
Donors who were temporarily suspended from giving blood (e.g. donors who have had
a tattoo recently), n = 3576
Female donors with AB+ blood, n = 438
Donors whose last procedure code was not whole-blood donation, n = 67
Donors who did not have an e-mail address held by NHSBT, donors who did not reside 
in mainland England and donors who are unwilling to participate in routine NHSBT
surveys, n = 12,089
Donors assessed for eligibility for survey
(n = 44,902)a
Donors eligible for the survey (all invited)
(n = 28,732)b
(Men, n = 14,726; women, n = 14,006)
Refused consent, n = 46
(Men, n = 25; women, n = 21)
Donors sent reminder e-mail
(n = 22,519)
(Men, n = 11,852; women, n = 10,667)
Donors who responded to survey
(n = 9392) (32.7% response rate)
(Men, n = 5005; women, n = 4387)
Refused consent after reminder, n = 38
(Men, n = 123; women, n = 15)
Responded to the survey, but did not
complete SP questions, n = 1206
Donors who completed at least one stated preference question
(n = 8933)
(Men, n = 4754; women, n = 4179)
FIGURE 5 A CONSORT-style diagram survey of ex-INTERVAL participants. a, Complete PULSE data are not available for 32 of these donors; b, complete PULSE data are not
available for one of these donors.
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Analysis of annual frequency of donation from the stated
preference surveys
The primary purpose of the SP surveys was to predict the average number of whole-blood donations per
year given different opportunities to donate, for example with respect to opening hours and travel time.
These predictions were central to the assessment of the cost-effectiveness analysis of alternative NHSBT
strategies (see Chapter 4).
We chose to use an ordered logit model for the base-case analysis to recognise that the response variable
was categorical, but also had a natural ordering (three times per year, two times per year, etc.). The
sensitivity analyses examined whether or not the findings were sensitive to the choice of model by
considering two alternative models: the two-part model, which recognises that the response ‘I would
probably not donate’ is a different kind of response from once, twice or three times per year; and a
gamma model, which treats the responses as continuous, but with a lower bound at zero.
The SP surveys for male and female donors had different levels for the minimum donation interval attribute,
and so we analysed the responses for each sex separately. We investigated whether or not there was effect
modification according to donor subgroup. We estimated two-way interactions of each attribute with the
following subgroups: age, blood type, ethnicity and venue for last whole-blood donation (see definitions
in Survey respondents). These estimated two-way interactions were used to report results according to
donor subgroup.
We used the estimated coefficients from the ordered logit model to predict each individual’s donation
frequency according to the alternative levels for each attribute. This was done in two stages. First, a
predicted probability for each donor for each category of response variable was calculated from the
coefficients of the ordered logit regression model. Second, for each level of each attribute, the expected
annual donation frequency for each donor was calculated using the predicted probabilities estimated in
the first stage for each response category. The average of these predicted annual donation frequencies
according to each attribute level was reported, together with the 95% uncertainty intervals, to reflect the
variation in these predictions across the survey sample. We also used the estimated coefficients from the
ordered logit model to report the proportion of donors who said that they ‘probably would not donate’
according to each attribute level.
To assess the concern that donors may overstate their donation frequency, we then compared each
individual’s predicted annual frequency with their actual donation frequency (recorded in the PULSE
database) over the year preceding the survey. Annual donation frequency was predicted by setting
attribute levels to represent the donor’s most recent experience, as recorded in PULSE in March 2016.
The algorithm used to determine the current service-level characteristics is shown in Figure 6. We then
adjusted these predictions using the predicted probability of deferral from the INTERVAL trial arms assigned
to the current minimum donation intervals (see Chapter 2). The average discrepancy between the predicted
donation frequency and observed donation frequency was reported overall, for men and women, and for
each subgroup, with 95% CIs to reflect the uncertainty in the predictions across individuals. However, these
CIs do not reflect uncertainty in the estimation of the models used to predict intended donation frequency
or deferral rates.
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Were at least 260 sessions run at this venue in the last 12 months?
(Consider only sessions where at least two units of whole blood were collected)
Attribute level
Every weekday: Monday – Friday
Attribute level
Every day: Monday – Sunday
Were at least 6 sessions 
at this venue held on
a weekend?
Were at least 
52 sessions at this venue 
held on a weekend?
Attribute level
1 day every 2 months: Monday – Friday
Yes
No
Yes
No
No
Yes
Note: only static donor
centres
Note: only mobile session
venues
Type of
centre
Mobile Static
Can you give blood 
until 8 p.m.? Session end 
is 8 p.m. or later
Yes
Attribute level
2 – 8 p.m.
No
Can you give 
blood between 
12 noon and 2 p.m.? 
(strict definition)
Yes
Attribute level
9 – 5 p.m.
NoAttribute level
9 – 12 p.m. and 2 – 5 p.m.
Can you give blood 
until 8 p.m.? Session end 
is 8 p.m. or later
Can you give blood 
between 12 noon and   2 p.m.? 
(strict definition)
No
Does session start
before 11.30 a.m.?
Yes
Yes
Attribute level
9 – 8 p.m.
No Attribute level
2 – 8 p.m.
Yes
Attribute level
9 – 5 p.m.
No Attribute level
9 – 12 p.m. and 2 – 5 p.m.
Attribute level
1 day every 2 months: Saturday or Sunday
FIGURE 6 Attributing current service-level characteristics.
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Although the surveys were designed to facilitate the prediction of donation frequencies for a range of
donation opportunities rather than in order to understand the factors which lead donors to continue or
discontinue donating, one of the potential responses was ‘I would probably not donate’. This response
can give some insight into, for example, whether increasing travel time might lead more donors to
discontinue donation. We report the use of this response category by subgroup.
The non-INTERVAL sample and the eligible ex-INTERVAL participants were invited to complete exactly the
same questionnaire. The preferences of the ex-INTERVAL respondents who had been in the intervention
arms of INTERVAL may well differ from those of the non-INTERVAL sample, partly because of the former
group having experienced shorter donation intervals. However, we would anticipate the preferences of
the non-INTERVAL sample whose last donation was at a static donor centre to be more similar to those of
ex-INTERVAL control arm participants. They might still differ by virtue of the ex-INTERVAL participants all
having expressed a willingness to be randomised to arms with more frequent invitations to donate. If the
preferences of the two groups are sufficiently similar, more precise predictions regarding future donation
behaviour can be obtained by pooling the two samples.
Survey respondents
The overall response rates were 25.2% for the non-INTERVAL survey and 32.4% for the ex-INTERVAL
survey (see Figures 4 and 5). Table 9 compares four groups of male whole-blood donors: respondents to
the non-INTERVAL survey, invitees to the non-INTERVAL survey, eligible donors and all donors. These
comparisons are made with respect to five donor characteristics: age (17–30, 31–45, 46–60 and ≥ 60 years),
blood type (distinguishing high and standard demand), ethnicity [distinguishing white, black/mixed black,
Asian/mixed Asian and not stated (for detail on how these are defined, see Appendix 3)], whether or not
a nursery donor, and the venue where the donor last gave blood (static donor centre or mobile session).
High-demand blood types are O–, A– and B–, and standard-demand blood types are O positive (O+),
A positive (A+), B positive (B+), AB+ and AB negative (AB–). A nursery donor is defined as a donor who
has given blood 1–4 times in the past 5 years, whereas those donating five times or more in the last 5 years
are not nursery donors.
TABLE 9 Background characteristics of the population and respondents for the SP survey of male non-INTERVAL
donors
Characteristic
Donors, n (%)
Responded to
the survey
(N= 15,652)
Invited to
the survey
(N= 66,656)
Eligible for
the survey
(N= 123,491)
All in March 2016
extract of PULSE
database (N= 353,763)
who had donated in
the past 12 months
Age group (years)
17–30 1646 (10.52) 16,925 (25.39) 31,307 (25.35) 73,411 (20.75)
31–45 3441 (21.98) 17,977 (26.97) 33,211 (26.89) 86,583 (24.47)
46–60 6825 (43.61) 22,547 (33.83) 41,982 (34.00) 131,920 (37.29)
≥ 60 3740 (23.89) 9207 (13.81) 16,991 (13.76) 61,849 (17.48)
Blood type
High demand 1551 (9.91) 6273 (9.41) 11,606 (9.40) 46,998 (13.29)
Standard demand 14,101 (90.09) 60,383 (90.59) 111,885 (90.60) 306,765 (86.71)
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As would be expected, the breakdown of eligible male donors differs from all male donors because of the
exclusions applied. The distribution of those invited by age, etc., as should be the case, closely follows that
of the eligible donors. Comparing the characteristics of the respondents with those of the invited donors,
older donors and those indicating white ethnicity are over-represented, and nursery donors, donors making
a single donation in the last 12 months and donors who last donated at a static centre are under-represented.
The patterns observed for male donors are repeated for female donors, shown in Table 10.
Tables 11 and 12, men and women, respectively, provide a comparison of ex-INTERVAL respondents,
eligible ex-INTERVAL participants (all of whom were invited) and all those assessed for eligibility, using the
same donor characteristics. For both men and women, nursery donors and donors with zero donations in
the last 12 months are under-represented in those eligible for the SP survey. As can be seen for both men
and women, respondents differ from those invited in that younger (older) donors are under-represented
(over-represented) and nursery donors and those who made no or only one donation in the last 12 months
are under-represented.
TABLE 9 Background characteristics of the population and respondents for the SP survey of male non-INTERVAL
donors (continued )
Characteristic
Donors, n (%)
Responded to
the survey
(N= 15,652)
Invited to
the survey
(N= 66,656)
Eligible for
the survey
(N= 123,491)
All in March 2016
extract of PULSE
database (N= 353,763)
who had donated in
the past 12 months
Ethnicity
White 14,639 (93.53) 60,559 (90.85) 112,270 (90.91) 323,912 (91.56)
Black/mixed black 98 (0.63) 738 (1.11) 1411 (1.14) 3518 (0.99)
Asian/mixed Asian 367 (2.34) 2992 (4.49) 5430 (4.40) 12,677 (3.58)
Other or not stated 548 (3.50) 2367 (3.55) 4380 (3.55) 13,656 (3.86)
Nursery donor
Yes 3542 (22.63) 26,144 (39.22) 48,636 (39.38) 110,279 (31.17)
No 12,110 (77.37) 40,512 (60.78) 74,855 (60.62) 243,484 (68.83)
Venue
Centre 1307 (8.35) 7670 (11.51) 14,241 (11.53) 52,808 (14.93)
Mobile 14,345 (91.65) 58,986 (88.49) 109,250 (88.47) 300,955 (85.07)
Number of donations in past 12 months
1 4054 (25.90) 28,172 (42.26) 52,819 (42.77) 129,404 (36.58)
2 5096 (32.56) 20,247 (30.38) 37,357 (30.25) 105,671 (29.87)
3 5204 (33.25) 15,112 (22.67) 27,582 (22.34) 93,273 (26.37)
4 1250 (7.99) 3023 (4.54) 5511 (4.46) 20,600 (5.82)
5 39 (0.25) 84 (0.13) 171 (0.14) 3196 (0.90)
6 9 (0.06) 18 (0.03) 51 (0.04) 1619 (0.46)
Notes
The number of donations in last 12 months for all donors in the March 2016 extract of PULSE is calculated on the 12 months prior
to March 2016; all other data in this table relating to ‘the last 12 months’ are calculated on the 12 months prior to July 2016.
For age group, ethnicity and number of donations, the % do not add up to 100% because of rounding.
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TABLE 10 Background characteristics of the population and respondents for the SP survey of female
non-INTERVAL donors
Characteristic
Donors, n (%)
Responded to
the survey
(N= 8329)
Invited to
the survey
(N= 33,333)
Eligible for
the survey
(N= 110,957)
All in March 2016
extract of PULSE
database (N= 427,265)
who had donated in
the past 12 months
Age group (years)
17–30 1663 (19.97) 10,983 (32.95) 36,360 (32.77) 115,333 (26.99)
31–45 2334 (28.02) 9793 (29.38) 32,841 (29.60) 118,922 (27.83)
46–60 2999 (36.01) 9301 (27.9) 31,001 (27.94) 135,936 (31.82)
≥ 61 1333 (16.00) 3256 (9.77) 10,755 (9.69) 57,074 (13.36)
Blood type
High demand 921 (11.06) 3647 (10.94) 12,158 (10.96) 64,950 (15.20)
Standard demand 7408 (88.94) 29,686 (89.06) 98,799 (89.04) 362,315 (84.80)
Ethnicity
White 7700 (92.45) 30,024 (90.07) 100,233 (90.33) 400,968 (93.85)
Black/mixed black 103 (1.24) 656 (1.97) 2198 (1.98) 4797 (1.12)
Asian/mixed Asian 195 (2.34) 1341 (4.0) 4283 (3.86) 9,050 (2.12)
Other or not stated 331 (3.97) 1312 (3.94) 4243 (3.82) 12,450 (2.91)
Nursery donor
Yes 3024 (36.31) 16,544 (49.63) 55,205 (49.75) 173,223 (40.54)
No 5305 (63.69) 16,789 (50.37) 55,752 (50.25) 254,042 (59.46)
Venue
Centre 746 (9.97) 3748 (11.24) 12,006 (10.82) 55,003 (12.87)
Mobile 7583 (91.04) 29,585 (88.76) 98,951 (89.18) 372,262 (87.13)
Number of donations in past 12 months
1 3094 (37.15) 16,963 (50.89) 56,791 (51.18) 187,862 (43.97)
2 2967 (35.62) 10,393 (31.18) 34,741 (31.31) 140,313 (32.84)
3 2063 (24.77) 5516 (16.55) 18,023 (16.24) 89,938 (21.05)
4 204 (2.45) 459 (1.38) 1392 (1.25) 8860 (2.07)
5 1 (0.01) 1 (0.00) 6 (0.01) 254 (0.06)
6 0 (0.00) 1 (0.00) 4 (0.00) 38 (0.01)
The number of donations in last 12 months for all donors in the March 2016 extract of PULSE is calculated on the 12 months
prior to March 2016; all other data in this table relating to ‘the last 12 months’ are calculated on the 12 months prior to
July 2016.
For venue, the percentages do not add up to 100% because of rounding.
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TABLE 11 Background characteristics of the population and respondents for the SP survey of male ex-INTERVAL
participants
Characteristic
Donors, n (%)
Responded to the
survey (N= 4754)
Eligible for the survey
(all invited) (N= 14,725)
Assessed for eligibility
for the survey (N= 22,249)
Age group (years)
17–30 253 (5.32) 1847 (12.54) 3210 (14.43)
31–45 897 (18.87) 3878 (26.34) 5798 (26.06)
46–60 1971 (41.46) 5743 (39.00) 8001 (35.96)
≥ 61 1633 (34.35) 3257 (22.12) 5240 (23.55)
Blood type
High demand 643 (13.53) 1946 (13.22) 2895 (13.01)
Standard demand 4111 (86.47) 12,779 (86.78) 19,354 (86.99)
Ethnicity
White 4464 (93.90) 3512 (91.76) 20,256 (91.04)
Black/mixed black 39 (0.82) 187 (1.27) 297 (1.33)
Asian/mixed Asian 106 (2.23) 494 (3.35) 784 (3.52)
Other or not stated 145 (3.05) 532 (3.61) 912 (4.10)
Nursery donor
Yes 18 (0.38) 421 (2.86) 2207 (9.92)
No 4736 (99.62) 14,304 (97.14) 20,042 (90.08)
Venue
Centre 4132 (86.92) 13,019 (88.41) 19,998 (89.88)
Mobile 622 (13.08) 1706 (11.59) 2251 (10.12)
Number of donations in past 12 months
0 154 (3.24) 2164 (14.70) 6914 (31.08)
1 278 (5.85) 1579 (10.72) 2239 (10.06)
2 552 (11.61) 2162 (14.68) 2907 (13.07)
3 1073 (22.57) 3084 (20.94) 3817 (17.16)
4 1699 (35.74) 3783 (25.69) 4248 (19.09)
5 853 (17.94) 1639 (11.13) 1752 (7.87)
6 145 (3.05) 314 (2.13) 372 (1.67)
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Results
The full results for the ordered logit models are presented in additional material available on the project
website. The incremental effects of changes in the levels of the different attributes were estimated using
the separate ordered logit models estimated for non-INTERVAL men and women and ex-INTERVAL men
and womem. The predicted changes in the annual frequency of donation are shown in Figures 7–18.
Figure 7 reports the results for the full male and full female samples of non-INTERVAL donors. Figures 8–11
report the results for four non-INTERVAL subgroups, namely 17- to 30-year-olds, high-demand blood types,
black/mixed black donors and nursery donors. Figure 12 reports the results for the full male and full female
samples of ex-INTERVAL donors. Figures 13–16 report the results for four ex-INTERVAL subgroups, namely
17- to 30-year-olds, high-demand blood types, black/mixed black donors and nursery donors.
TABLE 12 Background characteristics of the population and respondents for the SP survey of female ex-INTERVAL
participants
Characteristic
Donors, n (%)
Who responded to the
survey (N= 4179)
Eligible for the survey
(all invited) (N= 14,006)
Assessed for eligibility for
the survey (N= 22,621)
Age group (years)
17–30 431 (10.31) 2562 (18.29) 4761 (21.05)
31–45 1043 (24.96) 4293 (30.65) 7079 (31.29)
46–60 1609 (38.50) 4828 (34.47) 7147 (31.59)
≥ 61 1096 (26.23) 2323 (16.59) 3634 (16.06)
Blood type
High demand 580 (13.88) 2028 (14.48) 3193 (14.12)
Standard demand 3599 (86.12) 11,978 (85.52) 19,428 (85.88)
Ethnicity
White 3925 (93.92) 13,050 (93.17) 20,924 (92.50)
Black/mixed black 52 (1.24) 210 (1.50) 330 (1.46)
Asian/mixed Asian 76 (1.82) 286 (2.04) 502 (2.22)
Other or not stated 126 (3.02) 460 (3.28) 865 (3.82)
Nursery donor
Yes 65 (1.56) 1067 (7.62) 4085 (18.06)
No 4114 (98.44) 12,939 (92.38) 18,536 (81.94)
Venue
Centre 3639 (87.08) 12,387 (88.44) 20,377 (90.08)
Mobile 540 (12.92) 1619 (11.56) 2244 (9.92)
Number of donations in past 12 months
0 201 (4.81) 2883 (20.58) 8531 (37.71)
1 429 (10.27) 2203 (15.73) 3247 (14.35)
2 971 (23.24) 3175 (22.67) 4272 (18.89)
3 1952 (46.71) 4543 (32.44) 5238 (23.16)
4 617 (14.76) 1178 (8.41) 1298 (5.74)
5 6 (0.14) 12 (0.09) 13 (0.06)
6 3 (0.07) 12 (0.09) 22 (0.10)
For ethnicity, the percentages do not add up to 100% because of rounding.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 7 Incremental effect of alternative types of blood service on average number of donations per year for all non-INTERVAL respondents. For men (• n= 15,652) and
women (▴ n= 8329). The uncertainty intervals reflect the 5th and 9th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
      Maximum number of donations
 Four female, five male
 Six
FIGURE 8 Incremental effect of alternative types of blood service on average number of donations per year for non-INTERVAL respondents aged 17–30 years. For men
(• n= 1646) and women (▴ n= 1663). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 9 Incremental effect of alternative types of blood service on average number of donations per year for non-INTERVAL high-demand blood type respondent. For men
(• n= 1551) and women (▴ n= 921). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 10 Incremental effect of alternative types of blood service on average number of donations per year for non-INTERVAL respondents of black/mixed black ethnicity.
For men (• n= 98) and women (▴ n= 103). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target
population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2– 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 11 Incremental effect of alternative types of blood service on average number of donations per year for non-INTERVAL nursery respondents. For men (• n= 3542)
and women (▴ n= 3024). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2– 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 12 Incremental effect of alternative types of blood service on average number of donations per year for all ex-INTERVAL respondents. For men (• n= 4754) and
women (▴ n= 4179). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
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FIGURE 13 Incremental effect of alternative types of blood service on average number of donations per year for ex-INTERVAL respondents aged 17–30 years. For men
(• n= 253) and women (▴ n= 431). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 14 Incremental effect of alternative types of blood service on average number of donations per year for ex-INTERVAL high-demand blood type respondents. For men
(• n= 643) and women (▴ n= 580). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
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FIGURE 15 Incremental effect of alternative types of blood service on average number of donations per year for ex-INTERVAL respondents of black/mixed black ethnicity.
For men (• n= 39) and women (▴ n = 52). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant
target population.
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
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FIGURE 16 Incremental effect of alternative types of blood service on average number of donations per year for ex-INTERVAL nursery respondents. For men (• n= 18) and
women (▴ n= 65). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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These figures have a common structure. Throughout, • refers to men and ▴ refers to women. Consider,
for example, Figure 7. The first row describes the mean (95% uncertainty intervals) under the current
service configuration (status quo). All subsequent rows report the average predicted annual donation
frequency according to the specific attribute and level in question, and in the absence of any other
changes in the opportunities to donate. So in the figures the next three rows indicate the predicted effect
of changes in travel time. Thus, for example, if travel time were to increase by 30 minutes, it is predicted
that men would, on average, make 1.4 fewer donations per year and women would make 1.1 fewer
donations per year. Similarly, if opening hours were to change from the status quo to 2–8 p.m., the model
predicts that men would provide 0.5 more donations per year and women 0.3 more donations per year.
There are four important general findings. First, the estimated incremental effects are very much in line with
prior expectations. Thus, increases in travel time are predicted to reduce the annual number of donations.
Extending evening opening hours is predicted to increase the annual number of donations. Improved
availability of appointments is predicted to increase donations, whereas reduced availability of appointments
is predicted to decrease the number of donations. Introduction of a health report is predicted to increase
the number of donations. Reducing the minimum interval between donations (increasing the maximum
number of donations permitted annually) is predicted to increase the number of donations. Second, although
there are some subgroup differences, the similarities in the results across subgroups are more striking than the
differences. Thus, for example, introduction of a health report is associated with a relatively small increase in
frequency of donation for all subgroups. For all subgroups the greatest impact is with respect to increases in
travel time. Reducing the interval between donations such that annual opportunities to donate increase by 1
is predicted to increase annual donations on average by about 0.5. Third, although there are differences in
incremental effects between men and women, they are generally not large. The greatest differences are with
respect to increased travel time and reduced appointment availability. Fourth, these general characterisations
of the results apply to both the non-INTERVAL and ex-INTERVAL donors, although, interestingly, the predicted
effect of reducing minimum interdonation intervals is about two-thirds greater for ex-INTERVAL donors than
for non-INTERVAL donors.
Tables 13–16 report, for the different attribute levels, the predicted percentage of respondents from the
ordered logit model who indicate ‘I would probably not donate’. This is done for all attribute levels and by
the levels of donor characteristics. The baseline represents the individual-level service configuration the
donor experienced at their last donation. Tables 13–16 present this information for male non-INTERVAL,
female non-INTERVAL, male ex-INTERVAL and female ex-INTERVAL respondents, respectively. Increased
travel time is associated with markedly higher proportions of ‘stop donating’ responses. Opportunities to
donate in the evening and greater availability of appointments are associated with lower proportions of
‘stop donating’ responses. Provision of a health report is associated with a slightly lower proportion of
‘stop donating’ responses. Finally, increases in the maximum number of donations permitted annually are
associated with lower proportions of ‘stop donating’ responses.
Several patterns by subgroup can be observed in these data. The older the age group, the less frequently
they give the ‘I would probably not donate’ response. Generally, men are less likely than women to say
that they would stop donating. Although the difference is not marked, high-demand blood type respondents
are less likely than standard-demand blood type respondents to say that they will stop donating. For all
attribute levels, the proportion of ‘stop donating’ responses by nursery donors exceeds that of non-nursery
donors. Among non-INTERVAL donors, those whose last donation was made at a donor centre were less
likely to indicate that they would stop donating than those who last donated at a mobile session. Among
non-INTERVAL donors, there is a tendency for black/mixed black donors to give a ‘stop donating’ response
more often than other ethnic groups. Among ex-INTERVAL donors, there is a tendency for Asian/mixed Asian
donors to give a ‘stop donating’ response more often than other ethnic groups. More frequent donation in
the past 12 months is associated with lower percentages of ‘stop donating’ responses for men and women
in both the non-INTERVAL and ex-INTERVAL surveys.
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TABLE 13 Percentage of male non-INTERVAL respondents who would stop donating for each level
Level All
Age group (years) Blood type Ethnicity
Nursery
donors Venue
Number of donations in last
12 months
17–30 31–45 46–60 ≥ 60
Standard
demand
High
demand White
Black/mixed
black
Asian/mixed
Asian
Other or
not stated Yes No Centre Mobile 1 2 3 4 5 6
Baseline 18 25 21 17 14 19 17 18 24 21 16 22 18 15 19 24 19 15 13 10 7
Travel time
10 minutes shorter 20 26 23 19 16 20 19 20 19 22 15 23 19 16 20 25 20 17 14 11 7
15 minutes longer 31 44 37 30 24 31 32 31 34 35 26 37 30 24 32 40 32 26 21 15 10
30 minutes longer 46 60 53 44 36 46 44 46 44 41 41 50 45 37 47 53 47 41 36 29 23
Opening times
9 a.m.–12 p.m. and
2 p.m.–5 p.m.
18 26 21 17 14 19 17 18 25 21 16 22 18 16 19 24 19 15 13 10 7
9 a.m.–5 p.m. 20 27 23 19 16 20 19 20 23 24 17 23 19 16 20 25 20 17 14 10 8
9 a.m.–8 p.m. 15 16 16 15 15 15 15 15 17 18 16 18 14 10 16 19 16 13 10 7 6
2 p.m.–8 p.m. 12 12 12 12 11 12 11 12 13 14 11 14 11 11 12 15 12 10 8 7 5
Appointment availability
Every day:
Monday–Sunday
12 13 12 12 12 12 12 12 18 16 12 13 12 11 12 15 12 11 9 8 6
Every weekday:
Monday–Friday
19 24 21 18 16 19 18 19 35 26 19 21 18 19 19 24 20 16 14 11 10
1 day every 2 months:
Monday–Friday
25 35 29 23 19 25 24 25 32 31 22 30 23 24 29 32 26 21 17 14 12
1 day every 2 months:
Saturday or Sunday
19 22 20 18 17 19 18 19 31 21 19 21 18 22 18 22 19 17 15 13 12
Health report provided
Health report 16 22 18 15 12 16 15 16 17 17 13 18 15 13 16 20 16 13 11 8 6
Maximum number of
donations: five
13 16 14 12 11 13 12 13 16 17 12 15 12 10 13 18 13 10 7 5 3
Maximum number of
donations: six
10 10 9 10 10 10 8 9 16 14 9 12 9 7 10 15 10 6 4 2 1
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TABLE 14 Percentage of female non-INTERVAL respondents who would stop donating for each level
Level All
Age group (years) Blood type Ethnicity
Nursery
donors Venue
Number of donations in
last 12 months
17–30 31–45 46–60 ≥ 60
Standard
demand
High
demand White
Black/mixed
black
Asian/mixed
Asian
Other or
not stated Yes No Centre Mobile 1 2 3 4 5
Baseline 20 28 22 17 13 20 18 20 25 20 20 24 18 18 20 24 19 16 15 14
Travel time
10 minutes shorter 20 27 22 18 15 21 19 20 21 19 22 24 19 18 21 23 20 17 17 15
15 minutes longer 37 47 40 33 27 37 33 37 37 33 35 41 34 31 37 43 36 30 26 22
30 minutes longer 50 59 53 47 41 50 48 50 47 44 50 53 48 43 51 54 50 45 43 35
Opening times
9 a.m.–12 p.m. and
2 p.m.–5 p.m.
20 29 23 17 13 21 18 20 26 22 21 24 18 21 20 24 20 16 15 25
9 a.m.–5 p.m. 20 28 22 17 13 20 18 20 22 16 17 23 18 16 20 23 19 16 15 14
9 a.m.–8 p.m. 21 24 22 21 19 22 19 21 26 22 22 24 20 10 23 25 21 17 14 9
2 p.m.–8 p.m. 13 16 14 12 11 13 12 13 16 14 12 15 12 12 13 16 13 11 9 12
Appointment availability
Every day: Monday–Sunday 16 18 17 15 14 16 15 16 18 18 22 19 15 12 17 19 16 13 11 6
Every weekday:
Monday–Friday
29 36 31 26 22 29 26 28 36 35 35 33 26 24 29 33 28 24 22 14
1 day every 2 months:
Monday–Friday
21 31 23 17 13 21 19 21 26 22 22 25 19 28 20 25 20 17 16 13
1 day every 2 months:
Saturday or Sunday
19 23 20 17 15 19 17 19 25 17 22 21 18 24 18 22 19 16 14 9
Health report provided
Health report 19 27 21 15 12 19 17 19 19 19 18 22 16 17 19 22 18 15 13 13
Maximum number of
donations: four
11 16 13 10 8 12 10 11 14 11 13 15 10 8 12 16 10 7 5 3
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TABLE 15 Percentage of male ex-INTERVAL respondents who would stop donating for each level
Level All
Age group (years) Blood type Ethnicity
Nursery
donors Venue INTERVAL arm=
Number of donations in last
12 months
17–30 31–45 46–60 ≥ 60
Standard
demand
High
demand White
Black/mixed
black
Asian/mixed
Asian
Other
or not
stated Yes No Centre Mobile Control
Reduced
intervals 0 1 2 3 4 5 6
Baseline 18 31 24 18 13 18 17 18 18 29 21 44 18 18 21 20 17 28 25 21 19 17 14 13
Travel time
10 minutes shorter 19 28 24 19 16 19 19 19 18 28 23 45 19 19 20 21 19 30 26 23 20 18 16 14
15 minutes longer 26 41 34 26 21 27 23 26 26 37 23 37 26 26 33 29 25 40 36 32 28 24 21 19
30 minutes longer 41 63 53 40 31 41 36 40 48 53 47 86 41 41 42 40 41 58 51 46 42 38 36 34
Opening times
9 a.m.–12 p.m. and
2 p.m.–5 p.m.
18 31 25 18 13 18 17 18 13 31 20 46 18 18 21 19 18 27 24 21 19 17 15 14
9 a.m.–5 p.m. 18 31 25 18 13 18 17 18 22 28 21 41 18 18 22 20 17 30 26 22 19 17 14 12
9 a.m.–8 p.m. 14 17 15 14 13 14 14 14 10 14 13 25 14 13 19 15 14 21 19 17 15 13 11 10
2 p.m.–8 p.m. 15 17 16 15 14 15 13 14 13 16 19 38 15 15 13 15 14 21 18 16 15 14 13 12
Appointment availability
Every day:
Monday–Sunday
15 21 18 15 13 15 15 15 11 21 18 26 15 15 17 16 15 22 20 18 16 14 13 12
Every weekday:
Monday–Friday
18 31 25 18 14 19 17 18 20 31 20 42 18 18 22 20 18 29 25 22 19 17 15 14
1 day every 2 months:
Monday–Friday
24 40 32 23 17 24 25 24 15 38 21 47 24 24 21 24 24 37 31 27 24 22 20 19
1 day every 2 months:
Saturday or Sunday
24 36 30 24 20 24 24 24 21 25 21 37 24 24 23 24 24 34 29 27 25 23 22 21
Health report provided
Health report 16 26 21 15 12 16 15 16 21 23 17 28 16 15 19 17 15 26 22 19 17 14 12 11
Maximum number of
donations: five
9 15 12 9 7 9 9 9 11 14 12 22 9 9 11 10 9 18 15 12 10 8 7 6
Maximum number of
donations: six
5 6 6 5 4 5 5 5 3 5 6 29 5 5 6 5 4 15 10 7 5 3 2 2
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TABLE 16 Percentage of female ex-INTERVAL respondents who would stop donating for each level
Level All
Age group (years) Blood type Ethnicity
Nursery
donors Venue INTERVAL arm=
Number of donations in last
12 months
17–30 31–45 46–60 ≥ 60
Standard
demand
High
demand White
Black/mixed
black
Asian/mixed
Asian
Other or
not stated Yes No Centre Mobile Control
Reduced
intervals 0 1 2 3 4 5 6
Baseline 19 33 25 17 12 19 21 19 27 19 18 41 19 18 23 19 19 31 27 21 17 14 11 10
Travel time
10 minutes shorter 21 33 26 18 14 20 22 21 23 16 19 39 20 20 23 21 20 32 28 22 19 16 11 10
15 minutes longer 31 47 38 28 22 31 34 31 45 28 25 58 31 31 30 31 31 48 41 33 28 25 18 14
30 minutes longer 46 62 54 44 36 46 46 46 54 41 41 72 46 47 38 45 46 61 55 47 44 41 33 33
Opening times
9 a.m.–12 p.m. and
2 p.m.–5 p.m.
21 37 28 18 12 21 23 21 27 23 21 44 21 21 23 20 22 35 30 23 19 16 11 10
9 a.m.–5 p.m. 18 31 23 15 11 17 18 18 28 17 16 39 17 17 20 18 18 29 25 19 16 13 10 8
9 a.m.–8 p.m. 12 16 14 12 11 12 14 12 13 15 11 21 12 12 18 13 12 18 16 14 11 10 8 6
2 p.m.–8 p.m. 14 18 16 14 12 14 15 14 14 18 19 27 14 14 14 15 14 22 19 15 13 11 9 9
Appointment availability
Every day:
Monday–Sunday
15 22 18 14 12 15 16 15 19 14 15 30 15 14 21 15 16 24 21 17 14 12 12 10
Every weekday:
Monday–Friday
20 35 26 18 13 20 22 20 28 21 19 41 20 19 28 20 21 32 29 22 18 15 16 14
1 day every 2 months:
Monday–Friday
21 37 28 19 13 21 24 21 28 21 21 39 21 21 23 23 20 34 30 23 19 15 15 15
1 day every 2 months:
Saturday or Sunday
25 33 28 24 21 25 27 25 49 19 21 34 25 26 21 26 25 32 30 26 24 22 25 21
Health report provided
Health report 18 31 23 15 11 18 18 18 23 16 17 40 17 17 23 18 18 29 25 19 16 13 10 9
Maximum number of
donations: four
7 14 10 6 4 7 7 7 8 9 8 19 7 6 11 8 7 17 13 8 5 4 2 1
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There is a fairly mixed picture when comparing the percentages of ‘stop donating’ responses across
ex-INTERVAL and non-INTERVAL donors, except that ex-INTERVAL nursery donors consistently make fewer
‘stop donating’ responses than non-INTERVAL nursery donors.
Figures 17 (men) and 18 (women) compare the incremental effects on annual donations for the
non-INTERVAL donors whose last donation was at a static donor centre, and for ex-INTERVAL donors who
were in the control arm (thus not exposed to an increase in the maximum number of donations permitted
annually). Figure 17 shows similar patterns for the two groups; however, non-INTERVAL respondents are
more responsive to increased travel time, and ex-INTERVAL respondents are more responsive to increases
in the maximum permitted number of donations. The results for women follow a similar pattern to the
male results but, generally, any differences between the two groups are not statistically significant, possibly
reflecting the smaller numbers of respondents.
The discrepancy between mean ‘stated’ and mean ‘observed’ donations is shown for non-INTERVAL
respondents in Figures 19 (men) and 20 (women). ‘Stated’ consistently exceeds ‘observed’ for men
by nearly 20%, whereas the discrepancy for women was negligible. The comparable discrepancies for
ex-INTERVAL respondents, shown in Figures 21 and 22, indicate stated donations as less than observed
donations for both men (< 10%) and women (about 15%).
The incremental effects of changing attribute levels were estimated for all donors, and for high-demand
blood type donors, using a gamma model and a two-part model (for both the non-INTERVAL and
ex-INTERVAL respondents). The results are shown in Appendices 9–16. The overall pattern of incremental
effects is very similar to that reported in the Figures 7, 9, 12 and 14 (based on the ordered logit model),
respectively. The only systematic difference is that the estimated response to reductions in the minimum
donation interval is slightly reduced when estimated by the gamma and two-part models as compared
with the ordered logit model.
Discussion
The SP surveys provide plausible estimates of the effects of alternative future changes to the blood collection
service on the stated frequency of donation. We find that reducing the minimum recall period between
whole-blood donations, or changing appointment availability to include weekends or evenings, leads to
moderately large increases in the stated frequency of blood donation. By contrast, the introduction of a
donor health report is predicted to have a relatively small effect on the stated frequency. These findings are
in line with our a priori hypotheses, and with feedback from whole-blood donors attending the translation
workshops (see Appendix 17). A general concern with the use of SP surveys for service evaluation is that
there may be ‘hypothetical bias’; responders tend to overstate their willingness to provide a publicly funded
service with altruistic features.59 However, we found that for men who completed the non-INTERVAL survey,
the average annual frequency of donation from the survey responses was only moderately higher than the
actual donation frequency, for women the discrepancy was minimal, and for both sexes the discrepancy was
similar across subgroups. These findings applied to the current blood service characteristics experienced by
the survey responders. This provides a reasonable basis for the subsequent CEA to assume that the relative
estimates of service changes predicted from the survey responses predict the effect of future changes to the
blood collection service on donation frequency.
A potentially important finding from both surveys is that donors are willing to donate more often if there
are more frequent opportunities to donate, in particular if the minimum interval between invitations is
reduced. This implies that the overall findings from the INTERVAL trial could apply to donors attending
static centres outwith the trial setting. The survey results also extend the trial findings in showing that
the reduced interval strategies are predicted to increase donation frequency when considered against,
or alongside, alternative changes to the blood service. Of potential policy relevance is the finding that
appointment availability at weekends is predicted to increase donation frequency for those subgroups
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Five
 Six
FIGURE 17 Incremental effect of alternative types of blood service on average number of donations per year for male, high-demand blood type non-INTERVAL respondents
who donated at a static centre and male ex-INTERVAL control arm respondents. For men, high-demand blood type non-INTERVAL respondents who donated at a static centre
(• n= 137) and male ex-INTERVAL control arm respondents (• n= 211).
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four
FIGURE 18 Incremental effect of alternative types of blood service on average number of donations per year for female, high-demand blood type non-INTERVAL respondents
who last donated at a static centre and female ex-INTERVAL control arm respondents. For women, high-demand blood type non-INTERVAL respondents who last donated at
a static centre (▴ n= 78) and female ex-INTERVAL control arm respondents (▴ n= 78).
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FIGURE 19 Discrepancy between the mean number of ‘observed’ and ‘stated’ donations per year for male non-INTERVAL respondents. The error bars reflect the 95% CI
around the average discrepancy in the predicted vs. observed number of donations per year.
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FIGURE 20 Discrepancy between the mean number of ‘observed’ and ‘stated’ donations per year for female non-INTERVAL respondents. The error bars reflect the 95% CI
around the average discrepancy in the predicted vs. observed number of donations per year.
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FIGURE 21 Discrepancy between the mean number of ‘observed’ and ‘stated’ donations per year for male ex-INTERVAL respondents. The error bars reflect the 95% CI around
the average discrepancy in the predicted vs. observed number of donations per year.
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FIGURE 22 Discrepancy between the mean number of ‘observed’ and ‘stated’ donations per year for female ex-INTERVAL respondents. The error bars reflect the 95% CI
around the average discrepancy in the predicted vs. observed number of donations per year.
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where additional blood donations may be of relatively high value, for example donors with blood types
that are of ‘high demand’, donors whose ethnicity was defined as BAME, and nursery donors, who tend
to be more difficult to retain. The finding that increasing travel time will reduce donation frequency and
increase the rate with which donors leave the register is not surprising, but does have potential policy
implications. The NHSBT policy has been to close smaller mobile sessions (i.e. three and six beds), and
invest more resources in new static donor centres. Further moves that imply that donors will have to travel
longer distances would be predicted to reduce the pool of donors, including those donors whose blood
type is in high demand. Future evaluations should recognise the predicted reduction in the donor pool
when evaluating the cost-effectiveness of further ‘switching’ of blood collection from mobile sessions to
static donor centres.
The SP surveys have several strengths. First, the sample sizes (around 24,000 non-INTERVAL donors;
9000 ex-INTERVAL donors) are large compared with previous surveys, including DCEs in the evaluation of
health services,60 and enable the surveys to provide precise estimates, not just overall, but for subgroups
of prime interest. Specifically, we provided precise estimates of the relative effects of alternative service
changes for subgroups for which it is particularly important to identify strategies that increase the blood
supply, namely blood donors with high-demand blood types, BAME donors and nursery donors (all by sex).
This will allow the analysis to estimate interaction effects of the inter-related attributes required for the
subsequent CEA of alternative strategies. Second, the study administered three surveys in total. The pilot
survey was important to check that the survey design provided plausible estimates, and to refine the
design by modifying the choice of attributes and levels to try to reflect ‘real-life’ donations. In particular,
an additional attribute concerning the availability of blood donation appointments was included in both
main surveys. Feedback from the first donor translation workshop was that the definition of the attribute
was clear and that the levels specified were relevant both to donors attending donor centres and to those
attending mobile sessions (see Appendix 17). The second (non-INTERVAL) and third (ex-INTERVAL) surveys
elicit preferences (donation frequencies) from donors attending predominantly mobile sessions and static
donor centres, respectively. It was also useful to administer the same SP survey to two groups of donors
who had, and had not, experienced the INTERVAL trial protocols. Third, the analytical model (ordered logit)
respected the particular form of response data. We also undertook a thorough sensitivity analysis that
considered other modelling choices and found that the direction and magnitude of estimated effects
were robust to these choices (see Report Supplementary Material 7). Fourth, this study used appropriate
methods for eliciting preferences and adopted recommended design principles.46 The study therefore
provides a more robust basis for predicting future donation behaviour than previous surveys of blood
donors’ preferences.7–11
The limitations of the surveys are that, first, it was infeasible to include all the attributes and levels of future
policy relevance. Inevitably, choices had to be made according to those aspects of the service most likely
to be of future importance for service provision and in line with best practice for survey design; we have
reported the rationale for these choices. Second, although the response rates to the surveys were higher than
anticipated, around 75% of invited donors did not complete questionnaires. Furthermore, as in the INTERVAL
trial, donors who did not have an e-mail address were excluded. Rather than assuming that the requisite
survey data were ‘missing completely at random’, we assumed that they were ‘missing at random’, that is,
conditional on the variables included in the model.53 Nonetheless, the estimates could be biased because of
unobserved differences between the responders and the target population of prime interest. Third, although
the discrepancy analysis found that the donation frequency predicted was similar to that observed, this did
not consider the relative effect of service changes. These limitations have to be recognised in interpreting the
subsequent findings of the CEAs that use the SP survey results.
The estimates from the SP survey presented in this chapter are not in themselves sufficient to inform the
choice of future strategies for the following reasons. First, some of the strategies of interest require that
several of the attributes are combined. For example, the strategy that specifies that a static donor centre is
open at weekends requires estimates from the interaction of appointment availability and opening times
attributes. This can then provide the requisite estimates of the effects of a weekend or evening opening
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strategy in static donor centres (see Chapter 4). Second, the responders to the survey do not represent the
target population of interest, which may differ according to the strategy. However, the estimates presented
in this chapter can be used to predict the relative effects of the alternative changes to the blood service
for the relevant populations for each of the strategies considered in the CEA of the alternative strategies.
Third, the survey results suggest that the introduction of a health report would lead to a relatively small
increase in annual donation frequency, whereas strategies that would extend appointment availability
would lead to greater increases in annual donation frequency. However, it will also be important to consider
the relative costs of the alternative strategies. Chapter 4 will address these issues, using the estimates from
the SP surveys to evaluate the cost-effectiveness of alternative strategies for maintaining the supply of
whole blood.
DONORS’ PREFERENCES FOR ALTERNATIVE CHANGES TO THE BLOOD COLLECTION SERVICE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
54
Chapter 4 Cost-effectiveness analysis
Introduction
This chapter draws on results of the INTERVAL trial analysis (see Chapter 2), and the findings of two
large surveys of donors’ preferences (see Chapter 3), to answer the broader question of which strategies
available to the NHSBT are likely to represent value for money for the NHS in England. The NHSBT’s strategic
objective is to reduce costs while maintaining the blood supply to the NHS, particularly the supply of blood
types in high demand (O–, A– and B–). The research presented in this chapter addresses the third project
objective pertaining to the cost-effectiveness of alternative strategies for maintaining the supply of whole
blood. We focused on six strategies, which are all designed to improve opportunities for donors to give blood
or make blood donation more attractive to donors. These were (1) offering a health report, (2) extending
opening hours at static donor centres to weekends, (3) extending opening hours at static donor centres to
evenings, (4) shifting opening hours of mobile sessions to weekends, (5) shifting opening hours of mobile
sessions to evenings and (6) reducing the minimum interval between donations for donors attending static
donor centres. These strategies are not mutually exclusive and may be implemented in combination and in
conjunction with other initiatives. All six strategies are likely to increase the total volume of blood collected,
which will come at additional cost. Given that the overall demand for whole blood is falling, the NHSBT
would need to combine these strategies with other initiatives to release resources, several of which are
already in progress, such as the closure of three- and six-bed mobile sessions in favour of more efficient
nine-bed sessions. This analysis provides evidence to inform future decisions about the allocation of
resources. The NHSBT may be prepared to invest to encourage more frequent donations by particular
types of donors, such as those with high-demand blood types. Alternatively, these strategies could be
adopted in such a way that the collection of higher demand blood types could be substituted for the
collection of other blood types, by offering the service change described in each strategy exclusively to
these groups of donors, for example by offering preferential appointments at certain times of the day
or week.
This chapter sets out the methods used to identify the relevant target populations for each strategy
(see Methods, Target population), defines the relevant comparator according to service provision recently
experienced by donors (the status quo; see Methods, Comparator) and outlines those subgroups relevant
to the analysis (see Methods, Subgroups). We describe how the preferences of non-trial participants from
the SP survey were modelled to predict the donation frequency of all recent blood donors and how these
were combined with deferral rates estimated from the INTERVAL trial (see Chapter 2) to predict the likely
effect of each strategy on the volume of blood collected (see Methods, Predicted effect on the volume of
blood donated). Relevant costs measured from a NHS and Personal Social Services perspectives over a 1-year
time horizon are described (see Costs), with further details provided in Appendices 19 and 20. The results are
presented for each target population for all donors, and donors with high-demand blood types (see Results,
Base-case analysis), with results for other subgroups provided in additional material available on the project
website. Key assumptions made in the analysis are tested with sensitivity analysis (see Methods, Sensitivity
analysis and Results, Sensitivity analysis) and are discussed in relation to the main findings (see Discussion).
Strategies of interest
Six strategies of interest were identified through a review of NHSBT strategy documents, market research,
an informal review of relevant published literature, consultation with NHSBT colleagues and insights
from preliminary qualitative research with INTERVAL donors (R Lynch and S Cohn, LSHTM, personal
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communication, October 2015). Twelve initiatives were initially considered, of which six were selected for
evaluation, details of which are described in Appendix 1. The six chosen strategies were:
1. provision of health report for all whole-blood donors after every donation
2. static donor centres open at weekends in addition to current opening hours
3. static donor centres open on weekday evenings in addition to current opening hours
4. mobile sessions held at weekends (once every 2 months) instead of existing weekday sessions
5. mobile sessions held on weekday evenings (once every 2 months) instead of existing weekday
daytime sessions
6. reduced minimum intervals between whole-blood donations for men and women, such that men were able
to donate whole blood up to six times a year and women up to four times a year in static donor centres.
Each strategy involved a single change to the blood collection service compared with the current service,
as experienced by those donors who would be affected by the service change (described in Methods,
Comparator and summarised in Table 17). These changes are not mutually exclusive and are not scalable
to the same degree, so we compared each potential change to the relevant status quo for that specific
change. A 1-year time horizon was adopted because the longer-term demand for blood is unclear and
understanding the costs and benefits of the alternative strategies compared with the status quo over a
shorter time horizon was considered by the NHSBT to be more useful for decision-making.
Methods
Target population
The relevant population for the evaluation was whole-blood donors who successfully gave blood at
least once in the 12 months prior to March 2016 and who reside in mainland England. This population
represents the NHSBT’s core donor base and, therefore, the donors for whom it will be most important
to examine the potential effects of each strategy. This population excluded new and lapsed donors,
but included some donors who were not eligible for our SP survey (e.g. donors without an e-mail address).
In order to evaluate the potential impact of the strategies, we made some assumptions about which
donors would be affected by each change to the service.
Conceivably, all donors could be offered a health report after each donation, as specified in our SP survey.
The target population for the health report strategy is therefore all donors who met our initial criteria
(donors who gave blood in the 12 months and who reside in mainland England).
The donors who would be affected by strategies 2–5 are defined by the donor’s most recent blood
donation experience prior to March 2016 (see Chapter 3, Analysis of annual frequency of donation from
the stated preference surveys). We assumed that donors who last visited a static donor centre would
not be affected by changes to the opening hours of mobile sessions, and similarly that changes to static
donor centres would not affect donors who last gave blood at a mobile session. We also assumed that
the strategies to enable donors to give blood at weekends and weekday evenings would not affect those
donors who had already been able to donate at these times at their most recently attended session and
venue. The target population for strategy 2, to open static donor centres at weekends, was therefore all
donors who last gave blood at a static donor centre that was not normally open at weekends. The target
population for strategy 3, to open static donor centres on weekday evenings, was all donors who last gave
blood at a static donor centre in a session that did not permit a blood donation visit at 8 p.m. or later.
The target population for strategy 4, to hold mobile sessions on a Saturday or Sunday once every 2 months,
was defined by all donors who last gave blood at a mobile session – because no mobile sessions were
routinely open at weekends. The target population for strategy 5, to hold mobile sessions on weekday
evenings until 8 p.m., was all donors who last gave blood at a mobile session that did not permit a blood
donation visit at 8 p.m. or later (see Chapter 3, Analysis of annual frequency of donation from the stated
preference surveys).
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The strategy of reduced minimum intervals between donations (strategy 6) was judged as unlikely to apply
to mobile sessions and so the target population was limited to donors who attended static donor centres
at their last visit. The minimum interval was defined according to the lowest investigated in the INTERVAL
trial (8 weeks for men; 12 weeks for women). The number of donors in each target population is reported
in Table 17, along with a summary of the key methodological standpoints.
Comparator
For each target population, the status quo or comparator for each strategy was defined by the service-level
characteristics at each donor’s most recent blood donation visit using data from PULSE (see Figure 6).
Tables 18 and 19 show the numbers and percentages of donors who donated blood in the last 12 months
and who reside in mainland England. Fifteen static donor centres were routinely open at weekends (56%
of donations at static donor centres); five static donor centres offered sessions until 8 p.m. on weekday
evenings (8% of donations at static donor centres). The majority of donors, 86%, last donated at mobile
sessions, which are usually held during weekday daytime hours (Table 19).
These service-level characteristics were used in the SP model to predict donation frequencies under the
status quo, according to each individual donor’s personal characteristics.
Subgroups
The main subgroup of interest for the CEA was donors with high-demand blood types. The results of the
cost-effectiveness analysis were reported by subgroup. In doing so, we assumed that the strategies would be
offered to these groups exclusively, for example, a health report is given only to donors with high-demand
blood types and these donors are offered preferential appointments at certain times of the day or week.
Other subgroups of interest in the main analysis of SP survey data were also of interest in the CEA: ethnicity,
nursery/non-nursery donors, age, sex and number of donations in the 12 months prior to March 2016.
Strategies 2 and 3 were assumed to affect only donors who last gave blood at a static donor centre and
strategies 4 and 5 were assumed to be of relevance only to donors who last gave blood at a mobile session,
so results are not reported by static donor centre/mobile session subgroup. The relevance of other subgroups
is likely to vary by strategy, as some subgroup results may be more likely to influence the implementation of
that particular strategy. For example, results by sex may be important to understand the effect of reducing
the minimum donation interval, but would be unlikely to affect the decision of whether or not to open
at weekends.
Predicted effect on the volume of blood donated
The CEA required predictions of the average volume of blood donated per donor under each strategy
for the relevant target population of current whole-blood donors, recognising that some appointments
may be deferred. We initially calculated the annual frequency of intended blood donation visits before
and after the service change. We predicted the intended number of visits according to the status quo by
combining the estimated coefficients from the results of the ordered logit models applied to the SP survey
data for the non-INTERVAL respondents (see Chapter 3, Analysis of annual frequency of donation from the
stated preference surveys) with the relevant PULSE data for the appropriate target population. The same
model and target population were then used to predict the number of visits following the introduction of
each strategy, with the level of each relevant attribute switched to reflect the service change, for example
the introduction of the health report (see Table 17). The models used the estimated interaction effects
of venue for last donation (static centre vs. mobile session) with change in the level of each attribute
(e.g. appointment availability or not) to provide predictions specific to the strategy in question
(e.g. opening static donor centres at the weekend, see Table 17).
We fitted the ordered logit models to the full sample of responders to the non-INTERVAL survey (see
Chapter 3), but then limited the target population for the prediction to those donors whose PULSE data
showed that they did not have access to the service change in question at their last donation appointment
(see Tables 18 and 19). So, for example, the effect of providing weekend appointments in donor centres
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TABLE 17 Overview of the cost-effectiveness analysis
Strategy
Target population of
interest
Effectiveness
Costs Sensitivity analysis
Source of effectiveness
data
Attribute levels to
switch
1. Provision of a health
report for all donors
Donors who gave blood
in the 12 months prior to
March 2016
n= 781,028
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a mobile session or
donor centre
Deferral rates: INTERVAL
control arm
Health report not provided
→ health report provided
Opportunity cost of
measuring blood pressure
and a cholesterol test at
each donation
Communication of abnormal
tests
Opportunity cost of deferrals
Variable cost of blood
collection (weighted average
of donor centre and mobile
session)
Alternative source of
effectiveness data: SP survey of
INTERVAL participants in control
arm only
Alternative variable cost of
collecting blood at static
donor centres
2. Weekend opening at
static donor centres
Donors who gave blood in
the 12 months prior to
March 2016 who last donated
at a static donor centre not
routinely open at weekends
n= 60,640
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a donor centre
Deferral rates: INTERVAL
control arm
Appointment availability:
‘Every weekday:
Monday–Friday’ → ‘Every
day: Monday–Sunday’
Opportunity cost of deferrals
Variable cost of collecting
blood (disposables and
invitations only)
Unsocial hours payment
and normal staff costs for
additional blood donations
Alternative source of
effectiveness data: SP survey of
INTERVAL participants in control
arm only
3. Weekday evening
opening at static donor
centres
Donors who gave blood in
the 12 months prior to March
2016 who last donated at a
static donor centre not open
until 8 p.m.
n= 99,312
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a donor centre
Deferral rates: INTERVAL
control arm
Current opening hours
→ 9 a.m.–8 p.m.
Opportunity cost of deferrals
Variable cost of collecting
blood (disposables and
invitations only)
Unsocial hours payment
and normal staff costs for
additional blood donations
Alternative source of
effectiveness data: SP survey of
INTERVAL participants in control
arm only
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Strategy
Target population of
interest
Effectiveness
Costs Sensitivity analysis
Source of effectiveness
data
Attribute levels to
switch
4. Weekend opening of
mobile sessions
All who gave blood in the
12 months prior to March
2016 who last gave blood at
a mobile session which is not
routinely open at weekends
n= 646,898
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a mobile session
Deferral rates: INTERVAL
control arm
Appointment availability
‘1 day every 2 months:
Monday–Friday’ → ‘1 day
every 2 months: Saturday
or Sunday’
Opportunity cost of deferrals
Variable cost of collecting
blood (including cost of
disposables and invitations,
but excluding cost of staff,
travel and venue hire)
Unsocial hours payment for
additional blood donations
Alternative source of
effectiveness data: SP survey of
INTERVAL participants in control
arm only
5. Weekday evening
opening of mobile
sessions
All donors who gave blood in
the 12 months prior to March
2016 who last gave blood at
a session in a mobile site
which is not routinely open
until 8 p.m. on weekday
evenings
n= 582,910
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a mobile session
Deferral rates: INTERVAL
control arm
Current opening hours
→ 2 p.m.–8 p.m.
Opportunity cost of deferrals
Variable cost of collecting
blood (including cost of
disposables and invitations,
but excluding cost of staff,
travel and venue hire)
Unsocial hours payment for
additional blood donations
Alternative source of
effectiveness data: ex-INTERVAL
SP survey, control arm only
6. Shorter minimum
interval between
donations for both men
and women (static
centres only)
All who gave blood in the
12 months prior to March
2016 who last gave blood
at a static donor centre
n= 107,811
Stated preference survey of
non-INTERVAL participants
Predictions apply ordered
logit model estimates to
donors who last donated
at a mobile session or
donor centre. Deferral rates:
INTERVAL control arm
Maximum number of
donations per year:
Men four → six times per
year and women three
or four times per year
Opportunity cost of deferrals
Variable cost of collecting
blood (for disposables and
invitations only)
Alternative source of
effectiveness data: ex-INTERVAL
SP survey, control arm only
Use observed donation
frequency of participants in
INTERVAL trial (the average
annual donation frequency over
2 years; 8 weeks vs. 12 weeks
for men; 12 weeks vs.
16 weeks for women)
Alternative variable cost of
collecting blood at static centres
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was predicted only for those donors who did not have the opportunity to donate at the weekend at their
last donation visit.
The primary measure of effectiveness was the total volume of blood collected per year, in units of whole
blood. We calculated the volume of blood that would be collected under each strategy by subtracting the
predicted number of deferrals from the predicted frequency of intended blood donation visits. The predicted
deferral rate was taken from the INTERVAL trial data (control arm only for strategies 1–5, relevant trial arm
for strategy 6), and subtracted from the predicted number of blood donation visits at the individual level.
This adjustment for the likely number of deferrals provided estimates of the expected number of units of
blood donated per donor per year, according to donor characteristics (see Chapter 2). The approach to
incorporating the deferral rate recognised that the rate would differ according to the absolute frequency
of intended blood donation.
The incremental effect of each strategy was calculated as the difference between the predicted mean
volumes of blood before and after each potential service change. For example, the estimated effect of
the introduction of a health report on the annual frequency of donation, overall and according to donor
characteristics, was used to predict the effect of introducing this change for the relevant target population.
We multiplied the predicted annual number of units of blood donated per donor by the number of donors
in the target population to calculate the annual total volume of blood collected. We also used the estimates
from the ordered logit model to report the proportion of donors who stated that they would stop donating
before and then after the service change.
TABLE 18 Current service characteristics for donors depending on the venue of their most recent blood donation:
donors who last gave blood at a static donor centre
Opening hours
Appointment availability, n (%)
Weekdays only Monday–Sunday Total
9 a.m.–12 p.m. and 2 p.m.–5 p.m. 25,009 (23) 17,615 (16) 42,624 (40)
9 a.m.–5 p.m. 17,849 (17) 38,839 (36) 56,688 (53)
9 a.m.–8 p.m. 1 (0) 27 (0) 28 (0)
2 p.m.–8 p.m. 4312 (4) 4159 (4) 8471 (8)
Total 47,171 (44) 60,640 (56) 107,811 (0)
The percentages do not add up to 100% because of rounding.
TABLE 19 Current service characteristics for donors depending on the venue of their most recent blood donation:
donors who last gave blood at a mobile session
Opening hours
Appointment availability, n (%)
Monday–Friday Saturday or Sunday Total
9 a.m.–12 p.m. and 2 p.m.–5 p.m. 565,276 (84) 24,482 (4) 589,758 (88)
9 a.m.–5 p.m. 17,634 (3) 1837 (0) 19,471 (3)
9 a.m.–8 p.m. 0 (0) 0 (0) 0 (0)
2 p.m.–8 p.m. 63,988 (10) 0 (0) 63,988 (10)
Total 646,898 (96) 26,319 (4) 673,217 (0)
COST-EFFECTIVENESS ANALYSIS
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This approach is predicated on several assumptions. First, we assumed that the relative effects (on donor
donation frequency) observed in the SP survey accurately represent the future donation behaviour in
the respondents to the survey. As reported in Chapter 3, we found that for men there was a moderate
discrepancy between stated and observed donation frequency, and for women the discrepancy was
negligible; for both sexes the magnitude of the discrepancy was constant across subgroups.58 We
considered whether or not the CEA findings were robust to the source of data for predicted donation
frequency by using the donation frequencies estimated from the INTERVAL trial as an alternative source of
data for the alternative minimum donation interval strategies (see Methods, Sensitivity analysis). Second,
we assumed that the predictive model accurately predicted the relative effect of the strategy on the volume
of blood donated, which required that (1) the status quo attributes assigned to each donor provided an
accurate prediction of the current volume of blood donated and (2) the preferences of responders to the
survey represented those of donors in the target population, conditional on the variables in the model.
We explore the impact of two alternative predictive models on the cost-effectiveness analysis (see Methods,
Sensitivity analysis). Third, we assumed that the deferral rates from the INTERVAL trial applied to the
target population of interest, after recognising differences in observed donor characteristics between the
INTERVAL trial participants and the target population of interest for the specific strategy concerned.
Costs
The costs captured in the CEA were those relevant to the NHS and Personal Social Services, not just the
costs borne by the NHSBT. The costs considered were the variable cost of collecting an additional unit
of blood, costs associated with each specific strategy and the cost of deferrals, which have been shown
to increase with donation frequency (see Chapter 2). Costs beyond 1 year were not included. Although
processing costs are a significant driver of total cost, they were assumed to remain constant across
strategies. Unit costs are detailed in full in Appendix 18.
In estimating the costs of the alternative strategies, a key distinction was made between the setting (static
donor centre or mobile session) where the changes would be introduced. The changes to opening hours
and to appointment availability for donor centres (strategies 2 and 3) were assumed to be an addition to
the collection times available under the status quo. The implication for the costing was that these additional
sessions would therefore require additional staff time. In contrast, in the case of mobile sessions, it was
assumed that evening sessions or weekend availability (strategies 4 and 5) would replace existing sessions.
The ensuing assumption for unit costs was that existing sessions at other times of the day or week would
close, and the staff redeployed to provide these sessions in the evenings or at weekends.
Variable cost of collecting one unit of blood
The calculation of the unit cost of collecting an additional unit of blood required assumptions to be
made about the capacity of mobile sessions and static donor centres to collect additional units of blood
within their current resource constraints. Current data reveal that, on average, mobile sessions operate at
95% capacity, whereas sessions at donor centres operate on average at 75% capacity. Owing to the high
operating capacity of mobile sessions, in our base-case analysis we assumed that strategies 4 and 5 would
require additional resource to collect any additional units of blood. For strategies 1 and 6 it was assumed
that there is capacity to collect more blood at donor centres within existing constraints posed by the
number of beds and staffing levels.
Strategies 2 and 3 consider weekend and evening opening hours in static donor centres. The NHSBT advises
that it would be feasible to consider opening static donor centres for blood collection at these times only as
an addition to, rather than as a substitute for, current available appointment times. Hence, the cost analyses
recognised that these strategies would require additional staff to collect additional units of blood. In order
to meet this requirement, staff costs are captured in the analysis in order to reflect the true variable cost of
collecting additional blood. For these two strategies, the cost of collecting an additional unit of blood at
donor centres also includes the cost of disposables used (one copper sulphate test, one preoperative skin
preparation and one pack per successful donation) and the cost of invitations (5.3 invitations per unit of
blood collected at a donor centre) (NHSBT financial data 2015/16) (Laura Hontoria Del Hoyo, NHSBT,
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June 2016, personal communication; Colin Jackson, NHSBT, April 2017, personal communication). This
equates to a cost of £9.41 per additional unit of blood collected.
For all strategies undertaken in mobile sessions, the costing approach recognised that, as the sessions are
almost at capacity, more staff time will be required if additional units of blood are to be collected. The
variable cost of collecting an additional unit of blood at a mobile session includes staffing, travel and venue
costs, in addition to the cost of disposables and the cost of invitations (2.85 invitations per unit of blood
collected at a mobile site) (based on NHSBT financial data 2015/16). This equates to a cost of £35.61 per
additional unit of blood collected.
We test the main underlying assumption within the sensitivity analysis in Methods, Sensitivity analysis.
Strategy-specific costs
Unsocial hours payments
According to the NHS Agenda for Change61 (the current NHS grading and pay system for NHS staff), unsocial
hours payments are owed to staff who work beyond 8 p.m. on weekdays or on Saturdays (any time), and a
higher rate on Sundays and public holidays. The rate depends on pay band (donor carers NHS pay band 4,
nurses NHS pay band 6). Pay rates were calculated according to standard NHS sources.62 The cost to collect
an extra unit of blood at a mobile session at a weekend was calculated as the weighted average of working
on a Saturday or Sunday, instead of during weekday daytime hours, assuming staffing levels and efficiency of
a nine-bed session where 3 units of blood can be collected per bed per hour. This reflects the shift from
‘Appointment availability: 1 day every 2 months Monday–Friday’ to ‘Appointment availability: 1 day every
2 months Saturday or Sunday’. The additional cost of shifting a 6-hour mobile session into the evening was
calculated by assuming that 2 hours of a 9.35-hour shift would incur the unsocial hours payment.
The cost of collecting blood at the weekend or on weekday evenings at a static donor centre was different
because strategies 2 and 3 considered an extension to opening hours, reflecting the shift in attribute levels
from ‘Appointment availability: every weekday Monday–Friday’ to ‘Appointment availability: every day
Monday–Sunday’. Thus, the cost of extending static donor centre opening hours to the weekend consists
of the additional cost of employing staff to work during these hours (assuming session length of 8.5 hours,
shift of 9.35 hours). The cost of extending static donor centre opening hours into a weekday evening
consists of a 1-hour unsocial hours payment (assuming a session length of 12 hours, shift of 13.1 hours).
Health report
We assumed that the health report would consist of blood pressure and cholesterol readings. For cholesterol
readings we assumed that this would be carried out alongside other routine tests taken on a sample of
donated blood, at an additional cost of £4.20 per sample.63 We assumed that measurement of blood pressure
would be taken by the donor’s carer during the placement of the cuff prior to donation, but that this would
require an additional 1.5 minutes. Owing to the travel required by mobile teams, donor contact time is more
expensive in a mobile session than at a static donor centre. Costs for a blood pressure monitor (AND UA-767S
Digital Blood Pressure Monitor, Williams Medical Supplies, Rhymney, UK)64 assumed a lifetime of 5000 uses
in the base case. We assumed that the health report would be provided in an online format that would incur
no additional costs to the NHSBT. Finally, we assumed that 2% of tests would require some form of clinical
follow-up that would take the form of a mailed letter (estimated cost £0.55). This estimate reflects the
ongoing nature of the tests and that any particularly concerning test results are likely to be detected and
resolved at the first screen rather than generate clinical follow-up costs on an ongoing basis. The potential
costs and benefits of a health report were limited by the 1-year time horizon.
Cost of deferrals
The cost of deferrals was included for all strategies. Donors can have their donation deferred as a result
of low haemoglobin levels or for other reasons (donors who are not eligible to donate blood because
of reasons, such as travel, medication, lifestyle or infection/illness).
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Owing to low haemoglobin
We assumed that a donor undergoing a deferral for low levels of Hb would first receive a donor screen
undertaken by a donor carer. This would be followed by a copper sulphate test for low levels of Hb. Failure of
this test would then lead to confirmation of low levels of Hb with a HemoCue® (HemoCue, Radiometer Medical
ApS, Denmark). We assumed that each step would be undertaken by a donor carer. The time taken for donor
carers to undertake a health screen and fingerprick test and then a HemoCue test was estimated by NHSBT
colleagues. The cost of the reagents for the copper sulphate test was estimated from NHSBT financial data,
in 2016/17 prices. The cost of a HemoCue® machine and consumables (cuvettes) was taken from an online
source (£700 for a machine and £188 for 200 cuvettes).65 We did not adjust these costs for ‘bulk discounts’
but noted that the costs per test are modest. With regard to HemoCue lifetime we assumed 5000 uses in
the base case. We used baseline data from the INTERVAL trial to inform the assumption that 7% of donors
who defer because of low levels of Hb would incur downstream health-care costs. This included a general
practitioner (GP) appointment, a full blood count test and a serum ferritin test.62,66,67 We assumed that 50% of
these donors would require iron supplements and 10% would be referred for an outpatient appointment.68,69
Owing to other reasons
We assumed that in the case of deferrals for other reasons, donors would require a health screen and that
this would typically take 2 minutes and would be carried out by a donor carer.62
End points
The following end points will be reported:
l incremental mean volume of blood collected per donor per year (in units of whole blood)
l incremental cost per donor per year
l incremental cost per additional unit of whole blood collected
l incremental volume of blood collected per year for the target population (in units of whole blood)
l incremental cost per year for the target population
l change in percentage of donors who are predicted to stop donating after the service change.
The incremental cost per donor for each strategy compared with the status quo was calculated as
the difference in the cost of collecting the mean volume of blood per donor before and the predicted
mean volume of blood after the service change, in addition to the strategy-specific costs. Calculations to
determine the incremental costs of each strategy are provided in Appendix 19. It is important to note that
the incremental costs for an additional unit of blood apply only to the additional units of blood collected
beyond the current volume of blood collected by the NHSBT.
Sensitivity analysis
The analysis considered the impact of two forms of uncertainty on the model results – parameter
uncertainty and structural uncertainty. To assess the impact of parameter uncertainty we carried out a
probabilistic analysis. We resampled estimates of the incremental volume of blood donated from a gamma
distribution 10,000 times. This choice of the gamma distribution, which does not allow negative values
(in this case for estimates of the incremental volume of blood donated), was informed by the results of the
ordered logit model, which reported that the incremental effects of each strategy change were positive.
Unit costs were not subject to parameter uncertainty; uncertainty in incremental costs therefore reflects the
uncertainty in the volume of blood collected and associated resource use. Neither the uncertainty in the
estimation in the model of the SP survey responses nor the uncertainty in the estimation in the model for
estimating deferrals from the INTERVAL data is characterised in the probabilistic sensitivity analysis.
The probabilistic sensitivity analysis was rerun to examine the impact of two key structural assumptions of
the results. First, we examined the impact of our base-case assumption about current operating capacity.
If static donor centres do not have the required capacity, as may occur at the most popular appointment
times and/or venues, more blood cannot be collected without incurring the cost of additional staff time.
The probabilistic analysis was rerun with a variable cost of collecting a unit of blood that included
DOI: 10.3310/hsdr06400 HEALTH SERVICES AND DELIVERY RESEARCH 2018 VOL. 6 NO. 40
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Grieve et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
additional staffing costs for the additional units of blood collected at static donor centres. This cost is
not employed for strategies 2 and 3, which already include additional staff costs (as these strategies
represent the extension of current opening hours), but did affect strategies 1 and 6. The variable cost of
collecting an additional unit of blood collected at a donor centre used in this sensitivity analysis was
increased from £9.41 in the base case to £26.49 (see Appendix 18).
Second, we considered alternative predictive models using a two-part model and gamma model rather
than the ordered logit model chosen for the base-case analysis (see Chapter 3, Appendices 9–14 and
Report Supplementary Material 7). Third, we considered alternative sources of data for predicting the volume
of blood donated under the alternative strategies. The average annual frequency of donation observed over
the 2-year follow-up in the INTERVAL trial was used to estimate the incremental effect for strategy 6 only
(8-week arm vs. control arm, 12 weeks for men and the 12-week arm vs. control arm, 16 weeks for women).
The accompanying uncertainty in the trial estimate was propagated through the model. We also used the
results from the SP survey of ex-INTERVAL participants who had been randomised to the control arm in the
trial. The benefit of using these data is that all INTERVAL participants have experience of donating at a donor
centre but have not been exposed to the intervention (in this case, a reduction in the minimum donation
interval), which is thought to influence behaviour.
Results
Base-case analysis
For each of the new strategies compared with the status quo, the incremental (differences in means)
volumes of blood collected, incremental cost and incremental cost per additional unit of blood are
reported for the relevant target population. The incremental results are presented in Tables 20 and 21;
absolute values are reported in full in additional material on the project website.
The results predict that donors would be willing to donate blood more often if changes to the service
described in all six strategies were adopted, but that this would incur additional costs. Given the current
service and personal characteristics of the target populations, the base-case results predict that donors, on
average, successfully give blood between 2.2 and 2.5 times per year (see additional material on the project
website; http://hemo.lshtm.ac.uk, accessed November 2018). We now consider each of the strategies versus
the status quo, according to the additional units of blood donated per donor. Strategy 6, reducing the
minimum donation interval, is predicted to provide the highest gain in the volume of whole blood collected
per donor over 1 year, after allowing for the predicted increase in deferrals. The results suggest that, if asked
to donate at the shortest minimum interval considered in the INTERVAL trial, donors at static donor centres
would, on average, donate 0.68 additional units of blood per year. The strategy that leads to the next largest
gain in the volume of whole blood per donor is to extend all donor centres opening times to weekends for
all 25 static centres (strategy 2), followed by opening all donor centres into the evening. Opening mobile
sessions at weekends (strategy 4) and offering a health report (strategy 1) after each donation are predicted
to have the smallest impact, 0.07 and 0.11 additional units per donor, respectively.
The incremental cost per donor per year ranges from £3.16 to £18.12. This represents only the variable
cost of collecting the additional blood yield per donor according to the methods set out in the different
strategies. The strategy to substitute mobile weekday sessions to sessions held at weekends is the cheapest
(£3.16), yet this strategy is associated with the smallest predicted increase in blood donation.
The strategies are ranked in order of their cost-effectiveness in Table 20. At a cost of £136 per additional
unit of blood, the health report strategy is not likely to be cost-effective. It is associated with a high cost
(£15.34 per donor per year) because all donors donating will receive a health report, yet it results in a
small gain in blood volume (0.11 units per donor per year). The cost per additional unit of blood gained
with the other strategies ranges from £10 to £45. Offering mobile sessions at weekends is predicted to
have the smallest increase in donation frequency because our analysis assumes that weekend sessions will
COST-EFFECTIVENESS ANALYSIS
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TABLE 20 Base-case results: cost-effectiveness of each strategy vs. relevant status quo comparator, for all donors
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood collected
per donor per year
0.113 0.519 0.455 0.070 0.484 0.678
Incremental cost per donor per
year (£)
15.33 15.21 10.46 3.16 18.12 6.71
Incremental cost of collection,
per donor per year (£)
3.58 14.95 10.24 3.12 17.89 6.38
Incremental cost of deferrals,
per donor per year (£)
0.05 0.26 0.22 0.03 0.23 0.33
Incremental cost of health report,
per donor per year (£)
11.71 0.00 0.00 0.00 0.00 0.00
Cost per additional unit of
blood (£)
136.00 29.00 23.00 45.00 37.00 10.00
Ranking (1 – most cost-effective
strategy; 6 – least cost-effective
strategy)
6 3 2 5 4 1
Number of donors affected by
service change
781,028 60,640 99,312 646,898 582,910 107,811
Incremental units of blood collected
per year across target population
88,189 31,483 45,233 45,405 282,152 73,130
Incremental costs per year across
target population (£)a
11,977,545.00 922,051.00 1,038,927.00 2,042,047.00 10,563,294.00 723,908.00
a Refers to the additional costs across the target population.
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TABLE 21 Base-case results: cost-effectiveness of each strategy vs. relevant status quo comparator, for donors with high-demand blood
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood collected
per donor per year
0.100 0.489 0.408 0.030 0.199 0.714
Incremental cost per donor per
year (£)
15.27 14.29 9.34 1.35 7.46 7.02
Incremental cost of collection,
per donor per year (£)
3.17 14.09 9.17 1.34 7.37 6.72
Incremental cost of deferrals,
per donor per year (£)
0.04 0.21 0.17 0.01 0.09 0.30
Incremental cost of health report,
per donor per year (£)
12.05 0.00 0.00 0.00 0.00 0.00
Cost per additional unit of
blood (£)
152.00 29.00 23.00 45.00 37.00 10.00
Ranking (1 – most cost-effective
strategy; 6 – least cost-effective
strategy)
6 3 2 5 4 1
Number of donors affected by
service change
111,948 7965 12,874 94,258 85,075 13,884
Incremental units of blood collected
per year across target population
11,214 3896 5250 2829 16,970 9920
Incremental costs per year across
target population (£)a
1,708,888.00 113,819.00 120,228.00 127,098.00 634,620.00 97,511.00
a Refers to the additional costs across the target population.
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be offered instead of existing weekday sessions. Given that the predicted change in the volume of blood is
so small, the incremental cost per donor is also small, resulting in an incremental cost per additional unit of
blood of £45. The next best strategy in term of cost-effectiveness is to shift the opening hours of mobile
sessions into the evening (strategy 5). This strategy is predicted to result in the third highest donation
frequency of donors, but bears the high cost of collecting more blood at a mobile session in addition to a
relatively small unsocial hours payment (for 2 hours of the shift).
Proposed changes to static donor centre opening days (strategy 2) and times (strategy 3) are predicted
to increase donation frequency by 0.52 and 0.46 additional units per donor, respectively, and can be
achieved at a relatively low cost per donor, despite the need to employ staff to work unsocial hours in
addition to existing session times. Strategy 3, associated with an incremental cost of £23 per additional
unit of blood collected, is more cost-effective than strategy 2, as unsocial hours payments are payable for
only 1 hour of these sessions compared with the whole of the weekend session.
At £10, the strategy with the lowest cost per additional unit of blood gained is to reduce the minimum
donation frequency (strategy 6). This is the strategy that is predicted to have the biggest increase in
donation frequency, at a modest cost, but an outstanding concern about this strategy is the increased
rate of deferrals because of low levels of Hb and their associated cost to the service. Although these costs
have been included up to 1 year, the longer-term effects of this strategy have not been considered.
Graphs showing the probability that each strategy is cost-effective compared with the current status quo,
as willingness to pay for an additional unit of blood increases, can be found in Appendix 20. The cost-
effectiveness acceptability curves (CEACs) presented are extremely steep, representing the precision in the
estimation of effect, with the model used to analyse the large sample for the SP survey.
A summary of the base-case cost-effectiveness results is presented in Table 20 for all donors (men and
women) and then separately in Table 21 for donors with high-demand blood types. For a breakdown of the
base-case results, overall and by subgroup, see Report Supplementary Material 8. From a policy perspective,
the NHS might be willing to pay more for blood types of high demand or to release resources from
elsewhere in order to collect more of these blood types. The cost-effectiveness results show that, if the
service changes for each strategy were offered only to high-demand donors, the ranking of the strategies
would not change. In fact, only the cost of the health report varied, because this cost accrued for all
donations, not just additional donations. Given the responses to the SP survey, donors of black, mixed
black, Asian and mixed Asian ethnicities were predicted to donate more frequently than donors of other
ethnicities when offered the health report, but not sufficiently to significantly offset the associated costs.
The cost per unit of additional blood was on average £69 for black/mixed black donors and £102 for Asian/
mixed Asian donors, compared with £136 for all donors (Table 22). Strategy 4, opening mobile sessions at
weekends, resulted in fewer donations from donors of black and mixed black ethnicities. The results for
other subgroups showed slight changes in the incremental cost per unit of blood but no change in the
ranking of strategies. These results can be found in full in the additional material on the project website.
Table 23 shows the percentages of donors who would stop donating in response to the six strategies;
all of the strategies result in fewer donors deciding to stop donating than the status quo. The strategies
most likely to retain donors were reducing the minimum interval between donations, weekend opening
at static donor centres and evening opening of mobile sessions. Donors with high-demand blood types
were less likely to decide to stop donating in response to the possible service changes than other donors.
Conversely, black and mixed black donors were more likely than donors of other ethnicities to decide to
stop donating across all strategies.
Tables 20 and 21 also report the predicted number of donors affected by each strategy, as well as the
potential yield in terms of the maximum number of units of blood that could be collected via each strategy
and the total associated cost. If the NHSBT was willing to pay £10 for an additional unit of whole blood,
they could adopt the strategy to reduce the minimum donation interval and collect just over 73,000 units
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TABLE 22 Summary of cost-effectiveness analysis according to cost per additional unit of blood for each strategy vs. status quo, by subgroup
Target population
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Base case: all donors 136 29 23 45 37 10
Base case: all male donors 109 29 23 44.8 37 10
Base case: all female donors 210 30 23 45 38 10
Base case: all donors with
high-demand blood types
152 29 23 45 37 10
Base case: all donors with
standard-demand blood types
133 29 23 45 38 10
Base case: all nursery donors 132 29 23 43 38 10
Base case: all non-nursery donors 138 29 23 45 37 10
Base case: all white donors 141 29 23 42 37 10
Base case: all black/mixed black
donors
69 30 23 49 38 10
Base case: all Asian/mixed Asian
donors
102 30 23 41 38 10
Base case: all donors of other
ethnicity or not stated
115 29 23 48 37 10
Base case: all donors aged
17–30 years
132 29 23 45 38 10
Base case: all donors aged
31–45 years
135 29 23 45 38 10
Base case: all donors aged
46–59 years
136 29 23 45 37 10
Base case: all donors aged
≥ 60 years
142 29 23 45 37 10
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TABLE 23 Reduction in percentage of donors who will stop donating after the service change, by subgroup
Subgroup
Strategy (%)
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
All donors 2 9 8 2 9 9
High-demand blood type donors 3 8 6 2 10 8
Standard-demand blood type donors 1 11 9 3 9 10
Black/mixed black donors 2 8 7 1 4 9
Asian/mixed Asian mixed donors 2 10 8 2 5 9
White donors 2 11 9 4 11 9
Other ethnicity or not stated 2 8 7 1 8 9
Nursery donors 2 9 8 2 9 9
Non-nursery donors 7 16 8 1 13 10
Donors aged 17–30 years 3 12 8 4 10 8
Donors aged 31–45 years 3 10 7 1 9 8
Donors aged 46–60 years 2 13 11 7 16 11
Donors aged ≥ 60 years 2 10 8 3 11 9
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of whole blood (of which 9919 units would be from high-demand blood types). If more blood was
required, the next best strategy is keeping donor centres open on weekday evenings, which could yield
over 45,000 units of blood at a higher cost of £23 per additional unit of blood.
Sensitivity analysis
Assuming no additional capacity to collect more blood at donor centres
When staff costs are included in the variable cost per unit of blood for strategies 1 and 6, the cost per
additional unit of blood for the strategies increases, ranging from £23 to £138, as shown in Table 24
(for sensitivity analysis results presented in full, see Appendix 21). The ranking of strategies in terms of their
cost-effectiveness also changes. Now, strategies 2 and 3 are compared with other strategies that also bear
the cost of employing additional staff to collect extra units of blood, and are predicted to result in a higher
donation frequency. Evening opening hours at donor centres is the most cost-effective strategy, at £23 per
additional unit of blood collected, followed by strategy 6 (to reduce the minimum donation interval), at
£27 per additional unit of blood, closely followed by strategy 2 (to open static donor centres at weekends).
As in the base case, the strategy to offer a health report remains cost-ineffective, at £139 per additional
unit of blood. The cost-effectiveness ranking of strategies for high-demand donors is the same, with similar
cost per additional unit of blood to all donors (see Table 24).
Alternative predictive models
Estimates of the predicted change in mean annual donation frequency were carried out using two
alternative predictive models (see Appendices 9–16 and Report Supplementary Material 7), the two-part
model and the gamma model as described in Chapter 3, Analysis of annual frequency of donation from the
stated preference surveys, instead of the ordered logit predictive model used in the base-case analysis. The
results showed that both the two-part model and the gamma model predicted slightly higher mean annual
donation frequencies according to current service level characteristics than the ordered logit model, and also
resulted in bigger increments for several strategies than the base-case model. The ranking of strategies, in
terms of the volume of blood collected, differed slightly according to the predictive model employed, in part
because of how close some of the predicted incremental volumes of blood estimated (for each strategy)
were to each other. Both the two-part model and the gamma model predicted a smaller increment
associated with a reduction in the minimum donation interval for donors giving blood at donor centres.
Instead, the two-part model predicted the biggest increment in the volume of blood collected for weekday
evening openings of static donor centres, whereas the gamma model predicted that the biggest change
would be observed in opening donor centres at weekends. Both models predicted that more blood would
be donated if mobile sessions were offered on weekday evenings than in the base-case analysis. However,
in terms of cost-effectiveness, the ranking of strategies did not change compared with the base case. The
incremental cost per additional unit of blood was the same in the base-case analysis, except for very small
changes to the health report strategy (see Table 24).
Source of data for prediction of volume of blood donation: estimates from ex-INTERVAL
survey data
The sensitivity analysis, using estimates of effect from the stated preference, of ex-INTERVAL participants
survey data, again, resulted in predictions of bigger increases in donation frequency for all strategies,
except the strategy to open static donor centres at weekends (see Table 24). The prediction for strategy 6
(to reduce the minimum donation interval) resulted in donors giving blood more than one additional time
per year (0.36 times per year more than in the base-case analysis). The ranking of strategies in terms of
cost-effectiveness did not change from the base-case analysis (see Table 24).
Source of data for prediction of volume of blood donation: estimates from the
INTERVAL trial
The sensitivity analysis, using estimates of effect from the INTERVAL trial to predict the impact of each strategy
on donation frequency and cost, revealed very similar estimates of cost-effectiveness as the base-case analysis,
using estimates from the stated preference survey of non-INTERVAL donors (see Table 24). Owing to the
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TABLE 24 Summary of cost per additional unit of blood for base-case analysis and sensitivity analyses for all donors and donors with high-demand blood types, by strategy
Cost per additional unit blood (£)
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval at
static donor centres
Base case: all donors 136.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, higher variable cost of
collecting blood at static donor centres to
include staff costs: all donors
138.00 29.00 23.00 45.00 37.00 27.00
Sensitivity analysis, using two-part model
as alternative predictive model: all donors
129.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, using gamma model as
alternative predictive model: all donors
127.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, using ex-INTERVAL SP
survey to predict change in volume of
blood: all donors
114.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, using INTERVAL trial
data to predict change in volume of blood:
all donors
n/a n/a n/a n/a n/a 11.00
Base case: donors with high-demand
blood types
152.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, higher variable cost of
collecting blood at static donor centres
to include staff costs: donors with
high-demand blood types
155.00 29.00 23.00 45.00 37.00 27.00
Sensitivity analysis, using two-part model
as alternative predictive model: donors
with high-demand blood types
147.00 29.00 23.00 45.00 37.00 10.00
continued
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TABLE 24 Summary of cost per additional unit of blood for base-case analysis and sensitivity analyses for all donors and donors with high-demand blood types,
by strategy (continued )
Cost per additional unit blood (£)
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval at
static donor centres
Sensitivity analysis, using gamma model as
alternative predictive model: donors with
high-demand blood types
134.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, using ex-INTERVAL SP
survey to predict change in volume of
blood: donors with high-demand blood
types
116.00 29.00 23.00 45.00 37.00 10.00
Sensitivity analysis, using INTERVAL trial
data to predict change in volume of blood:
donors with high-demand blood types
n/a n/a n/a n/a n/a 11.00
n/a, not applicable.
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sample size of the INTERVAL trial, compared with the stated preference survey, the estimates of effect were
slightly less precise (see Appendix 20), which reveals a slightly less steep CEAC.
Discussion
This analysis has estimated the relative cost-effectiveness of offering whole-blood donors a health report
at each donation (strategy 1), extending static donor centre opening hours to weekends (strategy 2) and
weekday evenings (strategy 3), shifting mobile sessions to weekends (strategy 4) and weekday evenings
(strategy 5), and reducing the minimum interval between donations (strategy 6) – all compared with the
status quo (current practice). The results showed that the most cost-effective strategies are those that
would be implemented solely in donor centres, rather than those that would be implemented at mobile
sessions or at both types of venue (strategy 1). The findings were similar across all the subgroups of donors
considered, including those donors whose blood types are in relatively high demand. For BAME subgroups,
the incremental cost per additional unit of blood for the health report was £69 (compared with £135 for
the overall sample), which implies that the health report was still relatively cost-ineffective, although it
should be recognised that the sample size of BAME donors was relatively small for both surveys.
Strategy 6, reducing the minimum interval between donations to the shortest minimum interval for donors
of both sexes at donor centres, is predicted to have a relatively low additional variable cost of £10 per
additional unit of whole blood collected. The strategies to extend opening times in static donor centres to
weekday evenings and weekends can also provide additional units of whole blood at moderate additional
costs, an extra £23 and £29 per additional unit of blood collected, respectively. In other words, if the
NHSBT were to adopt these strategies, it would cost an extra £10 to £29 in variable costs for each unit of
blood collected beyond the current volume.
The NHSBT currently collects almost 1.6 million units of whole blood at a cost to the NHS of £120 per unit.
This cost covers the whole supply chain (collections, processing, transport, testing, donor marketing,
hospital services, storage and donor records), so is not directly comparable to the variable costs applied in
this analysis. The proportion of the £120 charge per unit that is attributable to blood collection is around
40%, and, hence, the comparable amount paid for a unit of blood, which includes both variable and fixed
costs, is around £48. The NHSBT has recently closed small mobile sessions as the costs per unit of blood
collected were relatively high (> £50 per unit). The incremental cost for an additional unit of blood for
all strategies except the health report, therefore, seems to be within an acceptable range, although the
cost-effectiveness threshold remains unknown. This is particularly the case for approaches to providing
more units of high-demand blood types: the NHSBT might be prepared to release more resources to pay
for an additional unit of these blood types or substitute the collection of other blood types. In contrast,
we find that the introduction of the health report is likely to be cost-ineffective.
The results were generally robust to the base-case assumptions concerning the source of data, as well as
the choice of model used to predict donation frequencies from the survey data. The results were somewhat
sensitive to the assumption that there is sufficient capacity at static donor centres to collect extra blood
with existing levels of staff. When the costs of additional static donor centre staff were included, the strategy
of reducing the minimum interval between donations became slightly less cost-effective compared with
the status quo. The results suggest that up to 73,130 units of blood could be collected by reducing the
minimum interval between donations for donors who give blood at static donor centres; this would be a
29% increase in the volume of blood collected at donor centres in 2015/16. Current staffing constraints
would not be sufficient to support the collection of additional blood in this quantity. However, if the extra
collection of blood was limited to high-demand blood types (up to 9900 units), it is feasible that this could
be accommodated at times and locations sufficiently convenient for donors to give blood at the frequency
predicted by their survey responses. Alternative approaches to providing more whole blood from the
high-demand subgroup of donors would be to extend the opening times for static donor centres into
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weekday evenings or weekends. These strategies would provide additional capacity for whole-blood
collection in static centres at a reasonable incremental cost per additional unit.
This analysis adds to the limited literature on the cost-effectiveness of alternative changes to the blood
collection service.18–28 Strengths of this analysis include the consideration of strategies of live policy
relevance, the results of which provide timely evidence to inform decision-making. The analysis was based
on the results of two large SP surveys, which had a combined sample size of > 30,000 whole-blood donors
in England. Responders had given blood within the past 12 months and donors attending mobile sessions
and static donor centres were well represented across the two surveys. The SP surveys were developed
to offer flexibility in assessing the potential impact of changing different aspects of the blood service for
two very different types of blood donation experience (static donor centres and mobile sessions), including
aspects that do not currently exist (provision of a health report). Predictions from the SP survey model were
similar to the observed donation frequency of female donors, differing moderately from the observed
donation frequencies of male donors, and were similar across donor subgroups. The analysis draws on
the deferral rates observed in the INTERVAL trial over 2 years and provides predictions about the population
of prime relevance – the donors who live in mainland England and who gave blood in the past 12 months.
An important limitation of the analysis was that the 1-year time horizon did not allow for the costs and
consequences of the strategies to be fully considered. In particular, although the increased rate of deferrals
was captured in the analysis, the long-term effects of deferrals were not. The INTERVAL trial analysis found
that, after 2 years, those in the reduced interval arms had lower haemoglobin and more haemoglobin-related
deferrals. Beyond the health-care costs associated with treating donors with very low haemoglobin levels,
there may well be longer-term costs and consequences, such as a higher proportion of donors leaving
the donor register in response to repeated deferrals. Replacing donors is costly in terms of recruiting new
donors and the opportunity costs of replacing a regular donor with another who may prefer to donate
less frequently. The ensuing reduction in blood volume collected and the associated increase in costs could
render this strategy less cost-effective than our analysis suggests. Further research is required on deferral rates
over time. The INTERVAL extension study may provide opportunity to undertake such research, given that it
will collect data on participants for up to 3 years.
The additional unit costs included in the model may not correspond to the full variable cost of collecting
blood. Although the costs of deferrals to the service were included, we did not account for costs associated
with donors who did not attend (DNA) their appointment, although there is no evidence to suggest that the
rate of DNAs increases with higher donation frequency. Processing costs were excluded from the analysis,
but in the likely event that the NHSBT does not collect more blood, but different blood types, these costs
will not change. There may also be cost savings to the service not considered in the analysis. We did not
consider efficiency savings of relying on a smaller pool of donors who give blood more frequently, which
may be considerable, given the high cost of recruiting new donors and keeping them engaged in the
process of regular blood donation. In addition, we did not incorporate the effects of patients switching from
donation at mobile sessions to static donor centres (and vice versa). If opening hours increase at static donor
centres, it is likely that some donors will opt to give blood at static donor centres instead of at their usual
mobile session, an approach that may become more common if mobile sessions are closed. Savings made
from the closure of less efficient mobile sessions might therefore improve the cost-effectiveness of strategies
to improve opportunities to donate at static donor centres. Any cost savings would be specific to the
particular session, but could potentially offset the additional costs required to implement these strategies.
Direct costs to donors were not considered. Opportunity costs faced by donors in donating whole blood
more frequently may have been captured in their responses to the SP surveys, in terms of how often they
would donate. Costs such as travel expenses may affect donation behaviour, although, because they are
accrued in the pursuit of an altruistic act, including these costs in an analysis should be accompanied by
the incorporation of benefits to donors in terms of increased utility from blood donation itself.
COST-EFFECTIVENESS ANALYSIS
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Uncertainty in the model predictions on donation frequency and associated resource use was incorporated
in the probabilistic sensitivity analysis. Unit costs were assumed to be fixed; the largest were set by standard
NHS sources and contracts, so are unlikely to vary. Other sources of uncertainty, most importantly structural
uncertainty in the costing model and uncertainty in the extent to which SP surveys predict actual donor
behaviour in response to service changes, have not so far been explored.
In conclusion, this analysis found that, for whole-blood donors attending static donor centres, reducing
the minimum intervals between donations or extending the opening times for blood collection to include
weekday evenings or weekends would provide additional units of whole blood at moderate additional
variable costs compared with current practice. In contrast, although the introduction of a donor health
report or extending opening times for mobile sessions are also predicted to increase the volume of whole
blood donated, the additional costs are somewhat higher. The results of the analysis were consistent
across a large number of prespecified subgroups, including those of prime policy relevance: donors with
high-demand blood types, BAME donors, young donors and nursery donors. Chapter 5 will consider the
overall conclusions from all aspects of this research and the general strengths, limitations and overall
implications for the blood service and for further research.
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Chapter 5 Discussion and conclusions
The HEMO study consisted of three interlinked components: SP surveys to elicit donor preferences,a CEA of reduced interdonation intervals from the INTERVAL trial, and a CEA of alternative strategies
for maintaining the supply of whole blood to the NHS. An important finding from the SP surveys is that if
donors attending static centres are offered further opportunities to donate at weekends or on weekday
evenings, or if the minimum interval between blood donations is reduced, then they would be willing to
donate whole blood more frequently. The INTERVAL CEA found that, although the reduced interval strategy
might be a relatively cost-effective way of increasing donation frequency, it does increase the rate of
deferrals because of low levels of Hb. Hence, a concern about extending this strategy to routine practice is
that it may lead to reduced donor retention and higher costs in the long run.
The CEA of alternative strategies reports that further opportunities to donate at donor centres, such
as offering appointments at weekends or during weekday evenings, are relatively cost-effective ways of
increasing whole-blood donation, with low additional variable costs per unit of whole blood donated of
around £29 and £23, respectively. As the NHSBT has a fixed budget, and any additional costs will have to
be funded by releasing resources elsewhere, these further opportunities to donate could be limited to those
donor subgroups about which there is concern that future demand will exceed supply, in particular donors
whose blood type is in high demand. The required resources could be released, by for example, providing
fewer opportunities to donate for other donor subgroups, or closing those mobile sessions that have relatively
high costs per additional unit of blood collected (> £50 per additional unit of whole blood collected).
The surveys found that, on average, the introduction of a donor health report or moving mobile sessions
from weekdays to weekends leads to small increases in stated donation frequency, and so these strategies
are predicted to have, on average, relatively high costs per additional unit of blood collected. The survey
findings also suggest that if there are changes to the blood collection service that increase donors’ travel
time, for example closure of mobile sessions, will increase the proportion of donors who say they probably
would not donate. The survey results show that some of the subgroups of donors who are particularly
important to retain (BAME and younger donors) are relatively likely to say that they probably would not
donate if travel time is increased by 15 or 30 minutes.
Patient and public involvement
The views of blood donors and a public representative informed the design of the research and the
interpretation and implications of the findings. The choice of strategies for evaluation was informed
by discussions with blood donors and suggestions from a public representative. Blood donors guided the
design of the SP surveys by suggesting aspects of the service that might be important to change, including
extending donation opportunities to weekday evenings and weekends. Blood donors also identified
attributes that should not be included, for example financial payment for donating blood, and provided
insights on what the questionnaire recipient might be thinking when attempting to answer the questions.
The questionnaire design was also informed by findings from qualitative research on blood donors’ views,
which suggested that it was important to recognise that donors may prefer to continue to donate at
the same venue rather than a different setting, irrespective of other features of an opportunity to donate
(R Lynch and S Cohn, LSHTM, personal communication, October 2015). The design of the SP survey was
informed by a large pilot study of blood donors; donors and the public representative reviewed the donor
information and consent forms prior to submission to the NHS Research Ethics Committee. The eventual
CEA was driven by the responses to the surveys administered to large numbers of blood donors, both those
who were previously participants in the INTERVAL trial (n = 9318) and those who were not (n = 25,187).
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The translation workshops with donors were an important element of the research. The first translation
workshop was undertaken following the preliminary analysis of the first SP survey, and it offered insight
into the early interpretation of the preference results. It also endorsed the changes to the survey design,
made in response to the results of the pilot study. The second translation workshop allowed the research
team to gather views on the overall cost-effectiveness findings from the project and provided insights as to
how they should best be communicated to donors and what, from the donors’ perspective, should be the
priorities for future research.
Strengths
The study provided estimates of the relative cost-effectiveness of alternative strategies of direct policy
relevance for donor subgroups of prime interest. The results presented extend the limited extant literature
on the cost-effectiveness of alternative strategies for maintaining the blood supply. In particular, the direct
input of the NHSBT during the design stage ensured that the study considered those strategies of prime
relevance for key subgroups of interest. This required the use of evidence from three complementary sources:
a large well-conducted RCT, SP surveys and the NHSBT donor registry. The INTERVAL trial provided estimates
of the relative effect of reduced donation intervals on donor health and on a key concern – relative rates of
deferral for donors attending static donor centres. The surveys investigated a key concern set out in the
NHSBT blood 2020 strategy document (pillar 1),4 regarding improving the donors’ experience, informed by
the understanding of their relative preferences for alternative changes to the blood service, including those
such as the introduction of a donor health report that are not currently available.
The study also extended previous research on blood donation by following choice-based principles. A
particular strength of the study was that it was replicated in two contrasting settings. Among ex-INTERVAL
participants, all of whom had experience of donating at a static donor centre, and among non-INTERVAL
participants, the majority of whom had donated at mobile settings. The main findings concerning donor
preferences were similar across the surveys of non-INTERVAL and ex-INTERVAL donors. The large sample
sizes in the INTERVAL trial and in both stated preference surveys enabled results to be reported across many
different subgroups, including those of prime interest to the NHSBT. The PULSE data set provided a sampling
frame for the study and allowed the representativeness of the study populations to be defined. It was also
used to define the target population for the CEA and the current practice experienced by blood donors.
This was important to ensure that the CEA results were provided for the population of prime interest.
The study provided a framework that could be followed in future evaluations, not just of alternative
changes to the blood service but also of health services more widely. In particular, the research found that
it was feasible to quickly elicit preferences from large samples of the public. The research also found that
the discrepancy between stated and actual behaviour was moderate (men) or small (women); this finding
from large survey and corresponding registry data extends the limited methodological literature in health
care on stated versus revealed preferences. Finally, the CEA was accompanied by extensive sensitivity
analyses, which found that the findings were robust to alternative standpoints, notably the source of data
for the estimates of relative donation frequency, and the assumptions underlying the unit cost estimates.
Limitations
The main time horizon for the cost-effectiveness analysis was 1 year, and so the long-term effects of the
alternative strategies on, for example, the rate and costs of donors leaving the register, or any effects of
the choice of strategies on fixed costs, were not considered. In particular, the INTERVAL trial found that
the reduced donation intervals did lead to increased rates of Hb-related deferrals and, if, in the long term,
this does encourage donors to leave the donation register, this will make this strategy less cost-effective.
Costs were measured from the perspective of the NHS, so any additional costs to donors, for example from
time off work or increased travel time, were not considered. This was consistent with the measurement of
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consequences, which excluded any change in donor’s well-being from donating blood more often
beyond that which would be detected by the generic measure of health-related QoL (SF-6D utility score).
The research did not evaluate all the strategies of potential interest to the NHSBT, such as expanding the
number of static donor collection centres or closing and/or merging of mobile sessions. The cost-effectiveness
results relied on estimates from the 25.2% (non-INTERVAL) and 32.4% (ex-INTERVAL) responders to the
SP surveys. The analysis adjusted for differences between the survey responders and the target population
(e.g. according to donation history), but does not allow for those differences that remain unobserved
(e.g. intrinsic motivation).
Conclusions and implications for the blood collection service
l Donors whose last donation was at a static donor centre would strongly prefer more opportunities
to donate during weekday evenings or at weekends. For donors with blood types that are in high
demand, providing improved opportunities to donate by extending opening hours to the evenings or
weekends in all donor centres would be relatively cost-effective (£23 and £29 per additional unit
donated, respectively).
l A strategy of reducing minimum intervals between donations from 12 to 10 or 8 weeks (men), or from
16 to 14 or 12 weeks (women), is preferred by donors, and can provide additional whole blood at £10
per additional unit. In the short run, this strategy might help maintain the required levels of red cells for
blood types that are in high demand, such as O–, but will increase rates of Hb-related deferrals and so
may lead to donors leaving the register and increase costs in the longer term.
l Moving mobile sessions to the weekends or providing a donor health report at each donation visit
would not, on average, lead to sufficient increases in the frequency of whole-blood donations to justify
the additional costs.
l Requiring donors to travel further to donate whole blood will encourage donors to leave the donation
register; subgroups of younger or less experienced donors and some BAME (ex-INTERVAL) donors are
among those most likely to stop donating. As it is important to retain these donor subgroups, if the
NHSBT continues to close mobile sessions and increase travel time for donors, it may be important to
adopt strategies targeted at retaining these particular subgroups of donors.
Implications for further research
l If any of these strategies are implemented, it will be important to monitor the preferences and donation
frequency for different donor subgroups, and in alternative settings. Such an evaluation could build
on the research framework presented here and consider the costs and consequences of scaling up the
strategy, in real time, by using large-scale surveys of preferences calibrated to actual donation behaviour
as recorded in the PULSE registry.
l Further research is required to investigate the effectiveness and cost-effectiveness of tailoring
opportunities to donate blood according to the preferences of particular donor subgroups. There
is a particular requirement to understand the preferences of BAME donors, as their blood is in high
demand, and only a relatively small sample of these donors were surveyed in the HEMO study.
l Improved understanding of how to predict which donors are likely to have Hb-related deferrals would
allow stratification of the donor population by likelihood of deferral. This could allow increased blood
collection using shorter interdonation intervals for a defined subpopulation of donors whose blood type
is in high demand.
l Further research is warranted on evaluating novel marketing strategies to encourage the recruitment of
particular subgroups of new donors (e.g. those with O– blood type, BAME donors, younger donors),
to ensure that there is the required mix of blood donors to sustain the future blood supply.
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Appendix 1 Choice of strategies to evaluate
Initially, the strategic objective for NHSBT was to reduce costs while maintaining the blood supply.Strategic initiatives that could help the organisation meet this objective were identified through a review
of NSHBT documents that describe future strategies and policies, market research, an informal review of
relevant published literature, consultation with NHSBT colleagues and insights from preliminary qualitative
research undertaken with INTERVAL donors. Twelve initiatives were identified as being of potential interest
for the evaluation. Of those, the strategies for evaluation were selected according to the following criteria:
l The strategy can be defined as a distinct series of service changes, with attributable costs and
consequences that can be estimated.
l The strategy is anticipated to have an effect on important attributes of the donor experience.
l Decisions by NHSBT on whether or not to adopt a particular strategy could be informed by evidence
from the study. Any strategies partially or fully adopted by NHSBT during the timeframe of this study
were excluded on the basis they were no longer relevant.
l Timing will allow for using the results of the INTERVAL trial.
l The strategy ensures that the survey has a manageable number of attributes.
Potential strategy
Included in
evaluation? Reason for exclusion
Provision of health reports for all whole-blood donors Yes
Closure of all three- and six-bed sites for whole-blood
collection
No No longer relevant – almost all three- and
six-bed mobile sites have been closed
Extension of opening times for both permanent and
temporary sites collecting whole blood
Yes
Increase in the maximum number of whole-blood
donations per year, pending the results of the
INTERVAL trial
Yes
Reduction in the time taken for booked appointments
to 1 hour (‘1 hour pledge’)
No Not feasible to define the service changes
required for NHSBT to meet this pledge. The
importance of total donation time to donors is
recognised and was included as an attribute in
the pilot survey
Reimbursement of parking charges No No longer relevant – has already been
introduced in some sites (both mobile
sessions and static donor centres)
Extension of the provision of Wi-Fi No Alternative forms of mobile internet access are
likely to become increasingly available and the
cost of Wi-Fi provision is likely to decline
Refurbishment of donation venues No It was not possible to describe the scope and
outcomes of these refurbishments for inclusion
in either the decision model or the SP survey
Elimination of walk-in appointments No Evidence from the study would not be
anticipated to inform a future decision
Provision of online check-in and completion of
pre-donation questionnaire
No No longer relevant as these strategies are
already planned
Provision of a non-invasive Hb test No Unlikely to have a substantial impact on costs
or donation frequency
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Appendix 2 Unit costs and assumptions
(trial-based analysis)
Resource-generating event Unit cost (£) Main source Costing assumptions made, items included
ISAT three-stage reminder
(first appointment,
no appointment,
last appointment)
2.68 ISAT recorded time, at NHS band 4 costs62
Low-Hb deferral 5.98 Expert opinion47 Includes cost of copper sulphate test (NHSBT
financial data 2016/17a), HemoCue® machine hire,65
consumables, and staff time at NHS band 4 costs62
Health-care costs for low-Hb
deferral
5.39 Expert opinionb Includes downstream health-care costs for 7% of
low-Hb deferrals who have a Hb of < 12.5 g/dl for
men or < 11.5 g/dl for women. GP appointment
(PSSRU),62 full blood count test,66 ferritin test,67
cost of iron supplements (expert opinion 50%
compliance, standard adult dose),68 10% attend
outpatient appointment69
Deferral because of other
reasons
0.97 Expert opinionb Based on NHS band 4 costs62
DNA three-stage reminders 3.10 Based on ISAT recorded time at NHS band 4 costs62
Faints on session 20.23 Expert opinion47 Based on moderate symptoms at NHS band 4 costs62
Variable cost of collecting
1 unit of blood (operating
with capacity)
7.62 NHSBT Based on disposables used [1 × copper sulphate test
(£0.02) including 1 × ChloraPrep™ (Becton Dickinson
and Company, Franklin Lakes, NJ, USA) (£0.74
including VAT), 1 × pack (£6.85 including VAT)
(NHSBT financial data, 2016/17 prices)]
ISAT, INTERVAL study administration team; VAT, value-added.tax.
a Laura Hontoria Del Hoyo, NHSBT, June 2016, personal communication; Colin Jackson, NHSBT, April 2017,
personal communication.
b Carmel Moore, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of
Cambridge, March 2016, personal communication.
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Appendix 3 Definition of subgroups
Subgroup Definition
Male Donors coded on the PULSE database as male
Female Donors coded on the PULSE database as female
17- to 30-years age group Donors aged between 17 and 30 years inclusive at the time the PULSE data were extracted
31- to 45-years age group Donors aged between 31 and 45 years inclusive at the time the PULSE data were extracted
46- to 60-years age group Donors aged between 46 and 60 years inclusive at the time the PULSE data were extracted
> 61-years age group Donors aged ≥ 61 years at the time the PULSE data were extracted
Standard demand blood
types
Donors with blood types O–, A– and B–
High-demand blood types Donors with blood types O+, A+, B+, AB+ and AB–
White ethnicity Donors coded as any of the following on the PULSE database: English, Welsh, Scottish,
Northern Irish, British, white Irish, other white background
Black/mixed black ethnicity Donors coded as any of the following on the PULSE database: black Caribbean,
black African, any other black African/Caribbean background, mixed white and
black Caribbean, mixed white and black African
Asian/mixed Asian ethnicity Donors coded as any of the following on the PULSE database: Asian-Indian, Asian-Pakistani,
Asian-Bangladeshi, other Asian Background, Chinese, mixed white and Asian
Other ethnicity or not stated Donors coded as any of the following on the PULSE database: any other mixed, multiple
ethnic background, Gypsy or Irish Traveller, Arab, unknown, not disclosed, any other group
‘Nursery’ donors Donors who have given blood between one and four times in the past 5 years, at the time
the PULSE data were extracted
Not ‘nursery’ donors Donors who have given blood between five or more times in the past 5 years, at the time
the PULSE data were extracted
Static donor centre donors
(sometimes referred to as
‘Centre’ donors)
Donors who last gave blood at a static donor centre, at the time the PULSE data were
extracted
Mobile session donors
(sometimes referred to as
‘Mobile’ donors
Donors who last gave blood at a mobile session, at the time the PULSE data were extracted
INTERVAL arm: control Ex-INTERVAL participants who were randomised to the control arm of the INTERVAL trial
(12-week intervals for men; 16-week intervals for women)
INTERVAL arm: control Ex-INTERVAL participants who were randomised to an intervention arm of the INTERVAL
trial which involved donating at shorter intervals than the control arm (8- and 10-week
intervals for men; 12- and 14-week intervals for women)
Recruitment source: centre Ex-INTERVAL participants who were recruited to the INTERVAL trial through their donations
at a static donor centre
Recruitment source: mobile Ex-INTERVAL participants who were recruited to the INTERVAL trial through their donations
at a mobile session
Recruitment source: no invite Ex-INTERVAL participants who were not invited to participate but who volunteered to the
INTERVAL trial
Number of donations in the
last 12 months: no/one/two/
three/four/five/six
Donors with no/one/two/three/four/five/six whole-blood donations recorded on the PULSE
database in the last 12 months, at the time the PULSE data were extracted
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Appendix 4 Number (%) of responses to the
Short Form questionnaire-36 items/Short Form
questionnaire-12 items at each time point
Results are presented for the SF-36/SF-12 questionnaires with complete information to calculate theSF-6D score.
Level
Sex, n (%)
Male Female
8 weeks
(N= 7417)
10 weeks
(N= 7413)
12 weeks
(N= 7411)
12 weeks
(N= 7549)
14 weeks
(N= 7545)
16 weeks
(N= 7528)
Baseline 6766 (91) 6765 (91) 6778 (91) 6776 (90) 6724 (89) 6746 (90)
6 months 5714 (77) 5644 (76) 5527 (75) 5673 (75) 5760 (76) 5652 (75)
12 months 5197 (70) 5183 (70) 5162 (70) 5148 (68) 5210 (69) 5133 (68)
18 months 4633 (62) 4659 (63) 4679 (63) 4515 (60) 4624 (61) 4533 (60)
24 months 4701 (63) 4747 (64) 4746 (64) 4506 (60) 4486 (59) 4444 (59)
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Appendix 5 Mean Short Form 6D score at each
time point, by randomised arm and sex
Level
Sex, n (%)
Male Female
8 weeks
(N= 7417)
10 weeks
(N= 7413)
12 weeks
(N= 7411)
12 weeks
(N= 7549)
14 weeks
(N= 7545)
16 weeks
(N= 7528)
Baseline 0.86 0.86 0.86 0.85 0.85 0.85
6 months 0.85 0.85 0.85 0.83 0.83 0.83
12 months 0.85 0.85 0.85 0.82 0.82 0.82
18 months 0.85 0.85 0.85 0.82 0.82 0.82
24 months 0.84 0.84 0.84 0.82 0.82 0.82
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Appendix 6 Summary of relevant donor
experience attributes and associated levels from the
pilot survey
Relevant donor experience attribute Attribute levels
1. Invitation to donate at usual blood donation venue l Yes
l No
2. Donors’ travel time to blood donation venue l Your usual travel time
l 10 minutes longer than your usual travel time
l 20 minutes longer than your usual travel time
l 30 minutes longer than your usual travel time
3. Opening times at blood donation venue l Monday–Friday (daytime only)
l Evenings
l Evenings and weekends
4. Total time to donate blood (from time of arrival at
blood donation venue to time of departure)
l 30 minutes
l 60 minutes
l 90 minutes
l 120 minutes
5. Availability of health report l Yes
l No
6. Maximum number of donations per year Women
l Three donations per year (current maximum)
l Four donations per year (pending INTERVAL)
Men
l Four donations per year (current maximum)
l Five donations per year (pending INTERVAL)
l Six donations per year (pending INTERVAL)
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Appendix 7 Example survey questions
Non-INTERVAL donors
Version 1.2, 13 May 2016 
Note: This is a representation of an electronic survey that appeared over 
multiple screens. It was preceded by information for donors (screens 1 and 2) 
and a consent question (screen 3), which are available on the project website. 
SCREEN 4: 
Question 1: How many times did you give blood in the last 12 months? 
If you can't remember, please give your best guess. 
· I did not give blood in the past 12 months 
· Once 
· Twice 
· Three times 
· Four times 
· More than four times (please specify) 
 
Question 2: How many times did you want to give blood in the last 12 months? 
This answer may differ from your answer to question 1 for many reasons. For example, you 
could not attend your appointment because you had to care for a sick child, or you wanted to 
give blood but the waiting time was too long. 
· I did not give blood in the past 12 months 
· Once 
· Twice 
· Three times 
· Four times 
· More than four times (please specify) 
The following questions ask about the last time you gave blood.  
 
Question 3: When you last gave blood, where did you travel from? 
If you can't remember, please give your best guess. 
· Your home 
· Your workplace 
· Somewhere else 
· Question 4: Roughly how far did you travel to the place where you last gave blood? 
· If you can't remember, please give your best guess. 
· Less than 2 miles  
· 2–4 miles 
· More than 4 miles 
Please tell us to the nearest mile (response limited to 3 integers)  
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Question 5: How did you travel to the place where you last gave blood? 
Please choose the answer that applies to the longest part of your journey.  
· Walk 
· Cycle 
· Car 
· Public transport (e.g. bus, tube, train or tram) 
· Question 6: How long did it take you to travel to the place where you last gave blood? 
· If you can't remember, please give your best guess. 
· Less than 10 minutes  
· 10–30 minutes 
· 30–60 minutes 
· More than 60 minutes  
Please tell us how long in minutes _ _ _(answer limited to 3 integers) 
 
Question 7: Roughly how long did your last blood donation visit take?  
From your scheduled appointment time, to the time you arrived at the tea table and were free 
to leave (including waiting time). 
· 1 hour or less 
· More than 1 hour 
 
Question 8: What prompted you to make your last appointment to give blood? 
Please choose the answer that best applies to you.  
· I booked at a previous blood donation visit 
· I received an invitation letter  
· I received an email, phone call or text message  
· I saw an advert, publicity or campaign  
· I booked without being prompted 
· I did not make an appointment 
· Other 
 
Question 9:  
[Question not asked if respondent answers “I did not make an appointment” to question 8] 
Are you able to book appointments to give blood as often as you would like, at a day and 
time that suits you? 
· Yes, easily 
· Yes, but with some difficulty or delay 
· No, it is very difficult 
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SCREEN 5:
The next 6 questions will ask how often you would donate blood under different scenarios.
The scenarios describe a service with different features that are described in the table below.
Each scenario is a little different but it would always take around 1 hour from your 
appointment time to the time you arrive at the tea table and are free to leave (including 
waiting time). 
Travel time to
the place where 
you donate 
blood 
This is the time it would take you to travel to the place where you donate 
blood. 
Travel time in the scenarios may range from 10 minutes shorter than your 
typical travel time, up to 30 minutes longer than your typical travel time. 
Appointment 
availability
These are that days the appointments are available for donors to give
blood. 
Options include: 
Every day (Monday–Sunday) 
Every weekday (Monday–Friday) 
1 day every 2 months (Monday–Friday) 
1 day every 2 months (Saturday or Sunday)
Opening times These are the times of the day, when you can give blood. Possible 
opening times include: 
9am–12pm and 2pm–5pm 
9am–5pm 
9am–8pm 
2pm–8pm
Health report
provided 
A health report is not currently provided. In the future if a health report
were to be provided it might give measurements such as your blood 
pressure and cholesterol. 
Maximum
number of 
donations per 
year
This is the maximum number of  times each year that you are allowed to
give blood in the UK for health and safety reasons. Currently this is 3 
times a year for women and 4 times a year for men. A clinical trial is
looking at the impact of donors giving blood more often. Depending on 
the results of the trial, donors might be allowed to give blood more often
in future.  Women may be permitted to give blood up to 4 times a year. 
Men may be permitted to give blood up to 6 times a year. 
For each question please pick a single answer. There are no right or wrong answers, we
are just interested in your views. If you are not sure, please give us your best guess.
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SCREEN 6:
Scenario 1: 
At the place where you last gave blood, suppose the service is like this: 
Description of Service
Travel time Your typical travel time
Appointment availability Every weekday (Monday–Friday) 
Opening times 9am–12pm and 2pm–5pm
Health report provided No
Maximum number of donations per year 3 donations per year
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse] 
In this scenario, how many times a year would you give blood? [Answer is mandatory]
I would probably not donate
Once a year
Twice a year
 Three times a year
 Four times a year
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SCREEN 7:
Scenario 2:
At the place where you last gave blood, suppose the service is like this:  
Description of Service
Travel time Your typical travel time
Appointment availability 1 day every 2 months (Monday–Friday)
Opening times 2pm–8pm
Health report provided No
Maximum number of donations per year 4 donations per year
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse] 
In this scenario, how many times a year would you give blood? 
 [Answer is mandatory]
I would probably not donate
Once a year
Twice a year
Three times a year
Four times a year
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SCREEN 8:
The next four scenarios ask you to imagine giving blood at a different place.
SCREEN 9:
Scenario 3:
At a different place to where you last gave blood, suppose the service is like this: 
Description of Service
Travel time 15 minutes longer than your typical travel 
time
Appointment availability 1 day every 2 months (Saturday or 
Sunday) 
Opening times 9am–8pm
Health report provided Yes, after each donation 
Maximum number of donations per 
year
3 donations per year
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse] 
In this scenario, how many times a year would you give blood? 
[Answer is mandatory]
I would probably not donate
Once a year
Twice a year
Three times a year
Four times a year
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SCREEN 10:
Scenario 4:
At a different place to where you last gave blood, suppose the  service is like this: 
Description of Service
Travel time 30 minutes longer than your typical travel time
Appointment availability Every day (Monday–Sunday) 
Opening times 9am–8pm
Health report provided Yes, after each donation 
Maximum number of donations per 
year
3 donations per year
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse]
In this scenario, how many times a year would you give blood? 
[Answer is mandatory]
I would probably not donate
Once a year
Twice a year
 Three times a year
 Four times a year
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SCREEN 11: 
 
Scenario 5:  
At a different place to where you last gave blood,  suppose the service is like this:  
 Description of Service 
Travel time  10 minutes shorter than your typical 
travel time 
Appointment availability  Every day (Monday–Sunday) 
Opening times   2pm–8pm  
  
Health report provided No 
Maximum number of donations per year 3 donations per year 
 
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse]  
In this scenario, how many times a year would you give blood?  
[Answer is mandatory] 
 
 
 I would probably not donate 
 Once a year 
 Twice a year 
 Three times a year 
 Four times a year 
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SCREEN 12: 
 
Scenario 6:  
At a different place to where you last gave blood, suppose the service is like this: 
 Description of Service 
Travel time  30 minutes longer than your typical travel 
time 
Appointment availability  1 day every 2 months (Monday–Friday) 
Opening times   9am–12pm and 2pm–5pm 
  
Health report provided No 
Maximum number of donations per 
year 
4 donations per year 
 
[Definitions of each attribute are available as “tool tips” by hovering over the left hand 
column with a mouse]  
 
In this scenario, how many times a year would you give blood?  
[Answer is mandatory] 
 
 
 I would probably not donate 
 Once a year 
 Twice a year 
 Three times a year 
 Four times a year 
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SCREEN 13: 
Thank you for taking the time to complete the survey. Your responses have been submitted.  
 
We are currently working in collaboration with researchers from London School of Hygiene 
and Tropical Medicine, University of London to review and improve the service we offer to 
our donors. 
 
We would like to re-iterate that the scenarios in this survey are hypothetical. For more 
information on the guidelines around blood donation, including permitted frequency,
please visit our website (https://www.blood.co.uk/who-can-give-blood/).  
 
Thank you for your continued support and generosity. 
 
Dr Gail Miflin 
Associate Medical Director, Blood Supply, NHS Blood and Transplant 
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 Thinking of the place where you usually donate blood, imagine the service is like 
this: 
 
 Description of Service 
Travel time Your usual travel time 
Opening times  Monday–Friday (day time only) 
Total time of the visit 120 minutes 
Health report provided No 
Maximum number of donations per year 3 donations per year 
 
In this situation, how many times a year would you donate blood?  
 
Please select one of the boxes below: 
 
Never, I 
would 
stop 
donating 
Once a 
year 
Twice a 
year 
Three 
times       
a year 
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Appendix 8 Summary of the responses to the
background questions in the survey of non-INTERVAL
and ex-INTERVAL donors
Question 1: how many times did you give blood in the last 12 months?
If you cannot remember, please give your best guess.
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
I did not give blood in the past 12 months 96 (1) 69 (1) 123 (3) 144 (3)
Once 2728 (17) 2283 (27) 187 (4) 300 (7)
Twice 5064 (32) 3179 (38) 487 (10) 816 (19)
Three times 5852 (37) 2470 (30) 1221 (25) 2171 (50)
Four times 1860 (12) 316 (4) 2232 (45) 864 (20)
More than four times (please specify) 50 (0) 8 (0) 657 (13) 32 (1)
Respondent specified (times)
3 1 (0) – (–) – (–) – (–)
4 1 (0) – (–) – (–) – (–)
5 28 (0) 5 (0) 473 (10) 21 (0)
6 9 (0) 1 (0) 153 (3) 4 (0)
7 3 (0) – (–) 11 (0) 1 (0)
8 – (–) – (–) 5 (0) 3 (0)
9 1 (0) – (–) 2 (0) 1 (0)
10 – (–) – (–) 2 (0) 2 (0)
11 – (–) – (–) 2 (0) – (–)
12 1 (0) – (–) 9 (0) – (–)
Total number of respondents 15,650 8325 4907 4327
Notes
For the non-INTERVAL donors, six men and two women indicated that they donated more than four times, but did not
provide a number.
A few donors gave irrational responses, in that they stated that they donated ‘more than four times’, but then entered ‘3’
or ‘4’ as their number of times.
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Question 2: how many times did you want to give blood in the last
12 months?
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
I did not give blood in the past 12 months 73 (0) 69 (1) 42 (1) 37 (1)
Once 607 (4) 590 (7) 37 (1) 53 (1)
Twice 1949 (12) 1725 (21) 122 (3) 273 (6)
Three times 5315 (34) 3546 (43) 648 (13) 1747 (40)
Four times 6748 (43) 2165 (26) 2646 (54) 1952 (45)
More than four times (please specify) 958 (6) 230 (3) 1374 (28) 254 (6)
Respondent specified (times)
0 1 (0) – (–) – (–) – (–)
3 1 (0) – (–) – (–) – (–)
4 2 (0) – (–) 1 (0) – (–)
5 176 (1) 47 (1) 570 (12) 89 (2)
6 453 (3) 91 (1) 614 (13) 126 (3)
7 13 (0) 2 (0) 38 (1) 2 (0)
8 25 (0) 4 (0) 44 (1) 7 (0)
9 2 (0) 2 (0) 4 (0) – (–)
10 14 (0) 3 (0) 14 (0) 7 (0)
11 – (–) – (–) 1 (0) – (–)
12 135 (1) 31 (0) 62 (1) 21 (0)
13 – (–) – (–) 2 (0) – (–)
14 – (–) – (–) 1 (0) – (–)
16 – (–) 1 (0) 1 (0) – (–)
17 1 (0) – (–) – (–) – (–)
18 – (–) – (–) 1 (0) – (–)
20 2 (0) – (–) 3 (0) – (–)
24 4 (0) – (–) 1 (0) – (–)
26 3 (0) – (–) 1 (0) – (–)
30 1 (0) – (–) – (–) – (–)
50 – (–) 1 (0) – (–) 1 (0)
52 5 (0) – (–) 3 (0) – (–)
55 1 (0) – (–) 1 (0) – (–)
100 – (–) 2 (0) – (–) – (–)
365 20 (0) 3 (0) 12 (0) 1 (0)
Total number of respondents 15,650 8325 4869 4316
Notes
For the non-INTERVAL donors, 99 men and 43 women indicated that they wanted to donate more than four times but did
not provide a number.
In addition, some donors provided inconsistent responses.
APPENDIX 8
NIHR Journals Library www.journalslibrary.nihr.ac.uk
116
Question 3: when you last gave blood, where did you travel from?
If you cannot remember, please give your best guess.
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
Your home 10,564 (68) 5887 (71) 3164 (65) 2796 (65)
Your workplace 4683 (30) 2218 (27) 1565 (32) 1402 (33)
Somewhere else 403 (3) 220 (3) 113 (2) 89 (2)
Total number of respondents 15,650 8325 4842 4287
Notes
For the non-INTERVAL donors, 122 men and 60 women indicated that they travelled more than 4 miles, but did not
provide a response. Similarly, for the ex-INTERVAL donors, 17 men and 2 women did not provide a response.
Question 4: roughly how far did you travel to the place where you last
gave blood?
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
< 2 miles 8114 (52) 4499 (54) 1366 (28) 1407 (33)
2–4 miles 4765 (30) 2622 (31) 1495 (31) 1532 (36)
> 4 miles (please tell us to
the nearest mile)
2771 (18) 1204 (14) 1933 (40) 1290 (31)
Respondent specified (miles)
5 405 (3) 194 (2) 204 (4) 187 (4)
6 492 (3) 228 (3) 287 (6) 198 (5)
7 249 (2) 123 (1) 170 (4) 132 (3)
8 285 (2) 124 (1) 171 (4) 105 (2)
9 116 (1) 44 (1) 74 (2) 66 (2)
10 247 (2) 122 (1) 227 (5) 138 (3)
11 44 (0) 31 (0) 47 (1) 32 (1)
12 141 (1) 59 (1) 128 (3) 78 (2)
13 31 (0) 14 (0) 34 (1) 24 (1)
14 25 (0) 19 (0) 36 (1) 30 (1)
15 105 (1) 49 (1) 104 (2) 71 (2)
16 34 (0) 18 (0) 33 (1) 29 (1)
17 35 (0) 12 (0) 26 (1) 14 (0)
18 31 (0) 9 (0) 37 (1) 23 (1)
19 13 (0) 2 (0) 10 (0) 4 (0)
20 70 (0) 23 (0) 84 (2) 38 (1)
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Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
21 7 (0) 4 (0) 8 (0) 2 (0)
22 18 (0) 4 (0) 14 (0) 5 (0)
23 11 (0) 2 (0) 11 (0) 5 (0)
24 12 (0) 2 (0) 5 (0) 6 (0)
25 58 (0) 14 (0) 47 (1) 25 (1)
26 5 (0) 4 (0) 11 (0) 3 (0)
27 7(0) 1 (0) 4 (0) 3 (0)
28 4 (0) 1 (0) 4 (0) 3 (0)
29 – (–) 1 (0) 1 (0) 2 (0)
30 47 (0) 14 (0) 33 (1) 12 (0)
31 4 (0) 1 (0) 1 (0)0 – (–)
32 3 (0) 3 (0) 6 (0) 1 (0)
33 3 (0) – (–) 2 (0) – (–)
34 2 (0) – (–) 4 (0) 4 (0)
35 25 (0) 2 (0) 19 (0) 8 (0)
36 5 (0) 1 (0) 2 (0) 6 (0)
37 3 (0) 1 (0) 2 (0) 2 (0)
38 2 (0) 3 (0) 2 (0) 0 (0)
39 – (–) – (–) 3 (0) – (–)
40 35 (0) 7 (0) 10 (0) 11 (0)
41 1 (0) – (–) 1 (0) 1 (0)
42 – (–) – (–) 1 (0) – (–)
43 2 (0) – (–) 1 (0) – (–)
44 – (–) 1 (0) – (–) – (–)
45 17 (0) 3 (0) 3 (0) 1 (0)
48 1 (0) – (–) 1 (0) – (–)
50 15 (0) 1 (0) 10 (0) 4 (0)
51 2 (0) – (–) 2 (0) – (–)
52 2 (0) – (–) 2 (0) – (–)
55 3 (0) – (–) 1 (0) 1 (0)
56 1 (0) – (–) 1 (0) – (–)
58 1 (0) – (–) 1 (0) – (–)
60 7 (0) 2 (0) 4 (0) 4 (0)
62 – (–) – (–) 1 (0) – (–)
63 1 (0) – (–) – (–) – (–)
64 – (–) – (–) 1 (0) – (–)
65 1 (0) – (–) 3 (0) 1 (0)
68 – (–) – (–) – (–) 1 (0)
69 – (–) – (–) 1 (0) 0 (0)
70 4 (0) 1 (0) 4 (0) 1 (0)
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Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
75 2 (0) – (–) 2 (0) 0 (0)
78 – (–) – (–) – (–) 1 (0)
80 3 (0) – (–) 5 (0) 0 (0)
82 – (–) – (–) – (–) 1 (0)
83 1 (0) – (–) 1 (0) – (–)
92 1 (0) – (–) – (–) – (–)
95 – (–) – (–) 1 (0) – (–)
96 – (–) – (–) 1 (0) – (–)
100 2 (0) – (–) 2 (0) – (–)
110 1 (0) – (–) 1 (0) – (–)
111 – (–) – (–) 1 (0) – (–)
120 2 (0) – (–) – (–) 1 (0)
124 1 (0) – (–) – (–) – (–)
130 – (–) – (–) – (–) 1 (0)
145 – (–) – (–) – (–) 1 (0)
170 1 (0) – (–) 1 (0) – (–)
190 – (–) – (–) – (–) 1 (0)
200 1 (0) – (–) 1 (0) – (–)
213 1 (0) – (–) – (–) – (–)
250 1 (0) – (–) – (–) – (–)
800 – (–) – (–) – (–) 1 (0)
999 – (–) – (–) 1 (0) – (–)
Total number of respondents 15,650 8325 4794 4229
Question 5: how did you travel to the place where you last gave blood?
Please choose the answer that applies to the longest part of your journey.
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
Walk 3909 (25) 1868 (22) 866 (18) 827 (19)
Cycle 734 (5) 182 (2) 302 (6) 166 (4)
Car 10,132 (65) 5629 (68) 2362 (49) 2013 (47)
Public transport (e.g. bus,
tube, train or tram)
875 (6) 646 (8) 1312 (27) 1281 (30)
Total number of respondents 15,650 8325 4842 4287
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Question 6: how long did it take you to travel to the place where you last
gave blood?
If you cannot remember, please give your best guess.
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
< 10 minutes 7661 (49) 4176 (50) 892 (18) 858 (20)
10–30 minutes 6803 (43) 3607 (43) 2511 (52) 2223 (52)
30–60 minutes 1077 (7) 508 (6) 1272 (26) 1089 (25)
> 60 minutes (please tell us how long in minutes) 109 (1) 34 (0) 164 (3) 112 (3)
Respondent specified (minutes)
10 1 (0) – (–) – (–) – (–)
12 – (–) – (–) 1 (0) – (–)
50 – (–) – (–) 1 (0) – (–)
61 – (–) 1 (0) 1 (0) – (–)
62 – (–) – (–) 1 (0) – (–)
65 3 (0) 2 (0) 12 (0) 7 (0)
67 – (–) 1 (0) 1 (0) – (–)
70 7 (0) 6 (0) 21 (0) 16 (0)
74 – (–) 1 (0) – (–) – (–)
75 13 (0) 5 (0) 32 (1) 24 (1)
76 – (–) – (–) 2 (0) – (–)
80 10 (0) 5 (0) 16 (0) 14 (0)
85 1 (0) – (–) 3 (0) – (–)
90 41 (0) 9 (0) 40 (1) 36 (1)
95 2 (0) – (–) 1 (0) 1 (0)
100 5 (0) 2 (0) 7 (0) – (–)
105 3 (0) – (–) 1 (0) – (–)
110 1 (0) – (–) 2 (0) 2 (0)
120 8 (0) 1 (0) 13 (0) 5 (0)
135 – (–) – (–) 1 (0) 1 (0)
140 1 (0) – (–) 1 (0) 1 (0)
150 2 (0) – (–) 3 (0) 1 (0)
160 – (–) – (–) – (–) 1 (0)
170 1 (0) – (–) 1 (0) 1 (0)
180 1 (0) 1 (0) – (–) – (–)
200 0 (0) – (–) 2 (0) 1 (0)
240 2 (0) – (–) – (–) – (–)
450 – (–) – (–) 1 (0) – (–)
600 – (–) – (–) – (–) 1 (0)
Total number of respondents 15,650 8325 4839 4282
Notes
For the non-INTERVAL donors who indicated that it took more than 60 minutes, seven men did not provide a response.
In addition, some donors provided inconsistent responses.
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Question 7: roughly how long did your last blood donation visit take?
From your scheduled appointment time to the time you arrived at the tea table and were free to leave
(including waiting time).
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
≤ 1 hour 11,673 (75) 5947 (38) 4228 (87) 3659 (85)
> 1 hour 3977 (25) 2378 (15) 614 (13) 628 (15)
Total number of respondents 15,650 8325 4842 4287
Question 8: what prompted you to make your last appointment to
give blood?
Please choose the answer that best applies to you.
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
I booked at a previous blood donation visit 8424 (54) 4308 (52) 3220 (67) 2711 (64)
I received an invitation letter 1470 (9) 814 (10) 416 (9) 531 (13)
I received an e-mail, phone call or text message 1395 (9) 712 (9) 369 (8) 337 (8)
I saw an advert, publicity or campaign 219 (1) 266 (3) 3 (0) 8 (0)
I booked without being prompted 3408 (22) 1870 (22) 644 (13) 528 (13)
I did not make an appointment 250 (2) 97 (1) 54 (1) 31 (1)
Other 484 (3) 258 (3) 77 (2) 74 (2)
Total number of respondents 15,650 8325 4783 4220
Question 9: are you able to make appointments to give blood as often as
you would like, at a day and time that suits you?
Response
Sex, n (%)
Non-INTERVAL donors Ex-INTERVAL participants
Male Female Male Female
Yes, easily 9154 (58) 4806 (58) 3788 (73) 3193 (70)
Yes, but with some difficulty or delay 4047 (26) 2293 (28) 686 (13) 734 (16)
No, it is very difficult 2449 (16) 1226 (15) 309 (6) 293 (6)
Total number of respondents 15,650 8325 4783 4220
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Appendix 9 Incremental effect of alternative
types of blood service on average number of
donations per year for all non-INTERVAL respondents
(two-part model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday –Sunday
 Every weekday: Monday –Friday
 1 day every 2 months: Monday –Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 23 Incremental effect of alternative types of blood service on average number of donations per year for all non-INTERVAL respondents (two-part model). For men
(• n= 15,652) and women (▴ n= 8329). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Appendix 10 Incremental effect of alternative
types of blood service on average number of
donations per year for high-demand non-INTERVAL
respondents (two-part model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday– Sunday
 Every weekday: Monday– Friday
 1 day every 2 months: Monday– Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 24 Incremental effect of alternative types of blood service on average number of donations per year for high-demand non-INTERVAL respondents (two-part model).
For men (• n= 1551) and women (▴ n= 921). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target
population.
A
PPEN
D
IX
10
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
126
Appendix 11 Incremental effect of alternative
types of blood service on average number of
donations per year for all non-INTERVAL respondents
(gamma model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday– Sunday
 Every weekday: Monday– Friday
 1 day every 2 months: Monday– Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 25 Incremental effect of alternative types of blood service on average number of donations per year for all non-INTERVAL respondents (gamma model). For men
(• n= 15,652) and women (▴ n= 8329). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
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Appendix 12 Incremental effect of alternative
types of blood service on average number of
donations per year for high-demand non-INTERVAL
respondents (gamma model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
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 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2– 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday– Sunday
 Every weekday: Monday– Friday
 1 day every 2 months: Monday– Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 26 Incremental effect of alternative types of blood service on average number of donations per year for high-demand non-INTERVAL respondents (gamma model).
For men (• n= 1551) and women (▴ n= 921). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target
population.
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Appendix 13 Incremental effect of alternative
types of blood service on average number of
donations per year for all ex-INTERVAL respondents
(two-part model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
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Opening times
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 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 27 Incremental effect of alternative types of blood service on average number of donations per year for all ex-INTERVAL respondents (two-part model). For men
(• n= 4754) and women (▴ n= 4179). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target population.
A
PPEN
D
IX
13
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
132
Appendix 14 Incremental effect of alternative
types of blood service on average number of
donations per year for high-demand ex-INTERVAL
respondents (two-part model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2– 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 28 Incremental effect of alternative types of blood service on average number of donations per year for high-demand ex-INTERVAL respondents (two-part model).
For men (• n= 643) and women (▴ n= 580).
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Appendix 15 Incremental effect of alternative
types of blood service on average number of
donations per year for all ex-INTERVAL respondents
(gamma model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
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Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 29 Incremental effect of alternative types of blood service on average number of donations per year for all ex-INTERVAL respondents (gamma model). For men
(• n= 4754) and women (▴ n= 4179).
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Appendix 16 Incremental effect of alternative
types of blood service on average number of
donations per year for high-demand ex-INTERVAL
respondents (gamma model)
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Incremental effect of alternative types of blood service on the average number of blood donations per year
Last donation experience (baseline)
Travel time
 10 minutes shorter
 15 minutes longer
 30 minutes longer
Opening times
 9 a.m. – 12 p.m. and 2 – 5 p.m.
 9 a.m. – 5 p.m.
 9 a.m. – 8 p.m.
 2 – 8 p.m.
Appointment availability
 Every day: Monday–Sunday
 Every weekday: Monday–Friday
 1 day every 2 months: Monday–Friday
 1 day every 2 months: Saturday or Sunday
Health report provided
Maximum number of donations
 Four female, five male
 Six
FIGURE 30 Incremental effect of alternative types of blood service on average number of donations per year for high-demand ex-INTERVAL respondents (gamma model).
For men (• n= 643) and women (▴ n= 580). The uncertainty intervals reflect the 5th and 95th percentiles in the predicted donation frequency across the relevant target
population.
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Appendix 17 Summary notes from
translation workshops
Translation workshop I: key themes from the discussion
Monday 21 November 2016, 11.15–15.15.
At LSHTM, London.
Attended by seven donors (all of whom were non-INTERVAL donors) and a public representative.
Attendees were split into three groups for the key discussions, joined by colleagues from NHSBT, and each
group was facilitated by a member of the research team (RG, SW and KDC).
This is a summary of the general feedback and discussion that followed each break out session at the
workshop, focusing on the main themes.
Discussion I: the strategies
The questions asked:
l How do you decide how often to give blood?
l Which of the six possible changes (reducing intervals, static donor centres on weekday evenings, static
donor centres at weekends, mobile sessions on weekday evenings, mobile sessions at weekends and
provision of a health report) would be important to you?
l How do you think other donors would react to these changes? Can you rank our suggestions from
best to worst?
l What else might encourage donors to give blood more often?
Summary of responses:
l Some donors rephrased the question to ‘would donors plan to donate less than they are able? What
would affect this?’
l Response from two groups that appointment availability is more limiting than the strategies listed
(Donor: ‘How often I give blood is not decided by me’). Noted that this will differ between static donor
centres and mobile sessions.
l Appointment reminders were also mentioned by two groups as having a big influence.
l Weekday evenings opening supported by two groups.
l A reflection from one group that reducing intervals would offer more choice to donors, but only if it
will affect appointment availability.
l Health report – a mixed response. One group positive/could be seen as a health promotion activity
(but felt it should be optional – select beforehand on the appointment booking), one ambivalent and
one felt it would deter people from donating.
Other comments and ideas mentioned:
l Suggested marketing/operating the blood service in shopping centres, etc.
l Could people donate more than 1 unit at a time?
l Make donation venues nicer places to be.
l Provide better, more dynamic, information (e.g. in an app) on ‘your nearest site with appointment
availability’ – would work for London-based donors in particular.
l Discussion about what an appointment means to a donor. Related to waiting time as the idea of being
seen within 10 minutes of your booked time slot was thought important.
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Discussion II: the survey and the discrepancy between observed and predicted number
of donations
The questions asked:
l What do you think about the way the questions are asked? Are there features missing?
l Do you feel confident answering a survey question?
l Why is there a difference between predicted and observed number of donations?
Summary of responses:
l Appointment availability was mentioned again as an important and limiting factor to the number of
donations. For example, if the donor has to cancel an appointment, another one will not be available
and so they will have a long interval between donations. Especially so at a mobile session (could they
be offered an alternative – static – venue at the time of cancellation?). Discussed strategies such as
allowing donors to book ‘back-up’ appointments that would then ‘auto cancel’ if the first appointment
was utilised.
l Felt there were important interactions between appointment availability, location, and maximum
number of donations allowed.
l Optimism about how healthy/free you may be.
l ‘Waiting time’ on the day also important but people have different views – some would rather travel
further/wait for less time, others would rather wait but donate locally.
Some questions for future exploration were raised:
l Could a future survey provide live feedback inside the survey to the donor about the difference
between their observed data and their survey responses? This might nudge them to be more realistic
and also provide an opportunity to ask them what is limiting their observed pattern of donations.
l Ask people about the probability of their needing to cancel a session.
l Some regular donors think more about ‘donation intervals’ rather than ‘number of donations per year’.
l Feedback that the survey may have forced unnatural choices – open questions would provide more
nuance – but accept they do not really work for this type of survey.
l Distinction between mobile sessions and static centres may not be clear; some donors did not know
static centres existed.
l Suggested question for future surveys: would you travel to your nearest static centre if your local
appointment is cancelled?
Discussion III: exploring a more personalised donation service
The questions asked:
l What are your views about tailoring the donation service more according to the particular donor’s
circumstances and donation history?
l What do you see as the ‘pros’ and ‘cons’?
l What further research would be useful?
Summary of responses:
l One group felt that making the donation service personal to the donor was acceptable if it is based on
patient need (i.e. for certain blood types) but less acceptable if it is based on donor behaviours. Basing it
on patient need would be understandable and motivating to donors if it was very clearly communicated.
l Use personalised ‘feedback’ to individual donors to help people understand their own behaviours/
intentions and limitations better → potentially more accurate survey responses and more reflection
from donors – especially motivating if their blood is understood to be in particular demand.
l A comment that personalising by subgroup is actually only a step towards personalisation.
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l Personalisation of communications would be helpful – for example, regular, committed donors do not
always feel the marketing is suitable for them.
l Have opportunistic appointments available for some donors?
l Could not understand the reasons for the sex difference in the impact of travel time on donations.
l Some uneasiness if the health report was only available for some people.
Other comments/ideas for future exploration raised:
l Survey people on an iPad/their own device while they are waiting for their appointment at the centre/
session? Ask them about what matters to them/what influences their own donation patterns.
l Share live waiting times on the website/app.
l Encourage those with a high-demand blood type to encourage their family members to donate (NHSBT
confirmed that they already do this).
l Noted that deferrals do put people off.
l Suggested future question: do you know if your blood type is high demand?
Translation workshop II: key themes from the discussion
Monday 24 April 2017, 5.30 p.m.–8.30 p.m.
At LSHTM, London.
Attended by 13 donors (a mix of ex-INTERVAL participants and non-INTERVAL donors, nursery and more
experienced donors). Attendees were split into three groups for the three discussions, joined by colleagues
from NHSBT and each group facilitated by a member of the research team (RG, SW and KDC).
This is a summary of the general feedback and discussion that followed each break out session at the
workshop, focusing on the main themes.
Discussion I: donor preferences
The results of the SP survey for the overall group and the high-demand subgroup were shared with
donors. The questions we asked were:
l What in these results surprises you?
l What in these results is as you expected?
Summary of responses:
l If a health report was to be implemented, additional support to donors would be required, specifically,
to help communicate and interpret the results of any such report.
l Evening opening was welcomed enthusiastically (although acknowledging that this group of donors
had chosen to attend a weekday evening workshop), weekend opening seen as less so.
l However, noted that there might be logistical issues – can NHSBT process blood late in the evening
and in what volumes/locations?
l Increasing travel time, which might happen if a donor can no longer donate locally but needs to go to
a static donor centre, was clearly noted as an issue for donors.
l One donor who had completed the survey said that they made an assumption, when the travel time
was set to 10 minutes shorter, that other aspects of the service might be less convenient to them than
their current, very convenient, blood service. It was also acknowledged that donors like to go where
they ‘know how things work’.
l Poor appointment availability can put donors off.
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l Some ex-INTERVAL participants who had donated at reduced intervals during the trial expressed
frustration at having to return to longer intervals after the trial finished.
l Several donors said they always book at the maximum number of donations allowed – or enabled – by
the appointment availability of their mobile session (where applicable). Some donors book their next
appointment as they leave the last one.
l One group suggested that if a donor has ‘made the commitment’ to donate then they would be
unlikely to be affected by the practical issues considered by the survey.
l Acknowledged that a range of individual circumstances would affect donors’ preferences.
l Donors welcomed the information about different blood types being in different demand, and
understanding that NHSBT needed to strive to not overcollect blood. Felt that there are opportunities
to educate more donors about these things and others (e.g. the tests that NHSBT carries out on blood
collected, at the ‘tea table’ after a donation).
Other comments and ideas mentioned:
l It was asked whether or not the INTERVAL trial had led to overcollection; this was not considered likely,
given the relative number of donors who participated in the trial.
l Observed that the survey does not tell us anything about the attributes of a blood donation service to
attract new donors.
l Consider a wider range of venues for mobile sessions that might attract particular subgroups of donors.
An example given was a Buddhist temple – although it was recognised that this might not be
economically viable.
l Some donors had received text messages after their donation to say at which hospital their blood had
been used. This was welcomed by donors, but some unease about the implication if they do not
receive a text that their blood has not been used (especially if two family members donate together
and only one receives the text).
l Donors enjoy being able to walk in to appointments.
l Some comments about the donation restrictions, for example following certain foreign travel.
Discussion II: making choices
The results of the CEA for the overall group and the high-demand subgroup were shared with donors.
The questions asked were:
l What in these results surprises you?
l What in these results is as you expected?
l What choice would you make (if you were NHSBT)?
Summary of responses:
l Reducing intervals, if safe to do so, was considered the strongest choice if more blood is needed.
Accepted that there would be operational issues for NHSBT to work through.
l Weekday evenings. It was surprising that extending collection opening times into the evening was not
more popular.
l Targeting specific donor subgroups, based on patient need, was suggested, and a number of approaches
to this were raised in different groups (e.g. targeted publicity, proactively asking people to donate via
their other interactions with health or other public services). It was noted that it would be interesting to
consider how subgroups behave in relation to the service attributes over long periods of time.
l Suggested employing some of the strategies at different times in response to stocks; if more/less blood,
or blood of a particular type, is needed temporarily, then particular strategies could be turned on or off
in sequence.
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l The cost of service changes to increase donation frequency should be compared with the cost of
attracting new donors (it was expected that service changes would be more costly) – although attrition
and retention would also need to be considered. Noted that some of the strategies being discussed
might well attract new donors.
l Interest in seeing results for more subgroups, for example nursery donors, different ethnicities.
l Could the choice NHSBT makes be to do nothing? Considered that this might be the most
cost-effective choice, but need to consider what will happen to the blood supply in the future.
Other comments and ideas mentioned:
l Suggested asking ‘how can we reduce the constraints on the donor?’, for example better digital services.
Discussion III: potential future work
The question asked:
l From today, what would your key piece of advice be for NHSBT?
Summary of responses:
l Reduce intervals, if safe to do so.
l Look creatively at recruiting new donors (social media, university recruitment, etc.) and encouraging
them to form the donation ‘habit’; for example, tell donors more about the importance of their blood
at their first donation.
l Related to this – it was felt that there are opportunities to help donors understand more about the
donation process, the testing that is done to donated blood and the reasons that donors may
sometimes be suspended. More knowledge would help donors stay more engaged.
The question asked:
l What questions could be asked by potential future research?
Summary of responses:
l Interested for research to consider travel time in more depth, including understanding how donors’
responses to that attribute were influenced by their current travel time and donation experience,
and the interaction between travel time and switching venues.
l Talk to lapsed donors. Find out more about why they lapsed and what constrains them. Acknowledged
that this is a hard-to-reach group. Related to this – when does someone consider themselves a
‘donor’? How recently do they have to have donated? How can ‘nursery’ donors be converted to
‘experienced’ donors?
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Appendix 18 Costing assumptions
(cost-effectiveness analysis)
Strategy Cost (£) Assumptions and sources
Health report (at a mobile
session)
4.82 Donor–carer time to measure blood pressure 1.5 minutes, costed according
to NHS band 4.62 Multiplier of 1.875 applied to mobile staff to reflect time
spent travelling from the mobile base to mobile venue. Blood pressure
monitor per use £0.006.63 Cholesterol test cost £4.20.66 Clinical follow-up
£0.01 (2% donors assumed require clinical follow-up, a mailed letter at
£0.55)
Health report (at a static
donor centre)
5.34
Static donor centre: session
held on a weekend
19.39 Weighted average of additional staff costs to shift opening hours to a
Saturday or a Sunday.61 Assumed 8.5-hour session, 9.35-hour shift according
to standard staffing levels for an average nine-bed donor centre where
3 units of blood are collected per hour per bed. NHS band 4, £24 per
working hour; band 5, £29.00; band 6, £36.4662
Static donor centre: session
held on a weekend until
8 p.m.
13.07 Staff costs to run an additional session from 9 a.m.–8 p.m. Assumed 12-hour
session, 13.1-hour shift to include 1 hour, which attracts the unsocial hours
payments after 8 p.m. Staffing levels according to an average nine-bed donor
centre where 3 units of blood are collected per hour per bed
Cost to shift mobile session
from weekday to a weekend
9.35 Weighted average of additional staff costs to shift opening hours to a
Saturday or a Sunday.61 Assumed 6-hour session, 9.35-hour shift according
to standard staffing levels for a nine-bed session where 3 units of blood are
collected per hour per bed
Cost to shift mobile session
from a weekday daytime to
weekday 2–8 p.m.
1.43 Additional staff costs to shift opening hours to include 2 hours which attract
the unsocial hours payments after 8 p.m.61 NHSBT data on standard staffing
levels for a nine-bed session where 3 units of blood are collected per hour
per bed
Cost of a deferral because of
low levels of Hb
9.21 Expert opinion (7 minutes of donor–carer time). Includes cost of copper
sulphate test (NHSBT prices 2016/17), HemoCue® machine hire, consumables
and staff time at NHS band 4 costs.62,65 Includes downstream health-care
costs for 7% of low-Hb deferrals who have a Hb of < 12.5 g/dl for men or
< 11.5 g/dl for women (baseline data from INTERVAL trial); GP appointment,
full blood count test, Ferritin test, iron supplements (expert opinion,
50% compliance), 10% assumed to attend outpatient appointment62,66–69
Cost of a deferral for other
reasons (not low levels of Hb)
0.97 Expert opinion (2 minutes of donor–carer time). NHS band 4 costs62
Variable cost per unit (at a
mobile session)
8.59 Includes cost of invitations (2.85 invites per unit of blood collected at
34p each) and the cost of disposables used (1 × copper sulphate test,
1 × preoperative skin preparation, 1 × pack per successful donation= £7.62)
Variable cost per unit
(at a static donor centre)
9.41 Includes cost of invitations (5.3 invites per unit of blood collected at
34p each) and the cost of disposables used as above
Variable cost per unit
including staff costs
(at a mobile session)
35.61 Average variable cost per unit of blood collected by mobile team, according
to NHSBT financial data 2015/16. Includes cost of travel and venue hire
Variable cost per unit
including staff costs
(at a static donor centre)
26.49 Used in sensitivity analysis only. Based on the West End donor centre staff
costs, according to NHSBT financial data 2015/16. Assumes a zero venue cost
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Appendix 19 Calculating incremental costs
Incremental cost per donor = fnUnitsNew × A + (nUnitsNew – nUnitsCurrent) × (B + C)
+ (nLowHbDeferralNew – nLowHbDeferralCurrent) × C
+ (nDeferralOtherNew – nDeferralOtherCurrent) × Dg / nD,
(1)
where:
nD = total number of donors affected by service change,
nUnitsCurrent = number of units of blood collected under status quo,
nUnitsNew = number of units of blood collected under new strategy,
nDeferralOtherCurrent = number of deferrals collected under status quo,
nDeferralOtherNew = number of deferrals collected under new strategy,
nLowHbDeferralCurrent = number of deferrals collected under status quo,
nLowHbDeferralNew = number of deferrals collected under new strategy,
A = variable cost health report,
B = variable cost of collecting blood,
C = variable staff costs at unsocial hours payment rate,
D = variable cost of deferrals because of low levels of Hb, and
E = variable cost of deferrals because of other reasons.
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Search
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval at
static donor centres
nD (n) 781,028 60,640 99,312 646,898 582,910 107,811
nUnitsCurrent (n) 1,779,986 139,037 245,086 1,449,946 1,279,563 268,715
nUnitsNew (n) 1,866,917 170,386 290,358 1,495,514 1,561,653 341,860
nLowHbDeferralsCurrent (n) 80,043 6419 11,287 64,810 57,178 12,459
nLowHbDeferralsNew (n) 83,947 7890 13,434 66,940 69,641 15,859
nDeferralOtherCurrent (n) 116,864 9112 16,043 95,332 83,943 17,596
nDeferralOtherNew (n) 122,628 11,158 18,938 98,325 102,532 22,288
A (£) 4.90 0.00 0.00 0.00 0.00 0.00
B (base case) (£) 31.68 9.41 9.41 35.61 35.61 9.41
B (sensitivity analysis) (£) 34.24 9.41 9.41 35.61 35.61 26.49
C (£) 0.00 19.39 13.07 9.35 1.43 0.00
D (£) 9.21 9.21 9.21 9.21 9.21 9.21
A
PPEN
D
IX
19
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
148
Base-case results
Search
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval at
static donor centres
IncrCostBlood (£) 2,753,974.00 294,988.00 426,007.00 1,622,656.00 10,045,248.00 688,300.00
IncrCostDeferrals (£) 41,544.00 15,53.007 22,583.00 22,527.00 132,817.00 35,869.00
IncrStrategyCost (£) 9,144,160.00 607,844.00 591,701.00 426,055.00 403,390.00 0.00
Incremental cost per donor (£) 15.29 15.14 10.47 3.20 18.15 6.72
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Appendix 20 Cost-effectiveness acceptability
curves comparing each strategy with the relevant
status quo comparator
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FIGURE 31 Cost-effectiveness acceptability curves for each strategy vs. status quo, for all donors.
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FIGURE 32 Cost-effectiveness acceptability curves for each strategy vs. status quo, for black and mixed
black donors.
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FIGURE 33 Cost-effectiveness acceptability curves for strategy 6 vs. status quo, using different sources of data to
predict volume of blood collected.
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Appendix 21 Results of the sensitivity analysis
for the cost-effectiveness analysis
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Sensitivity analysis: assuming no additional capacity to collect more blood at donor centres, for all donors
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.113 0.519 0.455 0.070 0.484 0.678
Incremental cost per donor per
year (£)
15.62 15.21 10.46 3.16 18.12 18.30
Cost per additional unit of blood (£) 138.00 29.00 23.00 45.00 37.00 27.00
Ranking 6 3 1 5 4 2
Number of donors affected by
service change
781,028 60,640 99,312 646,898 582,910 107,811
Incremental units of blood
collected per year across target
population
88,173 31,482 45,233 45,402 282,159 73,121
Incremental costs per year across
target population (£)
12,202,925.00 922,033.00 1,038,921.00 2,041,947.00 10,563,571.00 1,972,727.00
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Sensitivity analysis: assuming no additional capacity to collect more blood at donor centres, for donors with
high-demand blood types
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.100 0.489 0.408 0.030 0.200 0.715
Incremental cost per donor per
year (£)
15.52 14.29 9.34 1.35 7.46 19.23
Cost per additional unit of blood (£) 155.00 29.00 23.00 45.00 37.00 27.00
Ranking 6 3 1 5 4 2
Number of donors affected by
service change
111,948 7965 12,874 94,258 85,075 13,884
Incremental units of blood
collected per year across target
population
11,216 3895 5250 2825 16,973 9920
Incremental costs per year across
target population (£)
1,737,712.00 113,794.00 120,229.00 126,920.00 634,714.00 266,955.00
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Sensitivity analysis: using a two-part model to predict effect of strategies on the volume of blood collected,
for all donors
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.123 0.589 0.543 –0.044 0.543 0.500
Incremental cost per donor
per year (£)
15.93 17.25 12.48 –1.96 20.34 4.95
Cost per additional unit of blood (£) 129.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
781,028 60,640 99,312 646,898 582,910 107,811
Incremental units of blood
collected per year across target
population
96,237 35,708 53,952 –28,265 316,751 53,920
Incremental costs per year across
target population (£)
12,439,540.00 1,045,77.009 1,239,11.009 –1,270,531.00 11,858,679.00 533,669.00
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Sensitivity analysis: using a two-part model to predict effect of strategies on the volume of blood collected,
for donors with high-demand blood types
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.107 0.579 0.506 –0.085 0.508 0.546
Incremental cost per donor
per year (£)
15.73 16.91 11.58 –3.83 18.99 5.36
Cost per additional unit of blood (£) 147.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
111,948 7965 12,874 94,258 85,075 13,884
Incremental units of blood
collected per year across target
population
12,017 4611 6508 –8036 43,220 7577
Incremental costs per year across
target population (£)
1,760,503.00 134,724.00 149,024.00 –360,833.00 1,615,659.00 74,475.00
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Sensitivity analysis: using a gamma model to predict effect of strategies on the volume of blood collected,
for all donors
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.126 0.515 0.591 0.025 0.584 0.511
Incremental cost per donor
per year (£)
15.97 15.10 13.58 1.13 21.88 5.06
Cost per additional unit of blood (£) 127.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
781,028 60,640 99,312 646,898 582,910 107,811
Incremental units of blood
collected per year across target
population
98,562 31,257 58,725 16,193 340,711 55,114
Incremental costs per year across
target population (£)
12,469,393.00 915,414.00 1,348,863.00 728,565.00 12,755,962.00 545,484.00
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Sensitivity analysis: using a gamma model to predict effect of strategies on the volume of blood collected,
for donors with high-demand blood types
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.120 0.510 0.537 –0.004 0.571 0.578
Incremental cost per donor
per year (£)
16.08 14.90 12.30 –0.19 21.36 5.68
Cost per additional unit of blood (£) 134.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
111,948 7965 12,874 94,258 85,075 13,884
Incremental units of blood
collected per year across target
population
13,431 4061 6916 –392 48,606 8031
Incremental costs per year across
target population (£)
1,800,080.00 118,655.00 158,364.00 –17,553.00 1,817,062.00 78,929.00
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Sensitivity analysis: using data from the ex-INTERVAL SP survey, for all donors
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.129 0.427 0.584 0.131 0.572 1.036
Incremental cost per donor
per year (£)
14.70 12.52 13.41 5.89 21.42 10.25
Cost per additional unit of blood (£) 114.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
781,028 60,640 99,312 646,898 582,910 107,811
Incremental units of blood
collected per year across target
population
101,046 25,919 57,990 84,663 333,469 111,665
Incremental costs per year across
target population (£)
11,483,870.00 759,044.00 1,331,942.00 3,808,253.00 12,484,405.00 1,105,397.00
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Sensitivity analysis: using data from the ex-INTERVAL SP survey, for donors with high-demand blood types
End point
Strategy
1: health report
2: weekend opening
of static donor centres
3: evening opening of
static donor centres
4: weekend opening
of mobile sessions
5: evening opening
of mobile sessions
6: reduce minimum
donation interval
for donors at static
donor centres
Incremental units of blood
collected per donor per year
0.126 0.394 0.487 0.173 0.558 0.989
Incremental cost per donor
per year (£)
14.53 11.51 11.15 7.76 20.85 9.72
Cost per additional unit of blood (£) 116.00 29.00 23.00 45.00 37.00 10.00
Ranking 6 3 2 5 4 1
Number of donors affected by
service change
111,948 7965 12,874 94,258 85,075 13,884
Incremental units of blood
collected per year across target
population
14,059 3137 6269 16,293 47,450 13,729
Incremental costs per year across
target population (£)
1,626,856.00 91,661.00 143,570.00 731,828.00 1,773,758.00 134,969.00
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Sensitivity analysis: using estimate of effect of reducing the minimum
interval between donations from the INTERVAL trial
End point
Strategy 6: reduce minimum donation
interval for donors at static donor centres
Incremental units of blood collected per donor per year 0.62
Incremental cost per donor per year (£) 6.71
Cost per additional unit of blood (£) 11.00
Number of donors affected by service change 107,811
Incremental units of blood collected per year across target population 66,789
Incremental costs per year across target population (£) 723,827.00
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